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ABSTRACT  
 Obesity is a worldwide epidemic accompanied by multiple comorbidities.  
Bariatric surgery is currently the most efficient treatment for morbid obesity and its 
comorbidities.  The etiology of obesity is unknown, although genetic, environmental, and 
most recently, microbiome elements have been recognized as contributors to this rising 
epidemic.  The role of the gut microbiome in weight-loss or weight-gain warrants 
investigation, and bariatric surgery provides a good model to study influences of the 
microbiome on host metabolism.  The underlying goals of my research were to analyze 
(i) the factors that change the microbiome after bariatric surgery, (ii) the effects of 
different types of bariatric surgeries on the gut microbiome and metabolism, (iii) the role 
of the microbiome on the success of bariatric surgery, and (iv) temporal and spatial 
changes of the microbiome after bariatric surgery.   
Roux-en-Y gastric bypass (RYGB) rearranges the gastrointestinal tract and 
reduces gastric acid secretions.  Therefore, pH could be one of the factors that change 
microbiome after RYGB.  Using mixed-cultures and co-cultures of species enriched after 
RYGB, I showed that as small as 0.5 units higher gut pH can aid in the survival of acid-
sensitive microorganisms after RYGB and alter gut microbiome function towards the 
production of weight loss-associated metabolites.   By comparing microbiome after two 
different bariatric surgeries, RYGB and laparoscopic adjustable gastric banding (LAGB), 
I revealed that gut microbiome structure and metabolism after RYGB are remarkably 
different than LAGB, and LAGB change microbiome minimally.  Given the distinct 
RYGB alterations to the microbiome, I examined the contribution of the microbiome to 
weight loss.  Analyses revealed that Fusobacterium might lessen the success of RYGB by 
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producing putrescine, which may enhance weight-gain and could serve as biomarker for 
unsuccessful RYGB.   
Finally, I showed that RYGB alters the luminal and the mucosal microbiome.  
Changes in gut microbial metabolic products occur in the short-term and persist over the 
long-term.  Overall, the work in this dissertation provides insight into how the gut 
microbiome structure and function is altered after bariatric surgery, and how these 
changes potentially affect the host metabolism.  These findings will be helpful in 
subsequent development of microbiome-based therapeutics to treat obesity.  
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CHAPTER 1 
INTRODUCTION AND SIGNIFICANCE 
1.1 Obesity pandemic and bariatric surgery as a management strategy 
Defined as body mass index (BMI) of 30 kg/m2 or higher, obesity is a condition 
that affects multiple organs and causes severe health issues in children and adults.  
Comorbidities of obesity can be physiological or psychological and range in severity 
from depression to diabetes, hyperlipidemia, hypertension, and increased risks of cancers 
and strokes (Musich et al., 2016).  Obesity-related diseases escalate obesity to an 
expensive health condition: obese individuals incur ~US$1500 higher annual medical 
expenses than normal weight individuals (Musich et al., 2016).   
A global rise in obesity rates, especially in developed countries such as U.S.A., 
has boosted research into its etiology and treatment.  Obesity is often been associated 
with an imbalance between energy intake and energy expenditure (Serra-Majem et al., 
2013).  However, this over-simplified definition has been abandoned due to recent 
evidence showing that behavioral, neurological, hormonal, and genetic factors contribute 
to the development of obesity and related disorders (Mitchell & Shaw, 2015).  More 
recently, the gut microbiota has shown to be a contributing factor to the development of 
obesity (Ley et al., 2005; Turnbaugh et al., 2006).   
A number of diet, fitness, and behavioral improvement programs have been 
developed for the management of obesity and diabetes (Yumuk et al., 2015).  However, 
these strategies have limited success, especially on morbidly obese individuals with BMIs 
>40 (Buchwald & Oien, 2013).  Bariatric surgery is currently considered the most 
   2
effective treatment for morbid obesity (Buchwald & Oien, 2013; Dixon, Zimmet, Alberti, 
Rubino, & Int Diabet Federation Taskforce, 2011).  Numerous open and laparoscopic 
bariatric surgeries are available, with Roux-en-Y gastric bypass (RYGB), vertical sleeve 
gastrectomy (VSG), and adjustable gastric banding (LAGB) being the most commonly 
performed surgeries (Buchwald & Oien, 2013).  LAGB and VSG are restrictive surgeries, 
which limit food intake by decreasing the stomach size, but leave the digestive system 
otherwise intact.  RYGB is considered a restrictive and malabsorptive process (Aron-
Wisnewsky, Dore, & Clement, 2012).  RYGB reduces the size of the gastric pouch, 
bypasses the duodenum, reduces acid secretions, and rearranges the gastrointestinal tract 
(Aron-Wisnewsky, et al., 2012).   
In general, RYGB patients experience higher weight loss and remission of 
metabolic syndrome versus LAGB patients (Carlin et al., 2013).  Researchers have 
proposed that the gut microbiome is modified due to altered gastrointestinal tract 
anatomy after bariatric surgery (Tremaroli et al., 2015; Zhang et al., 2009), and it was 
demonstrated in mice that these changes have an important effect on the surgery’s 
success (Liou et al., 2013).   
1.2 Introduction to the gut microbiome world 
The trillions of microorganisms inhabiting our guts have many functions; they 
produce vitamins or metabolites that act as signaling molecules to the brain and convert 
undigested food into energy resources (Macfarlane & Macfarlane, 1997; Neuman, 
Debelius, Knight, & Koren, 2015).  With recent developments in 16S rRNA gene 
fingerprinting technologies, metabolomics, cultivation of previously “uncultivable” 
microorganisms, and bioinformatic tools, microbiome researchers are able to deeply 
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characterize microbe-host related health conditions.  With the initiation of the Human 
Microbiome Project, the gut microbiomes of healthy (Peterson et al., 2009) and 
unhealthy humans have been characterized, including disorders such as diabetes (Cani et 
al., 2007), obesity (Ley, et al., 2005), autism (Kang et al., 2013, Hsiao et al., 2013), and 
irritable bowel syndrome (Wu, Bushmanc, & Lewis, 2013).   
Host-microbe energy balance studies have demonstrated several important 
findings:  1) Microbiome composition differs between obese and lean hosts (Ley, et al., 
2005).  2) Microbes can regulate host fat storage (Backhed et al., 2004) and are involved 
in weight loss (Turnbaugh, et al., 2006).  3) Microbes can also transmit host phenotypes 
(Tremaroli, et al., 2015).  More recently, microbiome research has evolved to identify 
causative interactions between the microbiome and host metabolism.  With these new 
findings, the microbiome’s role on host energy regulation has been expanded from 
energy extraction to hormonal and neurological regulation as well as changes in circadian 
rhythms and mood.  Knowing that bariatric surgeries induce hormonal, neurological, and 
behavioral changes on hosts, it is crucial to understand the relationship between 
microbiome after RYGB and weight loss, remission of metabolic syndrome, and quality 
of life improvements.  
 1.3 Dissertation framework  
Recent studies interrogating the human gut microbiome suggest that the gut 
microbiota play a significant role in the regulation of host metabolism.  Many of the 
findings have been attained from animal studies and do not completely translate to the 
human metabolism.  Bariatric surgery serves as an invaluable model for gut microbiota 
and host energy metabolism studies as it imposes drastic temporary or permanent 
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environmental changes on microbiota.  Diet and other environmental factors change 
considerably after bariatric surgery, and this needs to be considered for better 
understanding of the factors that lead to successful and sustained weight loss post 
surgery.  Therefore, the underlying hypothesis for my research is that bariatric surgery 
imposes changes on the environmental conditions in the gut, altering the host-
microbiome and contributes to energy metabolism.  I pursued four major research goals 
to address my hypothesis: 1) determine differences in microbiome and metabolism after 
Roux-en-Y gastric bypass and Laparoscopic Adjustable Gastric Banding (LAGB); 2) 
identify microbial signatures of successful RYGB surgery; 3) evaluate spatial and 
temporal changes in the microbiome and metabolism after RYGB surgery; and 4) 
characterize microbial response to environmental changes due to alterations in gut pH 
similar to those that happen after RYGB.   
To accomplish these goals, I applied integrative molecular, microbial, and 
ecological approaches.  Below, I provide a brief summary of the organization of each 
chapter.  
Chapter 2.  Before addressing the research questions, I present a detailed 
background on microbiome research in the context of obesity, weight loss, and bariatric 
surgery.  This chapter provides a comprehensive literature review on the microbiome in 
obese and post-bariatric surgery patients, the role of microbiome on host energy 
regulation, methods to study microbiome structure and function, and factors that 
influence microbiome structure and function. 
Chapter 3.  RYGB surgery alters gastrointestinal anatomy and imposes 
environmental changes on gut microorganisms.  One environmental change is increased 
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gastrointestinal pH due to a reduction in gastric acid secretions.  An increased pH can 
change microbial community dynamics, enabling the survival of acid-sensitive bacteria.  
An altered microbial community can perform modified microbial reactions, especially 
fermentation.  Hence, pH is crucial for the understanding of microbial outcomes after 
RYGB surgery.  Another variable is the delivery of different carbon sources to the colon.  
To tackle this research goal, I developed enrichment cultures from a fecal sample 
collected from a healthy individual.  I exposed the cultures to different pH conditions.  
For each pH condition, I tested the secondary effects of the carbon source on the 
microbial community structure and fermentation pathways by tracking microbiome 
composition using16S rRNA gene and fermentation end products in each enrichment 
culture.  I assessed how small changes in initial pH and carbon type altered microbial 
community dynamics and interpreted those changes as a possible outcome of RYGB 
surgery.  
Chapter 4.  As shown in chapter 3, pH is an important environmental factor that 
controls the metabolic interactions among the gut microbial species.  pH inhibition or aid 
of certain gut species can have fundamental impact on the metabolic outcome of the 
microbial processes.  Based on the observations from chapter 3, I investigated the impact 
of pH on microbial interactions using pure cultures of Veillonella dispar, Bacteroides 
thetaiotaomicron, and Streptococcus salivarius.  By tracking down growth and 
metabolism of these monocultures and under various co-culture scenarios, I investigated 
the impact of pH-driven metabolic partnerships, especially as they relate to lactate 
metabolism.   
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Chapter 5.  RYGB and LAGB are two commonly performed bariatric surgeries 
for treatment of morbid obesity.  LAGB surgery is relatively unsuccessful compared to 
RYGB.  While changes in gut microbiota structure and metabolism after RYGB surgery 
have been established in small cohorts for humans and animals, and altered microbiota 
after RYGB has been shown to enhance weight-loss in mice studies. On the other hand, 
gut microbiota changes post-LAGB surgery has not been reported.  I hypothesized that 
RYGB imposes greater changes on the microbiome than LAGB, and this is one of the 
reasons why RYGB is more successful than LAGB.  I provide a holistic approach to 
addressing this hypothesis by integrating microbiota diversity, metabolites, and clinical 
data into an analysis of variations between normal weight, obese, post-RYGB, and post-
LAGB subjects.  I analyzed fecal microbiota composition and diversity to establish 
differences between LAGB and RYGB microbiota.  I correlate the abundance of several 
fecal metabolites with the microbiota in surgical weight loss groups.  Finally, I discuss 
the microbiome and fecal fatty acid data in the scope of clinical data that we collected 
including diet, exercise and weight loss of the subjects.  I show that changes in the 
microbiome after RYGB are due to the surgical intervention rather than changes in the 
lifestyle of the subjects.   
Chapter 6.  RYGB surgery patients experience varying success rates after 
surgery.  RYGB patients harbor different gut microbiota than obese and lean people; 
however, the structure of the microbial community and how it affects long-term surgical 
success are unknown.  Some microbial metabolites have long been associated with host 
energy metabolism.  Therefore, the RYGB-altered gut microbiota might enhance weight 
loss via production of specific metabolites.  Here, I hypothesize that some microbiota-
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specific metabolites are responsible for successful and sustained weight loss after RYGB 
surgery.  For this research goal, I divided the RYGB population into successful and 
unsuccessful groups using three approaches: 1) greater or less than 20% weight regain, 2) 
2-means clustering based on their excess weight loss percentages and, 3) greater or less 
than 85% maximum excess weight loss percentage.  I investigated the gut microbial 
ecology in successful and unsuccessful subjects and analyzed global metabolomics data 
to identify possible biomarkers specific to successful RYGB surgery.  
Chapter 7.  RYGB is a non-reversible surgery, which can have long-term impacts 
on patients’ life styles and metabolisms.  Patients often experience drastic weight loss in 
the first few months following surgery but regain some weight over the long-term.  The 
microbiota’s roles in long-term, successful weight loss and weight management 
following bariatric surgery are unknown.  Moreover, microbiota studies rely heavily on 
luminal samples, with changes in the microbiota at mucosal surfaces after bariatric 
surgeries being unknown.  In this chapter, I presented the results of longitudinal changes 
in the microbiota after RYGB surgery in mucosal and luminal surfaces.  Moreover, my 
comprehensive analysis on fecal metabolome that includes soluble and non-soluble 
metabolites in addition to fecal bile acids provide a deeper understanding to sustained 
changes in gut microbiome and metabolome after RYGB surgery in connection to weight 
loss.  
Chapter 8.  This chapter summarizes the key findings of the research chapters 3-
7 and provides recommendations for future studies to enhance the understanding of 
microbe-host interactions and microbiome mediated host metabolism regulation. 
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CHAPTER 2 
BACKGROUND ON OBESITY, MICROBIOME, AND BARIATRIC SURGERY 
2.1 Obesity  
Obesity is a worldwide problem that affects millions of individuals (Roth et al., 
2009), and is of a great concern because of it is associated with multiple comorbidities 
that lead to metabolic syndrome (Ali et al., 2006).  Obesity develops as a result of an 
imbalance between energy intake and energy expenditure (Roth et al., 2009).  Even 
though the origins of obesity are unknown, factors such as host genetics, dietary habits, 
host psychology and sedentary lifestyle are known to contribute to the development of 
obesity (Nieuwdorp et al., 2014).  Additionally, microorganisms that reside in the human 
gut, “the gut microbiota”, have been proposed as one of the factors that control obesity 
(Turnbaugh et al., 2006).  This chapter summarizes current findings related to: 1) 
microbiota implicated in host energy balance, and development of obesity and 2) 
approaches to study the gut microbiota, 3) factors affecting gut microbiome, and 4) 
microbiota related weight loss and weight gain mechanisms.  
2.2 Discovery of microbiome as a potential regulator of human energy balance 
2.2.1 Increasing recognition of host - microbiota symbiosis in the development of obesity  
The interactions between the host and gut microbiota are often mutualistic:  the 
host provides nutrients and space to live to the microbiota (Macpherson & Harris, 2004), 
and, in return, microbiota support the host health with various functional interactions 
(Tremaroli & Backhed, 2012).  For instance, the microbiota prompt a healthy immune 
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response (Round & Mazmanian, 2009), metabolize drugs (Xu et al., 2007), provide 
energy sources to colonocytes (Pryde et al., 2002), produce bioactive molecules such as 
vitamins (Sekirov et al., 2010), hydrolyze indigestible dietary components (Sekirov et al., 
2010), and contribute to the host energy metabolism (Tremaroli & Backhed, 2012).  
Additionally, the gut microbiota preserve the healthy function of the gut by competing for 
food and space with intruder microorganisms (Macpherson & Harris, 2004).  
In the context of obesity and its comorbidities such as diabetes, disruption of 
symbiosis between the host and gut microbiota could be an important contributor to 
energy expenditure.  The gut microbiota’s role on energy balance has been studied 
extensively in the past 10 years, and microbially enhanced energy harvest has been 
proposed to occur by multiple mechanisms summarized here: 1) microbiota hydrolyze 
undigested polysaccharides and increase bioavailable energy (Wolf, 2006), 2) microbiota 
produce short chain fatty acids, mainly acetate, propionate and butyrate; these can be 
readily absorbed by the host (Turnbaugh et al., 2006) and serve as signaling molecules to 
receptors in the gut or brain (Lin et al., 2012), and 3) microbiota are involved in hormone 
regulation pathways (Lin et al., 2012, Yano et al., 2015).  
2.2.2 Animal models show causality for body weight regulation 
 
Human studies exhibit two important challenges that can hinder isolation of cause 
and effect relationships between the microbiota and body weight regulation.  The first 
challenge is the inter-individual variations in host genetics and metabolism, and the 
second one is the difficulty to control environmental variables such as diet and exercise.  
Animal models, especially gnotobiotic mice models provide an opportunity to test 
mechanistic hypotheses (Thi Loan Anh et al., 2015); they provide a platform for gut 
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microbiota study designs with less inter individual variability and strict control of 
environmental and dietary variables such as identical food intake, and homogeneous 
genetic background (Spor et al., 2011).  Moreover fecal transplants to gnotobiotic 
animals have facilitated the translation of microbiota’s potential impact on host energy 
metabolism (Turnbaugh et al., 2006).  Furthermore, gnotobiotic animal studies allow 
researchers to study the effect of specific microbes on host body weight one at a time or 
in specific important combinations.  
Microbiota’s role on energy metabolism can occur in two directions: weight gain 
and weight loss.  Some studies that focus on weight gain include co-habitation of the 
gnotobiotic mice gut with specific microorganisms and fecal transplantations to prove 
specific hypothesis. For example, cohabitation of a fermenter (Bacteroides 
thetaiotaomicron) with a methanogen (Methanobrevibacter smithii) in the mice gut 
increased dietary energy extraction (Samuel & Gordon, 2006).  In another case, absence 
of one specific type of microorganism, Christensenella minuta, in the mice gut showed 
increased weight gain due to altered microbial community dynamics (Goodrich et al., 
2014).  Fecal transplants to mice provided scientific proof that microorganisms can 
increase the host’s energy intake. For instance, fecal transplantation from conventionally 
raised mice to gnotobiotic mice increased body weight and liver adiposity (Backhed et 
al., 2004).  Moreover, in a later study, when the transplantation was performed from 
obese humans to lean mice, an increase in mice body weight and adiposity was observed 
due to increased dietary energy harvest (Turnbaugh et al., 2006). Later research also 
showed that increased adiposity after fecal transplantation to mice correlated with the 
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abundance of endotoxin producing bacteria in the colon (Everard et al., 2013, Fei & 
Zhao, 2013), and this finding further strengthen the microbiota.  
On the other side of the energy balance equation, fecal transplantation studies also 
showed the microbiota’s potential to initiate weight loss in mice.  For instance, transfer of 
microbiota from mice that had bariatric surgery (Roux-en-Y Gastric Bypass) to 
gnotobiotic mice resulted with decreased body weight and adiposity (Liou et al., 2013). 
As a result, the RYGB-recipient mice produced higher propionate in comparison to 
acetate compared to the controls, these metabolic changes as a result of the fecal 
transplantation indicated causality (Liou et al., 2013).  The uses of gnotobiotic animals 
and their colonization with microbiota from humans or animals with different metabolic 
types have strengthened the acceptance of the microbiota’s role in host weight regulation. 
2.2.3 Human studies on the regulation of the microbiome 
Animal studies provide mechanistic insights into the microbial regulation of host 
energy balance.  However, they provide limited representation of the human metabolism 
due to physiological differences including the anatomy of the gastrointestinal tract (Thi 
Loan Anh et al., 2015).  Human gut microbiota studies grant indispensable medical 
translational power.  Initial studies done on human microbiota structure based on 16S 
rRNA gene and metagenome sequencing analyses showed that obese and lean individuals 
have different proportions of the two most abundant phyla of the human gut: Firmicutes 
and Bacteroidetes, and their associated genes (Ley et al., 2006, Turnbaugh et al., 2009).  
However, soon after Duncan et al. (2008) described how environmental factors 
contributed to the abundance of these phylotypes more than the body type (Duncan et al., 
2008), and many studies reported contradictory Bacteroidetes/Firmicutes ratios in obese 
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and lean populations (Armougom et al., 2009, Schwiertz et al., 2009, Walters et al., 
2014).  
Environmental factors that affect microbiota in humans include, but are not 
limited to: diet, exercise, and host genetics.  Diet has been shown to influence the gut 
microbiota more than the metabolic type or body mass index (Ley et al., 2006).  Weight 
loss diets that have higher protein to carbohydrate ratio decrease the abundance of 
Firmicutes in the obese individuals (Duncan et al., 2008).  Additionally, Jumpertz et al. 
showed that a decrease in nutrient load led to 20% increase in Bacteroidetes and decrease 
in Firmicutes relative abundance in lean and obese individuals (Jumpertz et al., 2011).  
On the other hand, a meta-analysis of the gut microbiota in an obesity study revealed that 
Bacteroidetes species are linked to weight loss independent of diet and body type 
(Angelakis et al., 2012).   
Besides diet, an exercise based weight-loss strategy in adolescents correlated with 
higher Bacteroides and lower Clostridium levels (Santacruz et al., 2009).  Human 
genetics and genetic variations observed in obese populations also have been linked to 
changes in the gut microbiota (Ley, 2015).  A gene polymorphism, peroxisome 
proliferator-activated receptor γ2 (PPAR-γ2) gene, observed in obese individuals was 
negatively correlated with Bacteroides abundance (Zuo et al., 2011).  
Human microbiota studies often report contradictory results; however studies with 
proper designs that include dietary control and obesity-related host genotypes would 
strengthen our understanding on the role of microbiota on host energy regulation. 
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2.3 Genetic and environmental factors dictate microbiota structure and function in 
obesity 
As seen in Figure 2.1, genetic and environmental factors have effects on the 
structure of gut microbial communities.  Diets that contain high amounts of fats, and 
antibiotic treatments are known to disturb microbiota structure (Krajmalnik-Brown et al., 
2012).  A healthy microbiota structure can be reestablished by fecal transplantation, 
customized synbiotics (pro- and pre-biotics), and balanced diet that contains high amount 
of fiber (Sonnenburg & Fischbach, 2011).   
Figure 2.1 Genetic and environmental factors control gut microbiota structure. 
2.3.1 Diet is one of the major factors that shape microbiota structure 
Soon after birth, our gastrointestinal tracts receive food and food-associated 
microorganisms. The dietary ingredients are not only fermentation substrates for the 
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colonic microbiota, but also form an inoculum for the gastrointestinal tract (David et al., 
2014). Diet accompanies the development of microbiota during infancy; microbiota 
structure greatly varies among formula-fed and breast-fed infants (Harmsen et al., 2000). 
Introduction of solid food to the diet alters the microbiota and initiates the first 
step to adulthood microbiota (Fallani et al., 2011). Even though microbiota reach a stable 
state at some point in time (Yatsunenko et al., 2012), short-term and long-term dietary 
habits have shown to alter the microbiome (Wu et al., 2011, David et al., 2014). 
David et al. (2014) described how short-term shifts in the diet composition from high 
carbohydrate to high fat changed the microbiota by increasing the abundance of bile 
tolerant Alistipes, Bilophila, and Bacteroides, and reduced the abundance of plant 
polysaccharide degraders such as Roseburia sp., Eubacterium rectale, and Ruminococcus 
bromii (David et al., 2014).  High fat diets change the microbiota by increasing the 
amount bile acids delivered to the colon (Fava et al., 2013).  Besides dietary fat, proteins 
also rapidly change the microbiota (David et al., 2014).  Apart from the composition of 
the diet, short-term changes in caloric intake also showed rapid and drastic changes in 
microbiota composition (Jumpertz et al., 2011).  An increase of 1000 kcal/day in the diet 
was associated with 20% increase in Firmicutes and increased energy harvest from the 
diet (Jumpertz et al., 2011).  
Besides short-term dietary changes, long-term dietary patterns also shape the gut 
microbiota.  Duncan et al. (2008) showed that a four-week consumption of high-protein 
low-carbohydrate diet decreased the abundance of butyrogenic microorganisms as well as 
Bifidobacterium (Duncan et al., 2008).  Drastic differences in the diet of children in 
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Western and African societies showed that gut microbiota composition varies based on 
diet (De Filippo et al., 2010).   
A diet with high fiber composition correlated with the abundance of cellulose 
degrading Prevotella and Xylanibacter (De Filippo et al., 2010).  Dietary fiber fosters 
abundance of microorganisms, microbial interactions including synthrophies, and 
metabolic outcomes such as butyrate production for healthy colons (Fischbach & 
Sonnenburg, 2011).  
Changes in the diet not only change the microbial structure, but they also affect 
microbial functions, such as amounts and types of short chain fatty acids that are 
produced (Fava et al., 2013).  For instance, David et al. (2014) reported that isovalerate 
and isobutyrate were more abundant in the feces of a group of humans consuming an 
animal based diet whereas acetate and butyrate were more abundant in a group of humans 
consuming a plant based diet.   
2.3.2 Bariatric surgery alters the microbiome in an irreversible way 
Diet, exercise, and weight loss drugs often fail to provide sufficient weight loss 
for morbidly obese individuals (Body mass index > 40) (Blackburn, 2005).  Bariatric 
surgery procedures are currently the most efficient management strategy of obesity and 
its comorbidities (Aron-Wisnewsky et al., 2012).  The bariatric surgeries mechanism of 
action can be restrictive, hormonal, behavioral, and malabsorptive (Blackburn, 2005).  As 
shown in Figure 2.2, laparoscopic gastric banding (LAGB) and vertical sleeve 
gastrectomy (VSG) are restrictive surgeries; biliopancreatic diversion (BPD) is a 
malabsorptive surgery, whereas Roux-en-Y gastric bypass (RYGB) is restrictive and 
malabsorptive (Aron-Wisnewsky et al., 2012).   
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Figure 2.2.  Gut physiology after two commonly performed bariatric surgeries: LAGB 
and RYGB.  
 
Physiological and anatomical changes due to bariatric surgery procedures result in 
changes in gut microbiota (Zhang et al., 2009, Furet et al., 2010, Aron-Wisnewsky et al., 
2012).  Those changes include, but are not limited to: bile flow, colonic pH, vagal 
modulation, enteric and adipose tissue hormones, flow of nutrients and quantities of 
nutrients delivered to the colon (Li et al., 2011).  To date, alterations in the microbiota 
after RYGB surgery in animals (Li et al., 2011, Liou et al., 2013, Osto et al., 2013) and 
in humans (Zhang et al., 2009, Furet et al., 2010, Graessler et al., 2013, Kong et al., 
2013) have been documented.  Changes in the microbiota of rats were also documented 
for the VSG surgery (Ryan et al., 2014).  For both types of surgeries, increases in 
Gammaproteobacteria and Verrucomicrobia species in the gut were observed (Zhang et 
al., 2009, Liou et al., 2013, Ryan et al., 2014).  Those differences in the microbiota 
structure did not bring the microbiota from obese to normal weight states (Liou et al., 
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2013), in fact resulted in microbiomes that were distinct from the microbiomes of 
metabolic types (Zhang et al., 2009).   
Fecal transplants from post-RYGB surgery animals to germ-free animals reduce 
body weight and adiposity (Liou et al., 2013).  The study published by Liou et al., (2013) 
provided the first line of evidence that transmissible post-RYGB microbiota can lead to 
weight loss and to reduction of body fat.  Even though this finding is promising, more 
studies are needed to identify which microorganisms or microbial consortia that develops 
after bariatric surgery lead to weight loss or remission of metabolic syndrome.  
Identifying microbiota that are responsive to the successful surgery can enhance the 
understanding of microbiota related weight loss.  Moreover, microbiota of other bariatric 
surgery procedures that initiate weight loss as well as resolution of the metabolic 
syndrome requires further evaluation.  Identification of microorganisms or microbial 
consortia, and their mechanisms of action could eliminate the need of bariatric surgery 
for morbid obesity.    
2.3.4 Host genetics might have a role on regulations of the microbiome 
Variations in diet, lifestyle, and genetics make it difficult to distinguish 
microbiota’s contribution to the host energy balance.  Among these factors, host genetics 
have been shown to influence gut microbiota composition (Spor et al., 2011).  When gut 
microbiota structure of more than 500 individuals were investigated using beta diversity 
metrics, host genetics were an important clustering factor of the microbiota: twins had the 
most similar microbiota (Peterson et al., 2009, Yatsunenko et al., 2012), and individuals 
from the same families had closer microbiota structure to each other than to the unrelated 
individuals (Yatsunenko et al., 2012).   
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The effects of host genome on gut microbiota structure were previously 
speculated.  One hypothesis is that twins or siblings are often subjected to similar 
environmental exposures/diets; therefore, they develop similar microbiota structures 
(Turnbaugh et al., 2009).  Another view is that expression of host genes can change the 
environment for microorganisms, and therefore, the microbiota structure (Spor et al., 
2011).  Host genes can control a single species or a group of taxa and can have putative 
pleiotropic effect on groups of microorganisms (Benson et al., 2010).  Animal models 
have successfully shown that single-nucleotide polymorphisms (SNPs) on the host 
genome results with different microbiota structure compared to the wild type animals 
(Spor et al., 2011).  For instance, mice deficient in Toll like receptor 5 developed 
metabolic syndrome and experienced reduced levels of Bacteroidetes in the colon (Vijay-
Kumar et al., 2010).  
2.3.5 Antibiotics can shape microbiome in early age and adulthood 
Widespread use of antibiotics has been associated with the development of many 
health conditions such as asthma (Russell et al., 2012) and diarrhea (Young & Schmidt, 
2004).  Short-term or long-term alterations in the gut microbiota structure due to the use 
of antibiotics have been previously reported (Jernberg et al., 2007, Antonopoulos et al., 
2009, Dethlefsen & Relman, 2011, Elena Perez-Cobas et al., 2013).  Even though the 
dominant members of the microbiota recovered from the antibiotic treatment within 
weeks, some minor members often disappeared (Dethlefsen et al., 2008).   
Antibiotics are considered as one of the environmental factors that contribute to 
human energy metabolism due to the use of antibiotics as growth promoters in the animal 
husbandry (Angelakis et al., 2012).  Due to variations in the mode of actions of 
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antibiotics and differences in the target microorganisms, the effects of antibiotics on the 
microbiota associated host metabolism have showed results.  While some studies reported 
increased body weight (Thuny et al., 2010, Angelakis et al., 2012), some others reported 
a decrease in body fat (Cani et al., 2008).  
Exposure to antibiotics such as amoxicillin, clarithromycin, vancomycin, and 
erythromycin was associated with childhood (Azad et al., 2014, Bailey et al., 2014) and 
adulthood (Thuny et al., 2010, Angelakis et al., 2012) obesity, and even though the 
mechanisms of action are unknown, these antibiotics are known to be more efficient in 
the treatment of infections due to Gram-positive bacteria.  On the other hand, mice 
models have shown that antibiotic treatment can protect against obesity and adiposity 
(Cani et al., 2008).  Antibiotics that are efficient against Gram-negative bacteria have 
shown that, lipopolysaccharides produced by Gram-negative bacteria initiate metabolic 
endotoxemia, which leads to increased inflammation and adiposity (Cani et al., 2008, 
Everard et al., 2013).   
2.4 Insights into microbial mechanisms that control host energy balance 
Microorganisms that reside in the human intestines contribute to host energy 
balance in multiple ways:  they increase the energy harvest (Turnbaugh et al., 2006), 
regulate the energy intake via production of hormones and neurotransmitters that are 
relevant to the appetite (Clarke et al., 2014), alter bile acid metabolism (Nieuwdorp et al., 
2014), and interact with the host at the epithelial surfaces (Nieuwdorp et al., 2014).  
These processes are illustrated in Figure 2.3.   
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Figure 2.3 Gut microbiota interacts with the host at multiple levels.  Interactions between 
the host and gut microbiota regulate host metabolism.  Modified from Krajmalnik-Brown 
et al., 2012.  
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Genomes of many gut microbes contain genes such as glycoside hydrolases that 
are essential to break down many plant polysaccharides such as arabinose, xylan, and 
pectin (Gill et al., 2006).  By converting otherwise energy-neutral complex nutrients into 
short chain fatty acids, the microbiome can increase energy extraction from the diet 
(Krajmalnik-Brown et al., 2012).  Besides increased energy harvest from the nutrients, 
gut microbes have shown to interfere with the absorption of digested nutrients (Jumpertz 
et al., 2011).   
Acetate, butyrate, and propionate are the major microbially produced short chain 
fatty acids (SCFAs) (Macfarlane & Macfarlane, 1997).  Gut bacteria also produce minor 
SCFAs: isobutyrate and isovalerate, gases (H2, CO2, and CH4 etc.), and vitamins 
(Macfarlane & Macfarlane, 1997).  Figure 2.4 demonstrates the stoichiometry of these 
reactions.  Hydrogen generation during fermentation, especially during acetate generation 
reactions, might have implication on overall SCFAs balance (Krajmalnik-Brown et al., 
2012).  For instance gnotobiotic mice experiment has shown that co-culturing mice gut 
with fermenter Bacteroides thetaiotaomicron and hydrogen-consumer 
Methanobrevibacter smithii increased total acetate production by removing hydrogen, 
which limits acetate production (Samuel & Gordon, 2006).   
Once SCFAs are absorbed and reach to the blood stream, they can be stored in the 
liver or adipose tissue; therefore, they can contribute to energy harvest.  SCFAs can also 
signal many receptors that are involved in energy regulation such as G protein coupled 
receptors (GPRs): GPR41 and GPR43 (Tazoe et al., 2008).  Propionate and, to a lesser 
extent, butyrate can regulate weight-loss hormones, such as glucagon-like peptide-1 
(GLP-1), and both were shown to protect against obesity (Lin et al., 2012).  Besides 
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GLP-1, propionate can induce secretion of appetite-reducing hormone peptide YY (PYY) 
(Chambers et al., 2015).   
Figure 2.4.  Regulation of microbial reactions by hydrogen gas.  (Krajmalnik-Brown et 
al., 2012) 
 
Most recently, it has been shown that microbiota can modulate the bile acid 
receptors: Farnesoid X receptor (FXR) and G-protein coupled receptor TGR5 by 
signaling via transformation of the bile acids (Fiorucci & Distrutti, 2015).  Those 
receptors are involved in regulation of insulin and glucagon secretions (Fiorucci & 
Distrutti, 2015), therefore contribute to host energy metabolism. Increase in activation of 
FXR receptor has been shown to reduction in body weight despite high-fat diet 
(Watanabe et al., 2006).  After vertical sleeve gastrectomy surgery, an increased 
activation of FXR receptor has shown to increase weight loss in mice that were fed high-
fat diet (Ryan et al., 2014).   
Gut microorganisms can also alter amino acids.  It has been shown that gut 
microorganisms can transform amino acids into neuro-transmitting molecules such as 
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serotonin (Clarke et al., 2014).  Serotonin can regulate appetite, stress and depression 
(Halford et al., 2005).  Spore-forming microorganisms have shown to increase serotonin 
production in mice models by signaling enterochromaffin cells that secrete serotonin 
(Yano et al., 2015).   
2.5 Multi-omic approaches to study human microbiome in obesity 
To understand the role of microbiota on host body weight regulation, we need to 
answer two essential questions: who are they and what do they do? Modern technology 
allows us to characterize the microbial community structure and their functions that affect 
the host metabolism by offering novel techniques including metagenomics, 
transcriptomics, and metabolomics (Figure 2.5). These techniques have advantages and 
limitations and I discuss them below as well as the advancements in microbiome era due 
to the initiation of Human Microbiome Project. 
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Figure 2.5.  Illustration of DNA-, RNA-, and metabolite-based approaches to study microbiome host interactions in the 
context of obesity . 
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2.5.1 Human microbiome project – goals and aims  
The human genome project (HGP), aimed to sequence and map all the genes of 
Homo sapiens, brought profound changes to the understanding of the genetic basis for 
some diseases.  Despite its breakthrough, the HGP focused on the human host, and 
excluded our second genome: “the microbiome”.  The human microbiome is composed 
of the genes of the trillions of microorganisms that reside on the surfaces of the human 
body (Relman & Falkow, 2001, Lederberg, 2002).  With the recognition of the host-
associated microbiota’s importance to human health, the National Institute of Health 
(NIH) launched the Human Microbiome Project (HMP).  Two important forces that 
impelled this project were: the lack of studies on microbial genomic compositions of a 
baseline healthy population, and the rapid development of faster and cheaper sequencing 
technologies (Peterson et al., 2009). 
The overarching goals of the HMP were to provide a reliable database of 
microorganisms living in symbiosis with the human host and standard protocols of 
sample preparation, sequencing and data analysis to a broad scientific community 
(Proctor, 2011, Gevers et al., 2012).  In order to achieve its goals, the HMP employed a 
multiple tier approach.  The first stage aimed to sequence 500 new reference bacterial 
whole genomes and 16S rRNA gene of 250 healthy individuals at five anatomical regions 
including the gut (Peterson et al., 2009).  During this phase, metagenomes of the same 
individuals were sequenced and then analyzed with bioinformatic tools to resolve the 
functional potential of the host-associated microbial communities (Peterson et al., 2009, 
Gevers et al., 2012).  The second stage began in 2012, after the completion of the first 
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one, and its main goal is to expand the scope of microbiome sequencing from healthy to 
different disease conditions (Peterson et al., 2009).   
Initial findings of the HMP surprised the scientific community because the human 
microbiome turned out to be unexpectedly diverse in contrast to the human genome 
(Turnbaugh et al., 2007).  Microbiota composition greatly varied among healthy 
individuals, but interestingly enough the microbial metagenomes (based on cataloged 
functions) were similar within populations (Huttenhower et al., 2012).  The HMP 
accomplishments have provided great milestones for molecular, ecological, evolutionary 
and microbiological sciences, in addition to the potential to identify causality of diseases 
that were not traditionally considered of microbial origin. These milestones can 
potentially lead to opportunities to develop personal medicine strategies to modify the 
microbiome for therapeutic purposes.  Because of its high plasticity and potential to be 
modified, the microbiome might have higher therapeutic value than the human genome. 
2.5.2 Who is there: 16S rRNA gene profiling 
 Every bacteria or archaea cell contains at least one copy of the 16S rRNA gene in 
their genomes. The conserved and hypervariable regions of the 16S rRNA gene make it 
as a target for phylogenetic resolution of microbial communities.  Microorganisms can be 
identified and abundances can be estimated by targeting one or a couple of the nine-
hypervariable regions of the 16S rRNA gene (Hamady & Knight, 2009).  There are a 
variety of pre-genomic methods such as denaturing gradient gel electrophoresis, 
fluorescent in situ hybridization (FISH), and sequencing to study microbial communities 
using the16S rRNA gene as a marker (Rittmann et al., 2008), although sequencing is 
currently by far the most feasible technique some of the other mentioned techniques have 
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other advantages such as price and time frames for data generation and analysis.  
Different sequencing platforms such as 454 pyrosequencing, Ion Torrent, and Illumina 
(HiSeq and MiSeq) can be used for sequencing.  Illumina is currently the leading 
sequencing technology due to its short turn-around time, high accuracy, low cost, and 
comparable read lengths to pyrosequencing (Nelson et al., 2014).  
16S rRNA gene profiling of microbial communities in the human gut provides a 
snapshot of the community, taxonomic resolution of uncultivable microorganisms, and 
phylotypes at low abundance including keystone species.  Keystone species are 
organisms that are low in abundance, but have essential functions in their habitats, once 
they are removed from the ecosystem, the ecosystem function gets disrupted (Mills et al., 
1993).   
 16S rRNA gene profiling usually allows identification and a certain degree of 
estimation of the abundance of microorganisms; it can provide comparison of multiple 
microcosms at a time and helps to identify which taxa differentiates microcosms from 
each other (Hamady & Knight, 2009).  In comparison to clone libraries, higher 
throughput 16S rRNA gene sequencing enables researchers to calculate within sample 
diversity (alpha diversity) and between-sample diversity (beta diversity), which provide 
an understanding of differences in microbiota structure and communities based on host-
associated conditions (Lozupone et al., 2012).  Another advantage of high throughput 
16S rRNA gene sequencing is the possibility to predict the microbiota’s potential 
function of using bioinformatic tools that generate metagenomes based on the available 
16S rRNA gene data (Langille et al., 2013).   
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Like every other technology, methods based on the16S rRNA gene have 
limitations; I discuss here four important limitations.  First, although 16S rRNA gene 
databases have been growing exponentially in the last 10 years, they are still incomplete 
and are not sufficient to cover all the human gut associated microorganisms; this leads to 
abundance of many unidentified sequences in most datasets.  Therefore, microorganisms 
with biological importance for the host health can be neglected unintentionally.  Second, 
methods based on the 16S rRNA gene rely on genomic content; this captures the presence 
of microorganisms, but does not capture the activity of microorganisms.  Third, genomes 
of microorganisms vary in their 16S rRNA gene numbers, which makes it difficult to 
estimate absolute number of species.  Fourth, different sample-preparation methods, such 
as DNA extraction; PCR-amplification errors, and biases due to primer selection, can 
yield different results (Ercolini, 2004, Goodrich et al., 2014), which is a common 
limitation for all genomic methods.  
2.5.3 Which activities are taking place? Transcriptomics with RNASeq and gene 
expression assays with quantitative PCR 
DNA based techniques can identify and estimate the relative abundance of 
microorganisms and their genes; however they cannot measure microbial activity. 
Microbial activities can be determined with transcriptomics, which catalogues RNA 
molecules including mRNA, tRNA, and rRNA (Wang et al., 2009) or quantitative PCR 
assays on reverse transcribed mRNA (Rittmann et al., 2008).  In this section, I focused on 
RNA-seq methods rather, than qPCR, since RNA-seq provides a more global approach 
rather than targeted approach.  Among the RNA molecules, mRNA (transcripts) is most 
helpful to microbial ecologist to uncover microbial functions.  Previous studies have 
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shown that RNA-sequencing is currently the most accurate metatranscript quantification 
method, even more than the microarrays (Fu et al., 2009, Wang et al., 2009).  
RNA-seq can reveal some of the activity of the gut microbiota.  Based on a study 
that was performed on fecal samples collected from 10 healthy individuals; carbohydrate 
metabolism and energy production were enriched functions, whereas amino acid and lipid 
metabolisms were underrepresented functions of the microbiota (Jose Gosalbes et al., 
2011).  Fecal transplantation from obese and lean humans to mice revealed that the obese 
and lean associated gut microbiome were enriched in different functions; obese 
microbiota expressed more of amino acid biosynthesis genes and lean microbiota 
expressed more of polysaccharide degradation genes (Ridaura et al., 2013). 
Even though transcriptomics is invaluable for human microbiota studies, the cost 
and challenges of working with RNA have delayed a widespread adaptation of this 
powerful technique to microbial communities that are associated with the human gut.  
These challenges include but are not limited to: 1) the difficulty of microbial mRNA 
isolation from fecal and biopsy samples, 2) fast degradation of microbial mRNAs, 3) the 
differences in sample preservation and extraction methods which greatly influence 
integrity and quantity of the RNA recovered (Xiong et al., 2012), and 4) only small 
fraction (~5%) of the extracted RNA is mRNA; therefore, cumbersome methods are 
required to remove 16S rRNA gene, which hinders mRNA sequencing (Giannoukos et 
al., 2012).  Yet another challenge with RNAseq comes from data analysis.  Most of the 
current bioinformatic tools are designed to handle eukaryotic RNA sequencing data, 
although new bioinformatic tools for microbial RNA are under development (McClure et 
al., 2013).  Microbial functions are important for host health and the development of 
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easier RNA-sequencing methods for sure will aid the identification of novel microbiota 
associated weight loss and weight gain mechanisms.  
2.5.4 What chemicals are being produced? Biochemical views including metabolomics 
Microbially derived metabolites in the human gut serve as communication signals 
between microorganisms and other microorganisms and the host.  Identification and 
quantification of these metabolites, metabolomics or fingerprinting microbial chemical 
outcomes (Marcobal et al., 2013), can contribute to the understanding of 
microorganisms’ importance to the human health (Beckonert et al., 2007), especially in 
the pathophysiology of obesity and diabetes (Calvani et al., 2014).  The most common 
analytical platforms to detect and quantify microbial metabolites in the urine, blood, or 
feces are nuclear magnetic resonance (NMR) spectroscopy and gas/liquid 
chromatography mass spectrometry (LC or GC-MS) (Beckonert et al., 2007, Wikoff et 
al., 2009, Calvani et al., 2014).   
Depending on the hypothesis being tested, global or targeted metabolomics 
approaches can be employed to study gut metabolism with these two platforms.  Global 
approaches capture a broader metabolites range; however they require more 
bioinformatics power (Oresic, 2009).  On the other hand, targeted approaches limit the 
number of metabolites detected, but they provide higher metabolic resolution of a certain 
function, for example metabolites of the bile metabolism (Oresic, 2009). 
Use of metabolomics techniques has brought deeper understanding to the 
microbial regulation of host metabolism.  Comparison of plasma metabolites of 
conventionally raised mice to germ-free mice revealed differences in many microbially 
produced/associated metabolites, especially amino acid metabolism products that are 
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absent in the plasma of germ free mice (Wikoff et al., 2009).  Metabolomics approaches 
also revealed in mice studies that microbial fermentation end products such as propionate 
have the potential to regulate satiety via activation of G protein – coupled receptors 
(Samuel et al., 2008).  Similar results have been reported in humans (Calvani et al., 
2010).  Use of NMR on urine samples collected from obese and lean individuals showed 
many metabolites derived from gut microbiota, including hippuric acid, 2-
hydroxyisobutyrate, and xanthine were able to distinguish obese metabolic type from lean 
metabolic type (Calvani et al., 2010), although a contribution of these metabolites to the 
obesity pathophysiology requires further investigation.  
Microbially derived metabolites have been associated with obesity-linked 
comorbidities.  For instance, identification in humans of microbially produced 
deoxycholic acid (DCA) suggested that the gut microbiota are involved in the 
development of obesity associated liver carcinoma (Yoshimoto et al., 2013).  Production 
of volatile compounds by the gut microbiota was recently associated with the 
development of obesity associated non-alcoholic fatty liver disease (Raman et al., 2013). 
Metabolomics in conjunction with 16S rRNA gene profiling and transcriptomics hold 
great promise to provide the missing link between the gut microbiota and development of 
obesity with its comorbidities.  Optimization of metabolomics techniques as well as a 
reduction in the cost of analysis will greatly enhance microbiome studies by making 
metabolomics more widely available to the scientific community.  
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2.6 Limitations of the current approaches to study microbiota in the context of 
obesity 
2.6.1 Fecal microbiota are not equal to gut microbiota 
Studies of the human gut microbiota frequently are performed on fecal samples 
and less commonly on tissues that are collected during colonoscopy.  Sampling bias is of 
major concern when considering if fecal microbiota is representative of:  1) the 
microbiota of the different parts of the colon (Macfarlane et al., 1992) and 2) the 
microbiota of luminal and mucosal surfaces (Zoetendal et al., 2002).  Other challenges 
with study design include lack of control on fecal-sample preservation and flaws in 
experiment designs that exclude age, diet, and gender matched controls (Goodrich et al., 
2014).  Here, I summarize and discuss biases associated with interpretation of human gut 
microbiota from fecal samples. 
2.6.2 Proximal and rectal colons are different ecosystems 
The limited accessibility of the distal and proximal sections of the human colon 
has forced human gut microbiota research to rely on fecal microbiota analyses.  In 
humans, microbiota associated with different parts of the colon can be studied post-
mortem (Macfarlane et al., 1992) or during colonoscopies (Zoetendal et al., 2002).   
Gastrointestinal samples collected during an autopsy showed that luminal microbiota 
varies along the different colon sections (Hayashi et al., 2005).  The differences are 
possibly due to gradients of substrate concentrations and variations in the environmental 
conditions such as pH and moisture across the colon (Macfarlane & Macfarlane, 1997).   
On the other hand, mucosal microbiota of different colon sections didn’t show 
variation (Zoetendal et al., 2002, Wang et al., 2003).  From a practical standpoint, animal 
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studies or bioreactors that simulate human colon offer the study of both microbiota 
structure and metabolism of different parts of the colon.  For instance, weaned pigs that 
were fed oligosaccharides had different abundance of fermentation end products and 
higher abundance of Bifidobacterium in the proximal than the distal colon (Tzortzis et al., 
2005).  Reactors that simulate different parts of the colon such as Simulator of Human 
Intestine Microbial Ecology (SHIME), also confirmed that microbiota develop differently 
due to gradient of conditions in the colon (Molly et al., 1994).  
In vitro and in vivo studies have shown that fecal samples are not representatives 
of the proximal colon (Mai & Draganov, 2009).  However, fecal samples are still 
valuable since they collect and carry the microbiota along the GI tract, and they reflect 
changes in the gut microbiota during health or disease states.  Experimental, 
bioinformatic, and mathematical approaches are necessary to better evaluate how fecal 
samples are representative and predict the microbiota of the proximal colon.  
2.6.3 Luminal space and mucosal space are different 
 The human colon offers a number of habitats to microorganisms.  A vertical 
cross section of the colon shows gradient concentrations of oxygen and substrate from 
mucosal to luminal surfaces that may lead to localization of the microbiota (Zoetendal et 
al., 2002).  Due to the decreasing oxygen gradient from mucosal to the luminal surfaces 
(Rabus & Widdel, 1995), mucosal microbiota consist of more oxygen tolerant and 
facultative anaerobe species, while luminal microbiota composes of more strictly 
anaerobic species (Van den Abbeele et al., 2011).   
Besides oxygen, nutrients have defining role on the microbiota structure.  Host 
glycans and dietary polysaccharides are the substrates for mucosal and luminal 
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microbiota, respectively (Van den Abbeele et al., 2011), as shown in Figure 2.6.   
Luminal communities are more susceptible to environmental variables such as pH and 
retention time than the mucosal communities, and these variables can change luminal 
communities rapidly in comparison to mucosal communities (Van den Abbeele et al., 
2011).  
 
 
 
 
 
 
 
 
Figure 2.6.  An illustration of a cross section of a healthy colon with its microbiota.  The 
outer mucus layer and the colon lumen are colonized by different microbiota and 
therefore, produce different metabolic end products.  
 
Contrasts in mucosal and luminal communities facilitate differential roles of 
microbiota.  Mucosal and luminal microbiota have differential roles on host-microbe 
interactions and body homeostasis, as mucosal communities prime the immune system 
and maintain the health of the mucosal layer, whereas luminal microbiota provide 
additional nutrients to the host by fermenting undigested polysaccharides (Van den 
Abbeele et al., 2011).  
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The decision to use luminal or mucosal samples for microbiota analysis should be 
done based on the goals of the study.  For instance, mucosal microbiota are particularly 
important in cases where direct interaction with the microbiota and the host epithelial 
cells or immune system are essential, such as conditions like leaky gut, irritable bowel 
syndrome, and diabetes (Walker et al., 2011).  For dietary modulation studies luminal 
samples might be more representative, since these microbiota are often associated with 
the food particles (Walker et al., 2008).  Due to differences in mucosal and luminal 
microbiota, scientist should be aware that luminal samples do not always represent the 
mucosal microbiota. 
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CHAPTER 3 
PH MEDIATES MICROBIAL AND METABOLIC INTERACTIONS IN FECAL 
ENRICHED COMMUNITIES 
3.1 Introduction 
 
Gut microorganisms use a variety of fermentative pathways to harvest energy, and 
the pathway utilized depends on many factors, including pH and available fermentation 
substrate (Chung et al., 2016; Walker, Duncan, Leitch, Child, & Flint, 2005).  The pH 
varies along the human colon (approximately from 5 to 7) (Evans et al., 1988), with the 
type and abundance of fermentation products, bicarbonate secretion by colonic epithelial 
cells, and nutrients establishing the pH (Fallingborg, 1999; Novak et al., 2011; Nugent, 
Kumar, Rampton, & Evans, 2001).  Many of the dietary nutrients are substrates for 
microbial metabolism, such as oligosaccharides or simple sugars, and they have an 
impact on pH as they promote acid production via fermentation (Campbell, Fahey, & 
Wolf, 1997).  Colonic pH along with gut microorganisms deviate from normal during 
gastrointestinal diseases or conditions such as colorectal cancer (Ohigashi et al., 2013), 
inflammatory bowel disease (Nugent et al., 2001), and constipation (Camilleri et al., 
2010).  Exogenous factors such as use of a proton pump inhibitor (William & Dangizer, 
2016) and bariatric surgery (Li et al., 2011) also alter gut pH.  It is likely that an 
abnormal pH in the gut can alter microbiota composition and its metabolism (Kassinen et 
al., 2007; Li et al., 2011).  
pH imposes selective pressure on microbial growth and metabolism.  While some 
bacteria, such as in Bacteroides, can grow over a wide range of pH values (Sylvia H. 
Duncan, Louis, Thomson, & Flint, 2009), others, such as in Veillonella and 
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Streptococcus, are inhibited by acidic pH (Bradshaw & Marsh, 1998), although some 
species from these genera can thrive in acidic pH (Bradshaw & Marsh, 1998).  
Furthermore, pH is an important determinant of the distribution of major fermentation 
end products.  For example, butyrogenic reactions occur at mildly acidic pH (Walker et 
al., 2005), propionate production often occurs at neutral pHs (Belenguer et al., 2007), and 
acetogenic reactions occur at various pHs depending on the microbial species producing 
it (Belenguer et al., 2007).  These microorganisms form metabolic networks in biofilms 
(Al-Ahmad et al., 2007), hence differences in their tolerance to acid production in mixed 
community settings can alter metabolic processes.  However, to date, the majority of the 
in-vitro studies (Chung et al., 2016; Walker et al., 2005) that characterize microbial 
growth and function have neglected the impact of pH on microbial and metabolic 
interactions. 
  Dietary carbohydrates have a major effect on the structure and function of 
microbial communities in the human gut (Chung et al., 2016; De Filippo et al., 2010).  
Prebiotic polysaccharides such as inulin and pectin can stimulate the growth of certain 
microbial species, and the community structures depend on starting pH (Chung et al., 
2016).  Monosaccharides and disaccharides can be found in the diet in their monomeric 
forms (Tappy & Le, 2010) and as building blocks of common polysaccharides such as 
cellulose, inulin, and oligofructose (Tappy & Le, 2010).  Among the components of 
dietary carbohydrates, glucose fermentation at different pH conditions has been well 
documented (Carlsson & Griffith, 1974; Egert et al., 2007; Miller & Wolin, 1981; 
Weaver, Krause, Miller, & Wolin, 1989).  In contrast to glucose, fermentation of other 
saccharides such as fructose and cellobiose by human gut microbiota has had minimal 
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attention.  Fructose is more accessible to the colonic microbiota than glucose because it is 
absorbed less efficiently than glucose in the small intestine (Tappy & Le, 2010).  
Cellobiose is a disaccharide whose bioavailability in the colon is limited by its hydrolysis 
by the gut microbiota (Nakamura, Oku, & Ichinose, 2004).  Therefore, the relative roles 
of these organic substrates and pH on the microbial community and its function remain 
unclear and demand more investigation.  
Here, we address the effects of pH and carbohydrates on the structure and 
function of anaerobic microbial communities derived from fecal slurry obtained from a 
healthy human.  We carried out batch in vitro experiments using glucose, fructose, or 
cellobiose as the organic substrate and initial pH values of 6.0, 6.5, or 6.9; these values 
range from normal to unusually low values associated with gastrointestinal abnormalities 
in the distal colon.  We evaluate impacts on the microbial communities’ structure and 
metabolic end products.  We apply electron-equivalent mass balances to quantify the 
effects of pH and substrate on community function. 
3.2 Materials and Methods 
3.2.1 Experimental Design 
A fecal specimen was collected from a female healthy subject and transported to 
the laboratory on ice packs.  After homogenizing one gram of the specimen in 50 mL 
sterile anaerobic 1X phosphate buffer saline at pH 7.2, we produced the fecal slurry used 
in the experiments.  The inoculum was diluted to a final concentration of 0.04 g/L solids, 
and all inoculations were carried out in anaerobic glove box.   
The culturing medium was an anaerobic fermentation medium (Lee, Salerno, & 
Rittmann, 2008) that contained 30 mM sodium bicarbonate (NaHCO3), 2% cysteine-
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sulfide solution, and 10 mM of one fermentable substrate (glucose, fructose, or 
cellobiose).  Glucose and fructose are monosaccharaides that have the same electron 
equivalence (24 electrons per mole), although they have different chemical properties and 
metabolism by bacteria (Andreese.Jr, Schaupp, Neuraute.C, Brown, & Ljungdah.Lg, 
1973).  By comparing glucose and fructose fermentation, we aimed to identify microbial 
development and function based on availability of different types of monosaccharides 
without varying the amounts of electrons provided to the bacteria for metabolism.  
Because the cultures had the same mmoles of substrate in the batch bottles, cellobiose 
cultures received twice the amount of the electrons that fructose or glucose cultures 
received, since cellobiose is a disaccharide.  By comparing cellobiose fermentation to 
glucose fermentation, we aimed to understand the impact of electron availability on 
microbial metabolism and community structure at different pH values. 
After preparing the medium anaerobically under a stream of 20/80 % CO2/N2 gas, 
we distributed 50 mL of medium into triplicate 125-mL serum bottles and then adjusted 
the pH to 6.0, 6.5, or 6.9 with 10% hydrochloric acid.  Before inoculation, we had flushed 
the headspace of the bottles with 20/80% CO2/N2 gas and equilibrated the bottle contents 
to atmospheric pressure (1 atm).  We labeled the cultures based on their initial pH and 
substrate:  Glu6.0, Glu6.5, Glu6.9, Fru6.0, Fru6.5, Fru6.9, Cello6.0, Cello6.5, and 
Cello6.9.  
All inoculated bottles were incubated at 37oC in a shaking incubator (New 
Brunswick Scientific, Enfield, CT) at 150 rpm.  The duration of the experiments was 72 
hours:  the first 24-48 hours to reach stationary phase and establish biomass, and another 
24 hours to ferment substrate.  We sampled the liquid and gas phases at the beginning 
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and end of each experiment.  All experiments were performed in triplicate, and the means 
and standard deviations of the triplicates are reported.   
3.2.2 Growth and Fermentation End-Product Measurements 
We documented growth by measuring optical density at 600 nm (Varian Cary 50 
Bio UV) and pH using a pH meter (ThermoScientific Orion).  We sampled the liquid 
phase at the time of inoculation and at the end of 72 hours using sterile syringes equipped 
with sterile 20-gauge needles and filtered the supernatant through 0.2-µm PVDF 
membranes (Acrodisc, LC 13 mm syringe filter).  
We analyzed substrates and metabolites using High-Pressure Liquid 
Chromatography (HPLC) (LC-20AT, Shimadzu) equipped with a carbohydrate column 
(Aminex HPX-87H column, Biorad) as previously described (Lee et al., 2008).  Short-
chain fatty acids (acetate, formate, butyrate, isobutyrate, isovalerate, valerate, propionate, 
lactate), alcohols (ethanol and methanol) were analyzed using 5 mM H2SO4 as the eluent, 
a 0.6-ml/min-flow rate, a column temperature of 50oC, and a 50-min run time.  The 
carbohydrates (glucose, fructose, and cellobiose) were analyzed using 18-ohm water as 
eluent, a 0.6-ml/min-flow rate, a column temperature of 30oC, and 30 minutes of run 
time.  The SCFAs and alcohols were detected with a photodiode array detector (PDA, 
Shimadzu), and the sugars and alcohols were detected with a refractive index detector 
(RID 10A, Shimadzu).  We normalized the mmole of SCFAs produced to mmole of 
hexose consumed. 
In order to perform electron-equivalent mass balances, we measured the total 
chemical oxygen demand (COD) of the samples before filtering and soluble COD after 
0.2-µm filtration using HACH COD analysis kit (HACH Co, Loveland, CO, U.S.A).  We 
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calculated the electron equivalents of sugars, fermentation end products, and biomass 
using the stoichiometric equations as specified in Rittmann and McCarty (Rittmann & 
McCarty, 2001).  We also calculated theoretical alkalinity based on initial pH, partial 
pressure of CO2, and pKa of the HCO3- using the equation specified in Rittmann and 
McCarty (Rittmann & McCarty, 2001).  The calculated pKa of HCO3- was 6.16 when the 
ionic strength of the media was 0.03.   
3.2.3 DNA Extraction and Sequencing 
We extracted DNA from the inoculum and the resulting mixed fermentative 
consortia using QIAamp Mini Stool kit (Qiagen, CA) and followed the manufacturer’s 
recommendation for pathogens with minimal modification.  Briefly, we incubated the 
lysis solution and bacteria mix at 95oC to enhance the lysis of Gram (+) bacteria.  We 
verified the quantity and quality of DNA samples by NanoDrop measuring the absorption 
at 260 and 280 nm and stored the extracts at -80oC until sequencing.  
We amplified genomic DNA with a bar-coded primer set targeting the V2-V3 
regions of 16S rDNA (Kang et al., 2013).  Sequencing libraries were prepared according 
to Claesson et al.(Claesson et al., 2010) and purified PCR products were sent to the 
DNASU Genomics Core Facility at the Virginia G. Piper Center for Personalized 
Diagnostics in the Biodesign Institute at Arizona State University (Tempe, AZ), which 
provided pair-end reads (2x100 bp) using the HiSeq2000 platform (Illumina Inc., San 
Diego, CA).  We received fastq files and deposited the sequences to Sequence Read 
Archive under SAMNO3120391-400 accession numbers. 
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3.2.4 Sequence Analysis 
We analyzed data using the QIIME 1.8 suite (Caporaso, Kuczynski, et al., 2010).  
We filtered the sequences using default values and setting the minimum quality score to 
21 and minimum length to 192.  We clustered sequences into operational taxonomic units 
(OTUs) at the 97% level of sequence similarity using Uclust (Edgar, 2010), picked the 
most abundant sequence as representatives of each cluster, and then assigned taxonomy 
to the sequences using RDP algorithm at 50% threshold (Wang, Garrity, Tiedje, & Cole, 
2007) and Greengenes Database 2013 release (DeSantis et al., 2006).  We aligned 
representative sequences using Pynast (Caporaso, Bittinger, et al., 2010) and identified 
chimeric sequences with ChimeraSlayer (Haas et al., 2011).  We calculated within 
sample (alpha) diversity indexes: Phylogenetic Distance Whole Tree (Faith, 1992)  for 
diversity and Chao1 (Chao, 1987) for richness.  The weighted Unifrac metric (Lozupone 
et al., 2006) was used to calculate inter-sample diversity (beta diversity).  
3.2.5 Statistics 
Since our data size is small (n=3), non-parametric tests were more suitable for our 
data sets.  We used Mann Whitney U test for significance and accepted P values less than 
0.05 as significant.  To find relationships between pH, microbial phylotypes, and 
metabolic end products, we performed Pearson and Spearman correlation tests, and 
accepted correlation coefficients with P values < 0.05 as significant associations.  All the 
statistical procedures were carried out with Statistical Package for Social Sciences 
version 22.  
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3.3 Results and Discussion 
3.3.1 Mixed Community Structure Depended more on pH than Carbon Type 
In order to identify whether pH or the substrate exerted greater selective pressure 
on the microbial communities, we compared Unifrac distances (Lozupone, Hamady, & 
Knight, 2006) of the cultures to each other and visualized the result on principal 
coordinates, as shown in Figure 3.1A.  We performed unweighted and weighted Unifrac 
analysis.  Unweighted analysis, which provides information on changes in taxa that are 
not abundant, did not yield clusters based on pH or carbon source (data not shown).  
Weighted Unifrac, which relies on abundance of phylotypes in addition to their presence 
or absence, provides information regarding most abundant taxa.  Since we had 
enrichment cultures from the same inoculum, weighed Unifrac was more suitable for our 
data set and revealed important changes.   
 Weighted Unifrac analysis shows that enrichment samples were distant from the 
inoculum and clustered according to pH on Principal Coordinate 1 (PC1), which 
explained 67% of the variation in the whole dataset, and PC2, which explained 22%.  The 
pH-6.0 cultures formed a cluster distant to the right on PC1 and lower on PC2.  The pH-
6.5 and -6.9 cultures overlapped on PC1, although the pH-6.9 cultures were higher on 
PC2.   
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Figure 3.1.  Beta and alpha diversity analysis of pH enrichments.  (A) Weighted Unifrac 
analysis visualized on Principal Coordinates shows that mainly the initial pH along with 
buffering determined the main phylotypes that drove the community structures in the 
system.  (B) Phylogenetic diversity tree and (C) Simpson reciprocal indexes calculated 
from 16S rRNA gene sequences for inoculum, pH 6.0, 6.5, and 6.9 cultures. 
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The medium’s buffering capacity played a substantial role in the development of 
microbial communities.  As shown in Table 3.1, 30 mM HCO3- provided 3.2-3.5 mM 
alkalinity to pH-6.0 cultures, whereas it provided 10.7-11.9 and 26.8-31.7 mM alkalinity 
to the pH-6.5 and -6.9 cultures, respectively.  Greater bicarbonate buffering at pH 6.5 and 
6.9 led to much smaller drops in pH in 72 hours, and this correlated with the development 
of similar microbial communities.  The concentration of acids produced in pH-6.0 
cultures and Cello6.5 cultures by 72 hours far exceeded the concentration of alkalinity, as 
summarized in Table 3.1.  Therefore, rapid fermentation led to insufficient buffering, and 
the pH dropped dramatically.  The substantial drop in the pH appeared to promote the 
survival of only acid-tolerant species, a trend that drove microbial communities away 
from pH-6.5 and -6.9 cultures.   
 Among the pH 6.5 cultures, Cello6.5 produced higher concentration of acid due to 
the double amount of electrons provided; hence, it did not have as much pH buffering as 
glucose and fructose cultures.  The drop in the pH of Cello6.5 culture moved its 
community structure towards to pH-6.0 cultures.  pH-6.9 cultures provided sufficient 
buffering for all cultures, and all three cultures developed similarly.  The experimental 
design also probed the impact of different organic substrate (glucose or fructose) on 
community structure.  Substrate type led to no clustering pattern.  
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Table 3.1.  Amount of biomass produced, initial pH, final pH, and initial theoretical 
alkalinity values of the experiments. 
Sample 
type 
Biomass 
(OD) 
 
Initial pH 
 
Final pH 
Initial 
Alkalinity 
(mmoles/L) 
Total acids 
produceda 
(mmoles/L) 
pH- 
6.0  
Glu 0.34± 0.03 5.99±0.04 4.50±0.22 3.54±0.28 16.16±2.13 
Fru 0.27±0.03 5.95±0.31 4.27±1.19 3.30±0.52 17.71±0.69 
Cello 0.29±0.03 5.95±0.05 4.33±0.03 3.23±0.35 18.13±0.61 
       
pH- 
6.5  
 
Glu 0.35±0.05 6.45±0.13 6.13±0.18 10.66±2.99 12.54±1.39 
Fru 0.39±0.03 6.53±0.04 6.39±0.09 12.37±1.04 13.83±0.70 
Cello 0.49±0.04 6.51±0.02 4.57±0.12 11.88±0.64 16.19±2.17 
       
pH- 
6.9  
Glu 0.32±0.02 6.86±0.07 6.77±0.01 26.82±4.23 13.71±1.20 
Fru 0.40±0.02 6.92±0.02 6.75±0.06 30.08±1.45 14.05±0.51 
Cello 0.55±0.01 6.94±0.03 6.45±0.05 31.75±1.96 23.07±0.23 
Glu, Fru, and Cello indicate that the initial substrate was glucose, fructose, or cellobiose, 
respectively.  ameasured after 72 hours 
 
 Figure 3.1A also shows the relative distributions of order-level phylotypes on the 
Principal Coordinates that clustered communities based on alkalinity and buffering.  
Bacteroidales, the most abundant order in the inoculum, was reduced in all cultures, 
while Clostridiales, Lactobacillales and Enterobacteriales increased in all the cultures.  
The main factors that separated the pH 6.0 cultures from the other cultures were the 
greater abundance of Lactobacillales (>65%) and lower abundances of Enterobacteriales 
and Bacteroidales.   
Besides beta diversity (the Unifrac metric), we calculated alpha diversity 
parameters to understand within-community diversity based on pH and substrate.  Figures 
3.1B and 3.1C demonstrate Chao1 and PD whole tree indexes for richness and diversity, 
respectively.  The Chao1 index shows that lower starting pH and alkalinity led to lower 
diversity overall.  This trend was accentuated for cellobiose, a disaccharide composed of 
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two glucose molecules, except when buffering was strongest at pH 6.9.  The PD whole 
tree index (Figure 3.1C), a phylogeny-based diversity index, showed similar patterns to 
Chao1.  In summary, alpha diversity reinforces that pH had the primary effect on 
community structure and the substrate type had the secondary effect.  Sugars like fructose 
and cellobiose, which likely reach the human colon (Nakamura et al., 2004; Tappy & Le, 
2010), should be important for maintaining microbial diversity in the human gut, as long 
as the pH is not substantially decreased. 
3.3.2 Acetate, Lactate, and Propionate Accumulation Depended on pH 
Figure 3.2 shows the major short chain fatty acids (SCFAs) in mmoles produced 
per mmole hexose consumed.  Acetate and propionate were present in every culture, and 
they were the dominant end products of the pH-6.5 and pH-6.9 cultures.  Acetate and 
propionate concentrations were 2- to 5-fold higher in pH-6.5 cultures and 7- to 27-fold 
higher in pH-6.9 cultures than pH-6.0 cultures.  Lactate was the main end product of the 
pH-6.0 cultures, but was undetectable or very low in all the pH-6.5 and -6.9 cultures.  
Lactate, which can be fermented to acetate and propionate (Seeliger, Janssen, & Schink, 
2002), probably accumulated in the pH-6.0 cultures due to the acid stress on lactate-
utilizing bacteria (Giraud, Lelong, & Raimbault, 1991). 
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Figure 3.2.  Major fermentation end products -- lactate, acetate, and propionate -- in 
mixed cultures fed glucose, fructose, or cellobiose at initial pH values of 6.0, 6.5, or 6.9.  
The mmol of each acid produced was normalized per mmole of hexose consumed.  Error 
bars represent the standard deviations of triplicates for each condition.   * indicates Mann 
Whitney U test P < 0.05 
 
Minor fermentation products were butyrate, ethanol, and citrate (Table 3.2).  
Butyrate accumulation was minimal at all pH values.  Similar to lactate production, 
butyrate production is favored at acidic conditions, such as pH ≤ 5.5 (Walker et al., 
2005), but butyrate producers require longer acclimation and incubation periods (Le 
Blay, Michel, Blottiere, & Cherbut, 1999).  Thus, low butyrate generation might be 
explained by short experimental time of 72 hours.  Citrate, an intermediate in propionate 
and acetate fermentation (Newbold et al., 2005), was only detectable in pH-6.0 cultures, 
as well as in the  Cello6.5 culture.  Our results are consistent with those of Ramos et al, 
who showed that pH regulates citrate fermentation to acetate, with citrate fermentation to 
acetate becoming greater at a higher pH (6.2 in comparison to pH 5) (Ramos, Lolkema, 
Konings, & Santos, 1995).  Citrate accumulation in these cultures indicated incomplete 
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acetate and propionate fermentation, and the presence of citrate and lactate explained low 
acetate and propionate concentrations in the pH-6.0 and Cello6.5 cultures.  We did not 
observe this trend in the Glu6.5, Fru6.5 and pH-6.9 cultures, because the initial substrate 
was completely depleted, indicating that fermentation intermediates were converted into 
final fermentation products. 
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Table 3.2.  Electron balances based on each metabolite’s electron equivalence.  % Recovery was calculated based on 
how much of the initial electron equivalents could be tracked by measurements at the end of the experiment.  Values 
represent means with standard deviation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RSa stands for remaining substrate at the end of experiment 
 
 
 pH 6.0 pH 6.5 pH 6.9 
 Glu Fru Cello Glu Fru Cello Glu Fru Cello 
Substrate 13.29±1 13.59±1 26.18±3 13.102 11.94±1 24.31±1 12.21±0 11.83±0 19.95±1 
Products          
Lactate 7.37±1 8.24±1 7.46±1 0.00±0 0.08±0 1.61±0 0.00±0 0.00±0 0.01±0 
Acetate 1.14±0 1.10±0 0.98±0 2.80±0 2.94±0 2.14±1 3.09±0 3.27±0 5.08±0 
Propionate 0.24±0 0.28±0 0.29±0 4.32±1 4.39±0 2.40±4 4.10±0 4.26±0 7.60±0 
Butyrate 0.48±0 0.50±0 0.43±0 0.53±0 0.60±0 0.52±0 0.61±0 0.61±0 0.75±0 
Formate 0.02±0 0.10±0 0.18±0 0.03±0 0.01±0 0.10±0 0.06±0 0.01±0 0.00±0 
Isobutyrate 0.03±0 0.05±0 0.03±0 0.61±1 0.18±0 0.98±0 0.10±0 0.08±0 0.12±0 
Valerate 0.08±0 0.16±0 0.22±0 0.10±0 0.18±0 0.16±0 0.20±0 0.20±0 0.16±0 
Isovalerate 0.04±0 0.09±0 0.25±0 0.00±0 0.06±0 0.43±0 0.00±0 0.12±0 0.09±0 
Citrate 0.40±0 0.64±0 1.42±0 0.00±0 0.02±0 2.97±2 0.00±0 0.00±0 0.01±0 
Hydrogen 0.08±0 0.15±0 0.02±0 0.29±0 0.15±0 0.28±0 0.13±0 0.04±0 0.04±0 
Ethanol 0.21±0 0.21±0 0.29±0 0.68±0 0.62±0 0.67±0 0.77±0 0.69±0 1.34±0 
Biomass 0.89±0 0.76±0 1.15±0 1.22±0 1.09±0 1.86±1 0.74±0 1.07±0 1.55±1 
RSa 0.00±0 0.00±0 13.21±4 0.00±0 0.00±0 5.36±5 0.00±0.0 0.00±0 0.00±0 
Total 10.76±1 12.06±1 25.63±3 9.91±1 9.69±0 18.82±1 8.65±1 9.67±0 15.42±1 
% 
Recovery 
80.90±4 88.78±5 97.96±1 75.85±3 81.22±2 77.41±1 73.12±6 81.69±3 77.38±4 
50 
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The electron mass balances in Table 3.2 show that 73 to 98% of the electrons of 
the initial substrate were captured by our SCFAs and biomass measurements.  The 
unaccounted electron equivalents likely were present in amino acids and other metabolic 
products that were not measured.  Electron balances verified that the majority of the 
electrons were accumulated in intermediate molecules such as lactate and citrate when 
HCO3- alkalinity was limiting, and electrons were accumulated in mainly acetate and 
propionate when buffering with HCO3- was sufficient. 
3.3.3. The Interactions Between Lactate-producing and -Consuming Microbial 
Communities were Driven by pH 
Figure 3.3 shows that the inoculum consisted of diverse butyrate-producing 
species, including Faecalibacterium (6.8%), Roseburia (2.4%), and Lachnospira (4.7%).  
However, these butyrate producers were almost eradicated by batch culturing, and the 
low abundances of these phylotypes in the resulting cultures (<1%) can explain the 
observed low butyrate yields.  In contrast, genus-level phylotypes including Citrobacter, 
Escherichia, Streptococcus, and Veillonella were present in low abundances in the 
inoculum, but became the majority of the phylotypes in the cultures.  
Due to substantial differences in lactate, propionate, and acetate concentrations 
with the different pH conditions, we focused the role of pH on lactate-producing and -
utilizing communities.  These genus-level phylotypes were mainly from Lactobacillales, 
Enterobacteriales, Clostridiales, and Baceroidales orders that drove the cultures with 
limited buffering away from sufficient buffering (Figure 3.1).  We examined phylotypes 
similar to dominant genera of lactate-producing Streptococcus (Bender, Sutton, & 
Marquis, 1986) and Citrobacter (Oh, Kim, Park, Kim, & Ryu, 2008), lactate-utilizing 
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Veillonella (Kolenbrander, 2006), and lactate-producing and lactate-utilizing Bacteroides 
(Schultz & Breznak, 1979) and Escherichia (Bunch, MatJan, Lee, & Clark, 1997; Clark, 
1989).  The initial pH and the buffering capacity (affecting the final pH) had substantial 
impact on the relative abundance of these phylotypes.  Only when buffering was 
sufficient (at pH 6.5 and 6.9), we observed that the substrate type had the secondary 
effects on abundances of phylotypes (similar to alpha diversity indices).   
 
 
Figure 3.3.  Relative abundance of phylotypes at the genera level in inoculum and 
fermentation cultures with initial pH values of 6.0, 6.5, or 6.9, and with glucose, fructose, 
or cellobiose as initial substrate.  Green bars represent genera that belong to 
Bacteroidetes, blue bars represent genera that belong to Firmicutes, and orange bars 
represent genera that belong to Proteobacteria. 
 
Lactate-producing Streptococcus phylotypes comprised only 1.5% of the 
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cultures, respectively (Figure 3.3).  Abundances of Citrobacter, another lactate-producer, 
did not mimic the trend of Streptococcus abundance, and it was at the greatest abundance 
in Cello6.5 cultures.  Figure 3.4 shows parametric correlation coefficients for the 
associations between fermentation end products, pH, and major microbial phylotypes.  
The abundance of Streptococcus phylotypes strongly and positively correlated with 
lactate concentration (Pearson r = 0.91, P < 0.05), and the dominance of Streptococcus 
phylotypes at pH 6.0 can explain lactate accumulation in these cultures.  Citrobacter did 
not significantly correlate with the abundance of citrate or lactate (Pearson correlation 
coefficient r = 0.56, P > 0.05), possibly because citrate is an intermediate of fermentation 
by Citrobacter, which gains energy from fermenting glucose to citrate and lactate and 
subsequently fermenting citrate and lactate to acetate (Gyaneshwar, Kumar, & Parekh, 
1998).  
Veillonella, reported lactate utilizers (Kolenbrander, 2006), were less than 1% of the 
inoculum and in the pH-6.0 cultures; their low abundance in the pH-6.0 cultures could be 
due to poor acid tolerance (Kolenbrander, 2006).  Veillonella phylotypes varied from 1 to 
35% in the pH 6.5 and 6.9 cultures, with the highest in the Cello6.9 (35%) and the lowest 
in the Cello6.5 culture (~1%).  Unlike Bacteroides, Veillonella lacks the ability to 
ferment sugars, but it ferments organic acids, such as lactate and pyruvate, to propionate 
and acetate (Kolenbrander, 2006).  The abundance of Veillonella phylotypes had negative 
correlation with lactate accumulation (Pearson correlation coefficient r = -0.61, P < 0.01) 
and positive correlation with propionate accumulation (Pearson r = 0.70, P < 0.05). 
 
 
   54 
Figure 3.4.  Parametric correlation coefficients (Pearson’s) between combinations of 
taxa, initial pH, and fermentation end products. * Indicates correlation coefficient 
significant when P < 0.05, and ** indicates correlation coefficient significant when P 
<0.01.  
 
Bacteroides phylotypes were 37% of the inoculum, but they declined to less than 
2% in the pH-6.0 cultures and 2-12 % of the pH-6.5 and -6.9 cultures.  This observation 
is consistent with Bacteroides having weak acid tolerance (Walker et al., 2005).  The 
abundance of Bacteroides phylotypes correlated negatively with lactate concentration 
(Pearson correlation coefficient r= -0.78, P< 0.05), but positively with acetate and 
propionate concentrations (Pearson r = 0.97, P < 0.01).  Along the same lines, high 
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lactate accumulation and low accumulations of acetate and propionate in the Cello6.5 
culture can be explained by the low relative abundances of the lactate consumer and 
propionate producers Veillonella and Bacteroides.  The lower abundances of Bacteroides 
and Veillonella phylotypes in pH 6.0 cultures happened in concert with lactate 
accumulation.  
Escherichia were relatively abundant in all cultures (5-28%), especially for pH 
6.5 and 6.9.  The high abundance of Escherichia at pH 6.5 and 6.9 suggests that they 
replaced Streptococcus for the lactate-production niche. Escherichia are able to either 
produce or consume lactate, and this metabolic versatility may explain why it was a key 
member of all culture communities.  Lactate-utilizing and acetate- and propionate-
producing bacteria such as Bacteroides, Escherichia and Veillonella, and butyrate-
producing microorganisms such as Faecalibacterium and Roseburia are essential for 
removing accumulated lactate in the colon (S. H. Duncan, Louis, & Flint, 2004).  An 
absence of lactate consumers in the colon can lead to reduced pH of the colon via d-lactic 
acidogenesis, and the consequence of lower pH is a deterioration of the host’s health 
(Fiddiangreen, 1993).  
Our results on the microbial composition have implications for microbiota 
consuming simple carbohydrates post-bariatric surgery.  The microbiota composition at 
pH 6.5 and 6.9 were similar to the reported colonic microbiota of post-Roux-en-Y gastric 
bypass (RYGB) surgery patients (Zhang et al., 2009).  RYGB surgery enriched 
Gammaproteobacteria phylotypes (Zhang et al., 2009), more specifically Escherichia 
(Furet et al., 2010; Kong et al., 2010) and Citrobacter (Graessler et al., 2013), as well as 
phylotypes most closely related to Veillonella, a lactate-consuming propionate-producing 
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in the Firmicutes phylum (Graessler et al., 2013).  Because this weight-loss surgery 
reduces gastric acid secretions, it might select for less acid-sensitive microorganisms 
(Palleja et al., 2016) and increase fecal propionate concentration (Liou et al., 2013).  A 
limitation of this study is that we utilized batch bottles and enriched for microbial species 
with single carbon source, which cannot represent the complexity of the human gut.  
Nevertheless, findings of our study can be useful for the interpretation instances in which 
the pH of the intestines changes due to scenarios in which buffering is low compared to 
acid production in or input to the human intestine.  
We studied how pH, alkalinity, and carbohydrate substrate affect the microbial 
community structure and function of a mixed-culture inoculum taken from the stool of a 
healthy human.  Low pH, caused by limited bicarbonate alkalinity, had by far the 
strongest impact on community structure and metabolism.  Impacts of substrate type on 
microbial community structure were secondary and evident only when alkalinity was not 
sufficient.  Thus, a transient shift in pH from 6 to ~4 led to a less-diverse microbial 
community that formed less of acetate and propionate, but more lactate.  As a 
consequence of limited buffering, a drop in the pH disrupted the growth of some 
community members, hence restrained microbial and metabolic interactions between 
lactate-producing and lactate-utilizing communities. 
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CHAPTER 4 
PH CONTROLS THE LACTATE METABOLISM IN CO-CULTURES OF 
VEILLONELLA, STREPTOCOCCUS, AND BACTEROIDES SPECIES  
4.1 Introduction 
 As explained in chapter 3, pH and alkalinity are important for microbial 
community structure and function.  Microorganisms have different levels of tolerance to 
their surrounding pH; different environments such as host gastrointestinal (GI) tracts, 
host oral cavity, and soils expose microorganisms to fluctuating pH conditions (Lund et 
al., 2014).  Fluctuations in proton conditions influence the growth and metabolism of 
microorganisms, especially neutralophilic bacteria, depending on their ability to 
overcome acid stress (Lund et al., 2014).   
 Chapter 3 demonstrated the impact of pH on mixed communities and metabolism. 
Particularly, lactate metabolism and microorganisms that are involved in lactate 
production and fermentation were affected by the initial pH imposed on them.   Lactate 
producing Streptococcus (Russell & Hino, 1985) and Bacteroides (Falony et al., 2009), 
and lactate-consuming Veillonella (Al-Ahmad et al., 2007) responded to the changes in 
the initial pH and alkalinity among the other members of the microbiota.  Therefore, it is 
important to study microbial interactions between these lactate-producing and -
consuming microorganisms at the species level using mono and co-cultures.  
 Streptococcus, Bacteroides, and Veillonella are important members of the human 
gut and oral microbiota (Suau et al., 1999, Al-Ahmad et al., 2007).  Symbiosis between 
lactate-producing Streptococcus, and lactate-consuming Veillonella (Egland et al., 2004) 
can overcome gut acidosis due to removal of accumulated lactic acid (Russell & Hino, 
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1985).  Unlike these two species Bacteroides species are more versatile and can do both 
lactate production and consumption (Falony et al., 2009), although its efficiency to 
produce lactate compared to Streptococcus and to consume lactate compared to 
Veillonella are unknown.  
Lactate can be fermented into acetate and propionate via methylmalonyl-CoA or 
acrylyl-CoA pathways (Seeliger, Janssen, & Schink, 2002).  The active lactate 
fermentation pathway depends on microbial composition (Bourriaud et al., 2005) and 
environmental conditions (Ushida & Sakata, 1998) and due to the acid stress imposed on 
microorganisms at pH 6.0, lactate fermentation was inhibited which lead to lactate 
accumulation.  
The objectives of this chapter were: (i), to reveal the impact of pH on interactions 
between lactate producing and consuming species and (ii) to demonstrate the impact of 
co-existence of metabolically-bond species on each other’s growth in the context of pH. 
We selected Streptococcus salivarius, a probiotic that enhances the immune function 
(Cosseau et al., 2008), Veillonella dispar, a species that can aggregate on Streptococcus 
cells (Palmer et al., 2007), and Bacteroides thetaiotaomicron, a  versatile species that can 
form many metabolic reactions and can enhance growth of specific groups of 
microorganisms (Samuel & Gordon, 2006).   
Using the same initial pHs from chapter 3, we grew S. salivarius, B. 
thetaitomicron, and V. dispar as mono-cultures and as co-cultures at different 
combinations and we characterized their growth and metabolism in response to co-
culturing and initial pH.  Our results showed that pH could impact the lactate metabolism 
due to different acid tolerance of microbial species.   
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4.2 Materials and Methods 
4.2.1 Batch Experimental Conditions for Co-Culture Experiments 
Streptococcus salivarius, Veillonella dispar, and Bacteroides thetaiotaomicron 
(B. theta) were purchased from American Type Culture Collection.  I grew all the strains 
using reinforced clostridial medium (7714) (attc.org) with 10 mM glucose for S. 
salivarius and B. theta and 10 mM lactate for V. dispar.  I adjusted the strains to 10-fold-
diluted medium in order to reduce yeast extract and peptone fermentation by the cultures.  
I prepared 10-fold diluted reinforced clostridial medium with addition of 10 mM glucose 
and 30 mM of HCO3- anaerobically.  I distributed 15 mL of medium into serum bottles 
and autoclave-sterilized them.  Then, I adjusted the pH to 6.0, 6.5, and 6.9 with 10% HCl, 
and equilibrated the bottles over-night.  
For inoculation, I prepared over-night seed cultures by inoculating sterile media 
with frozen stocks of the cultures.  After measuring protein content with the BCA protein 
assay (Thermo-Scientific Inc.) of the over-night cultures, I inoculated 0.3 mg/L of each 
culture to bottles set to the different initial pHs.  I grew S. salivarius, V. dispar, and B. 
theta in monocultures, S. salivarius and B. theta with V. dispar, and finally I grew all 
three cultures together at three different initial pH settings.  I mixed the cultures equally 
based on their protein content.  
Both mixed culture, monoculture, and co-culture bottles were exposed to same 
environmental conditions.  Briefly, I incubated the inoculated bottles at 37oC and shaken 
at 150 rpm to achieve mixing.  The duration of the experiments was 72 hours; first 24-48 
hours to reach stationary phase and establish biomass, and another 24 hours to ferment 
substrate. I collected liquid and gas samples at time 0, 16, 36, and 72 hours for biomass 
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and metabolic analysis.  All experiments were performed in triplicates, and the means 
and standard deviations of the triplicates were calculated for reporting.   
4.2.2 Growth and Fermentation Product Measurements 
The samples collected at time 0, 16, 36, and 72 hours were subjected to biomass, 
pH, and fermentation end product measurements.  Using a spectrophotometer (Varian, 
AA20, Australia), I measured the biomass at 660 nm.  pH was measured with a pH meter 
(Orion, U.S.A).  For fermentation end product analysis, I filtered the supernatant through 
0.2 µm PVDF membranes (Acrodisc, LC 13 mm syringe filter).  
I analyzed substrates and metabolites using High-Pressure Liquid 
Chromatography (HPLC) (LC-20AT, Shimadzu) equipped with a carbohydrate column 
(Aminex HPX-87H column, Biorad) as previously described (Lee et al., 2008). Short-
chain fatty acids (acetate, formate, butyrate, isobutyrate, isovalerate, valerate, propionate, 
lactate), alcohols (ethanol and methanol) were analyzed using 5 mM H2SO4 as the eluent, 
0.6 ml/min flow rate, the column temperature of 50oC, and 50 minutes of run time. The 
carbohydrates (glucose, fructose and cellobiose) were analyzed using 18-ohm water as 
eluent, 0.6 ml/min flow rate, the column temperature of 30oC, and 30 minutes of run 
time. The SCFAs and alcohols were detected with a photodiode array detector (PDA, 
Shimadzu) and the sugars and alcohols were detected with a refractive index detector 
(RID 10A, Shimadzu).  I normalized the amount of SCFAs produced per mmole of 
hexose consumed.  Additionally, I calculated electron equivalence of each product, 
substrate and the biomass produced, hence provided electron balance.   
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4.2.3 Extraction of DNA, Plasmid Construction, and Quantitative PCR Analysis of 16S 
rRNA Genes from V. dispar, S. salivarius, and B. theta. 
I extracted DNA from the pure cultures and co-cultures using QIAamp Mini Stool 
kit (Qiagen, CA).  I followed the manufacturer’s recommendation for pathogens with few 
modifications.  Briefly, I incubated the lysis solution and bacteria mix at 95oC to enhance 
the lysis of Gram (+) bacteria.  I verified the quantity and quality of DNA samples by 
NanoDrop measuring the absorption at 260 and 280 nm. We stored the extracts at -80oC 
until sequencing.  
I performed PCR using 8F and 1525R primers that target 16S rRNA gene for each 
of the strains as described (Zhao et al., 2013).  Using TOPO TA Cloning kit (Invitrogen), 
I constructed plasmid for qPCR standards.  I used the primers and protocols for B. theta 
from Liu et al. (Liu et al., 2003), V. dispar and S. salivarius from van den Bogert et al. 
(van den Bogert et al., 2011).  I generated the standard curves by running serial dilutions 
of the standards from 1x10-1 to 1x10-7 ng/uL. 
The qPCR reactions were performed in 20 ul reactions: 10 uL SYBR green Ex 
Taq I mastermix, 8.6 ul water, and 0.2 uL of each primers with a concentration of 10 
mM, and 1 uL 10 times diluted DNA.  Once I obtained gene copies for each strain, I 
normalized them based on how many 16S rRNA genes exists in each strain: V. dispar 
contains four, B. theta contains five, and S. salivarius contains six copies of 16S rRNA 
gene per cell. 
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4.3 Results and Discussion 
4.3.1 Co-cultures of Streptococcus, Bacteroides and Veillonella produced different 
amounts of acetate, lactate, and propionate 
Lactate, acetate, and propionate were the main fermentation end products of the 
cultures similarly to the results from mixed communities reported in chapter 3, as shown 
in Figure 4.1, V. dispar mono-cultures have very low concentration of all products and 
did not consume the glucose in the media since they cannot utilize glucose 
(Kolenbrander, 2006). Accumulations of SCFAs at minor quantities in these cultures are 
probably a result of fermentation of yeast extract.   
All monocultures had similar levels of acetate accumulation and the 
concentrations were less than 4 mM.  Propionate was at minor quantities in S. salivarius 
and V. dispar cultures, while it was at greater abundance in B. theta cultures.  S. 
salivarius produced mainly lactate and minor quantities of acetate and propionate.  S. 
salivarius showed higher lactate accumulation at pH 6.5 and 6.9 compared to 6.0.  B. 
theta  cultures produced mainly lactate and propionate and small quantities of acetate, 
regardless of the initial pH.  B. theta produced more lactate at pH 6.9 than pH 6.0 and 6.5, 
whereas it produced more propionate at pH 6.0 than 6.5 and 6.9.  This finding suggests 
that B. theta is either more efficient producing lactate at pH6.0 than at pH6.5 and pH6.9, 
or it can convert lactate to acetate and propionate more efficiently at pH6.0.  Compared to 
B. theta, S salivarius was more efficient producing lactate at pH6.5, and at pH6.9 their 
lactate production levels were comparable.  
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Figure 4.1. Main fermentation product distribution of V. dispar, S. salivarius, B. theta in 
monocultures and co-cultures at pH 6.0, 6.5 and 6.9. 
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Co-culture experiments depicted different fermentation results.  When B. theta 
and S. salivarius were co-cultured with V. dispar, lactate levels dropped in the cultures 
and propionate and acetate concentrations increased at pH 6.5 and 6.9.  We did not 
observe this trend in pH 6.0 cultures because growth of V. dispar is limited at low pH.  B. 
theta co-cultures produced more propionate than S. salivarius co-cultures because unlike 
S. salivarius, B theta has been shown to produce  propionate (Liu, et al., 2003).  Co-
culturing S. salivarius and B. theta with V. dispar produced comparable levels of acetate.  
When all three strains were cultured together, the trends were similar to two strain co-
cultures; however, acetate production was greater than propionate production.   
Starting pH had an impact on co-cultures metabolism.  Both S. salivarius and B. 
theta co-cultures with V. dispar produced more lactate at lower starting pH and more 
acetate and propionate at higher starting pH.  This could be due to the limited growth of 
V. dispar at low pH.  
 Our co-culturing strategy under different initial pH scenarios showed that 
microbial partnerships are controlled by pH and they have an important role in lactate 
metabolism and fermentation end-product distribution.  Figure 4.2 illustrates these 
microbial interactions.  Veillonella, a genus that lacks carbohydrate fermentation genes 
rely on lactate-producing species for survival (Kolenbrander, 2006).  Veillonella and 
Streptococcus are found together in oral biofilms or dental cavities (Egland et al., 2004) 
due to the metabolic interactions regards to carbohydrate metabolism.  Our results 
showed that starting pH could control the metabolic interactions between S. salivarius 
and V. dispar, therefore can alter the fermentation end product distribution.  When we co-
cultured V. dispar with B. theta, we observed similar fermentation end-product trends to 
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co-culture with S. salivarius although the results were less drastic due to B. theta’s ability 
to produce acetate and propionate from glucose fermentation intermediate lactate (Liu, et 
al., 2003).   
 
 
Figure 4.2.  Illustration of microbial interactions that yield acetate, lactate, and 
propionate fermentation regards to initial pH. 
 
4.3.2 Co-Culturing Streptococcus, Bacteroides and Veillonella Had Different Effects on 
Each Other’s Growth 
As seen in Figure 4.3, by the end of 72 hours pH dropped in B. theta and S. 
salivarius monocultures, and the drop was greater when the initial pH was 6.0.  This 
result was consistent with mixed-culture results that were presented in chapter 3.  The 
amounts of acids produced at pH 6.5 or 6.9 was not concentrated enough to drop the pH 
below the pKA of HCO3-, therefore these cultures remained well-buffered until the end of 
the experiment. 
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Figure 4.3.  Changes in pH over time (72 hours) in monocultures of V. dispar, S. 
salivarius, B. theta, and their co-cultures.  Green triangles represent pH 6.9 cultures, red 
squares represent pH 6.5 cultures, and purple diamonds represent pH 6.0 cultures.  
 
V. dispar monocultures did not change the pH; this was mainly because V. dispar 
cannot utilize glucose as energy source (Kolenbrander, 2006), so its growth was limited 
by the nutrients from the yeast extract.  Co-culturing S. salivarius, and B. theta with V. 
dispar showed similar pH drop patterns to B. theta or S. salivarius.  When we co-cultured 
the three strains together, the drop in the pH was more prominent compared to other co-
cultures.   
 
 
   67 
Changes in the pH were consistent with the amount of 16S rRNA gene copies at 
the end of the experiment.  Figure 4.4 shows number of cells per culture detected for each 
of the strains: V. dispar, S. salivarius, and B. theta in monocultures and co-cultures at 
initial pHs of 6.0, 6.5, and 6.9.  Based on these, the growth for V. dispar was undetectable 
at pH 6.0 or 6.5, and it was the lower than S. salivarius and B. theta for pH 6.9 cultures.  
S. salivarius had limited growth  at pH 6.0 and cells per culture were higher at pH 6.0 and 
6.5.  B. theta had the highest amount of cells per culture, even though the number of 
copies at pH 6.0 was lower compared to pH 6.5 and 6.9, the difference was less than 10 
fold. 
Figure 4.4.  Normalized 16S rDNA copy numbers of V. dispar, S. salivarius, and B. theta 
at pH 6.0, 6.5, and 6.9 in monocultures and co-cultures  
 
When V. dispar was co-cultured with S. salivarius, B. theta, or with both, cells per 
culture was above the detection limit.  16S rRNA gene copy numbers were the greatest at 
pH 6.9 and comparable at pH 6.0 and 6.5.  When co-cultured, V. dispar generated more 
16S rRNA gene copies with S. salivarius than with B. theta.  The difference in the growth 
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of V. dispar was even more prominent at pH 6.0, co-culturing with S. salivarius helped V. 
dispar to grow better at pH 6.0.   
Co-culturing V. dispar with S. salivarius had a positive impact on S. salivarius 
growth as well.  More cells of S. salivarius were detected when it was co-cultured 
compared to grown on monocultures.  Presence of V. dispar did not affect the amount of 
B. theta cells.  When all three strains were together, V. dispar and S. salivarius showed 
similar trends of 16S rDNA copy numbers to their two species co-culture. In three 
species co-cultures, their copy numbers were lower in general, possibly due to 
competition with B. theta for resources.   
Our results from this co-culture experiment showed that pH is important for 
microbial interactions in between species.  Metabolic interactions among Streptococcus 
and Veillonella species rely on both of the species tolerance on pH.  Streptococcus-
Veillonella co-occurrence in dental biofilms has shown previously (Al-Ahmad et al., 
2007), however, B. theta supporting the growth of V. dispar has not been shown before.   
The human GI tract is a complex ecosystem with multiple elements affecting its 
function; therefore, it is difficult to determine causality from in-vivo studies.  Small 
differences in pH shift SCFA producing pathways, which could lead to important 
changes to host metabolism by altering production of lactate, acetate, and propionate.  
Co-culture experiments verified the major findings of the mixed culture 
experiments from chapter 3 that pH is important for the distribution of fermentation end 
products and the growth of neutralophilic microorganisms.  For some strains, it can 
influence the end products just because pH limits the growth, i.e., S. salivarius.  For 
some, i.e., B. theta, pH doesn’t affect its growth but have a substantial role in the 
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fermentative pathways.  In case of lactate utilizing, V. dispar, the proton conditions 
limited its growth at pH 6.0.  Co-culture experiments help us identify those physiological 
differences and metabolic interactions at strain level.   
We can expand the implications of pH on these model microorganisms on host 
health.  For instance, lactate accumulation can lead to acidosis (Russell & Hino, 1985) in 
the gut.  Absence of lactate consumers in the colon due to perturbations of microbiota or 
diseases can lead to reduced pH of the colon via d-lactic acidogenesis, and consequently 
deteriorate the host’s health (Fiddiangreen, 1993).  Here we showed that even though B. 
theta can consume some lactate, co-culturing B. theta and S. salivarius with V. dispar 
significantly reduced the total amount of lactate being accumulated.  Introducing V. 
dispar to the co-cultures also increased the total amount of propionate being produced, 
which exerts beneficial effects on host metabolism.  Propionate is a short chain fatty acid 
that can reduce liver fattiness by signaling free fatty acid receptors (Nilsson et al., 2003) 
and increase intestinal gluconeogenesis (De Vadder et al., 2014).  By impacting the 
survival of lactate consuming species, gastrointestinal pH can indirectly affect gut 
metabolism.  A slight increase in gut pH can increase propionate production (Walker et 
al., 2005).  Conditions or treatments such as proton pump inhibitor use that increase gut 
pH demonstrated an increase in propionate production and abundance in lactate utilizers 
(Imhann et al., 2016).   
In summary, we demonstrated that slight differences in initial pH have an impact 
on growth or metabolism of lactate utilizing and producing communities.  pH has primary 
effect on metabolic interactions between microorganisms that establish partnerships 
based on their metabolic requirements.  Greater propionate production at higher pH due 
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to survival of lactate consuming microorganisms such as Veillonella holds promise for a 
probiotic to enhance liver and gut health.  
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CHAPTER 5 
WEIGHT LOSS-ASSOCIATED GUT MICROBIOMES AND METABOLITES IN 
GASTRIC BYPASS AND BANDING PATIENTS 
5.1 Introduction 
Rising obesity rates and ineffective weight management strategies have increased 
the prevalence of bariatric surgery approaches to treat morbid obesity (Korner et al., 
2009).  At present, laparoscopic adjustable gastric banding (LAGB) and Roux-en-Y 
gastric bypass (RYGB) are the most commonly performed surgeries (Yurcisin, Gaddor, 
& DeMaria, 2009); however, RYGB achieves greater and more sustained weight loss, as 
well as better resolution of obesity-related comorbidities such as diabetes and 
hyperlipidemia (O'Brien, 2010).   
Both bariatric operations limit food intake.  While LAGB surgery places an 
adjustable band around the proximal stomach to restrict the flow of ingested food, RYGB 
surgery creates a small gastric pouch by partitioning the stomach into proximal and distal 
parts (Korner et al., 2009).  Additionally, with the RYGB, a section of jejunum (i.e., the 
Roux limb) is then connected to the proximal gastric pouch, thereby excluding the 
majority of the stomach, duodenum, and proximal jejunum from exposure to ingested 
food (Korner et al., 2009).  The digestive secretions produced by the bypassed stomach, 
duodenum, and pancreas reconstitute with the flow of chyme through a surgical 
connection with the Roux limb (i.e., the biliopancreatic limb) at a certain length distal to 
the connection of the Roux limb with the gastric pouch (Wittgrove & Clark, 2000).  In 
addition to limiting food intake, and unlike the LAGB, RYGB may induce malabsorption 
of digested food depending upon the length of the Roux limb, change hormonal response 
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for appetite (Korner et al., 2009), increase intestinal transit, and alter bile-acid 
metabolism (le Roux et al., 2006).  These factors have been shown to contribute to 
weight loss after RYGB surgery (Korner et al., 2009).  Although an altered response of 
the orexigenic hormone ghrelin has also been observed after LAGB, the clinical 
significance of this finding remains uncertain (Shak et al., 2008). 
A role of gut microbiota on host energy regulation and metabolism has been 
postulated.  For example, the structure of the gut microbial community has been shown to 
differ between lean and obese hosts (Ley et al., 2005), and altered microbial metabolism 
in obese hosts appears to contribute to weight gain (Turnbaugh et al., 2006).  Humans 
(Furet et al., 2010; Zhang et al., 2009) and animals (Li et al., 2011; Liou et al., 2013) that 
had undergone RYGB were shown to exhibit significantly different microbial-community 
structures than obese or lean comparators.  To our knowledge, changes in gut microbiota 
after LAGB surgery have not been studied. 
Recently, the transplantation of fecal from post-RYGB mice to gnotobiotic mice 
altered gut microbiota and induced weight loss (Liou et al., 2013) and the deposition of 
adipose tissue (Tremaroli et al., 2015) independently from diet.  Although the 
microbiota-associated mechanism of weight loss remains unclear, microbial metabolites, 
such as a short-chain fatty acid (SCFA), propionate, which was found to  increased after 
RYGB surgery in mice (Liou et al., 2013), have been implicated as signaling molecules 
that interact with the free-fatty-acid receptor in a way that protects against diet-induced 
obesity (Lin et al., 2012).  Besides propionate, two branched-chain-fatty-acids (BCFAs) -
- isobutyrate and isovalerate -- also serve as signaling molecules that show potent activity 
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against the G protein-coupled receptor GPR41 (Le Poul et al., 2003) and free-fatty-acid 
receptors 2 and 3 (Schmidt et al., 2011). 
 A comparative analysis of the transformations in gut microbiota after successful 
and unsuccessful bariatric operations in humans, along with changes in microbial 
metabolites, may provide further insights into the mechanism of weight loss following 
these operations.  Moreover, microbiota and microbial metabolites after LAGB and 
RYGB, in connection to diet composition, body mass index, and percent excess weight 
loss warrant further investigation.  The objectives of our study were to:  i) determine 
differences in microbial community structure after RYGB and LAGB surgeries, ii) 
identify microbial signatures of surgical weight loss, and iii) identify microbe-produced 
metabolites that contribute to successful bariatric surgery outcomes.  To accomplish these 
objectives, we studied the microbial community structure and metabolic products in fecal 
samples from individuals who had previously undergone either RYGB or LAGB.  
5.2 Materials and Methods 
5.2.1 Experimental Design and Subject Characteristics  
 
The Institutional Review Boards of Mayo Clinic and Arizona State University 
(IRB# 10-008725 for both) approved our study and all subjects provided signed informed 
consent.  Our study compared gut microbial ecology in four groups:  subjects who had 
previously undergone RYGB or LAGB surgery, healthy normal weight (NW) 
individuals, and morbidly obese controls who were scheduled to undergo bariatric 
surgery.  The subjects were recruited at Mayo Clinic, Scottsdale between 2011 and 2014.  
Importantly, the morbidly obese subjects were on a recommended weight loss diet in 
preparation for their upcoming surgeries and they were in negative energy balance.  We 
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use abbreviations “PreB-Ob” and NW for pre-bariatric surgery morbidly obese and 
normal-weight subjects, respectively.  
We excluded subjects from the study who had undergone other types of 
gastrointestinal surgery or had uncontrolled gastrointestinal, endocrine, or other chronic 
diseases.  Prebiotic/probiotic agents were avoided two weeks prior to feces collection and 
antibiotic use was not allowed within two months of feces collection.  Participants were 
asked to refrain from the use of medications that can alter gastrointestinal secretory or 
motor function (e.g., proton pump inhibitors or prokinetic agents) for at least 2 weeks 
prior to feces collection; however, if they were unable to do so, this did not disqualify 
them from participation. 
In order to avoid short-term disturbances in the microbiota, we included only 
subjects who had their surgeries more than 9 months before the sample collection.  Fecal 
samples were collected at the Mayo Clinic, Scottsdale, shipped to Arizona State 
University on dry ice, and stored at -80oC until the time of analysis.  
Around the time of feces collection, we obtained 4-day food diaries and food 
frequency questionnaires from the subjects, and the subjects were educated by a dietitian 
on how to accurately record their food intake. Dietary information was analyzed using 
DietOrganizer software (dietorganizer.com).   
5.2.2 DNA extraction, 16S rRNA gene sequencing, and genomic predictions 
We extracted genomic DNA using the QIAamp Mini Feces kit (Qiagen, CA) 
following the manufacturer’s recommendations, but with an additional lysis step at 95oC 
to enhance the DNA extraction from Gram-positive bacteria.  DNA extracts were sent to 
University of Minnesota Genomic Center.  Sequencing was performed with an Illumina 
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Miseq Instrument using V4-V6 primers (F 5′-GTGCCAGCMGCCGCGGTAA-3′ and R 
5′-ACAGCCATGCANCACCT-3′).  Sequences were submitted to NCBI Sequence Read 
Archive under accession numbers from SAMN05001554 to SAMN05001616.  Forward 
and reverse reads were paired using PANDAseq (Masella, Bartram, Truszkowski, Brown, 
& Neufeld, 2012) and analyzed using the QIIME 1.8 suite (Caporaso et al., 2010).  After 
quality filtering, we attained a total of 3 369 231 sequences and median number of 
sequences per sample was 50 035.  Details of the analysis were previously reported 
(Kang et al., 2015) with the following modification: clustering was performed at 99% 
sequence similarity.  We calculated within-sample (alpha) diversity metric: Phylogenetic 
Distance Whole Tree (Faith, 1992).  We used the Unifrac metric (Lozupone, Hamady, & 
Knight, 2006) to calculate inter-sample (beta) diversity and Linear Discriminant Analysis 
Effect Size scores to identify microbial discriminants of bariatric surgeries (Segata et al., 
2011).  In order to understand the role of gut microbiota in metabolite production, we 
predicted functional-gene content in the samples from 16S rRNA gene data using 
Phylogenetic Investigation of the Communities by Reconstruction of Unobserved States 
(PICRUSt) (Langille et al., 2013).  We analyzed wide-scale properties of the microbiota 
after bariatric surgeries using the BugBase tool (Caporaso et al., 2010; Langille et al., 
2013).  
5.2.3 Biochemical Characterization of Feces  
For each fecal specimen, approximately one gram of wet weight (precise weight 
was recorded and used for calculations) was diluted with 20 mL of milliQ water (18 
ohms).  The homogenate was vortexed for 10 minutes and centrifuged at 13,000 rpm for 
15 minutes before supernatants were filtered through 0.2-um PVDF membranes (PALL 
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Corporation).  SCFAs were analyzed using High-Performance Liquid Chromatography 
(HPLC) (LC-20AT, Shimadzu) equipped with a carbohydrate column (Aminex HPX-
87H column, Biorad) and photodiode array detector (PDA, Shimadzu) (Lee, Salerno, & 
Rittmann, 2008).  The SCFAs analyzed included acetate, formate, butyrate, isobutyrate, 
isovalerate, valerate, propionate, and lactate.  We normalized the SCFA concentrations to 
grams of fecal dry weight.   
A global metabolomics approach was employed to obtain assignment and 
quantitation of small metabolites via 1H-NMR.  The 1D 1H NMR spectra of all samples 
were collected following standard Chenomx  (Edmonton, Alberta) sample preparation 
and data collection guidelines (Weljie, Newton, Mercier, Carlson, & Slupsky, 2006).  For 
our study, we prepared and analyzed a subset of samples (only RYGB, NW, and PreB-Ob 
groups) in triplicates for extraction and duplicates for NMR.   NMR samples were 
prepared as fecal extracts described above but then but diluted with a 10% (v/v) spike of 
a NIST calibrated reference solution (100% D2O, 5 mM 2,2-dimethyl-2-silapentane-5-
sulfonate-d6  (DSS) and 0.1% sodium azide). The resulting 500 uM DSS internal 
reference standard yields quantitation compared to spectral features and intensities for a 
wide-range of metabolites found in a Chenomx NMR reference library (DeAngelis et al., 
2013). 
5.2.4 Statistics 
Statistical analyses were conducted using the IBM SPSS Statistics for Macintosh, 
Version 23.0 (Armonk, NY: IBM Corp).  Group medians were compared using the 
Mann-Whitney U test and the P-values corrected using Monte Carlo simulations.  Median 
values were reported with median absolute deviation values.  Spearman’s rank-order 
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correlation coefficients that pass the critical values were used to assess associations 
between microbiome and weight loss.  Corrected Padj values < 0.05 using Monte Carlo 
simulations were considered statistically significant.  
5.3 Results and Discussion 
5.3.1 RYGB is More Effective than LAGB 
Fecal samples were collected from 63 subjects:  24 post-RYGB, 14 post- LAGB, 
10 NW, and 15 PreB-Ob subjects.  Table 5.1 shows subject characteristics in each group.  
The median age among the groups was not statistically significant.  
Table 5.1.  Subject characteristics of each experimental group:  NW, RYGB, LAGB and 
PreB-Ob.  For age and time after surgery categories, the numbers represent median 
values with standard deviation.  
 
 
 Figure 5.1A shows the calculated body mass index (BMI) of all subjects.  NW 
and RYGB subjects had lower BMI than the LAGB and PreB-Ob subjects.  The median 
BMI (kg/m2) of the populations were: NW: 22.32, RYGB: 30.8, LAGB: 36.6, and PreB-
Ob: 43.48.  Despite substantial weight loss, the majority of the subjects from RYGB and 
LAGB groups remained in the overweight or obese categories based upon BMIs being > 
25 kg/m2.  The RYGB group was composed of mainly over-weight and obese subjects, 
whereas the LAGB group was mainly composed of obese and severely obese subjects 
(BMI > 30).  The median pre- or post-surgical BMIs of the groups did not differ 
significantly (P>0.05). 
 NW RYGB LAGB PreB-Ob 
Age 41±15 50±9 47±11 54±9 
Gender (F/M) 7/3 16/8 14/2 8/7 
Time after surgery (months) NA 34.5 ± 12.8 36.0 ± 14.0 NA 
   78 
In order to assess surgical success, we calculated percent excess weight loss (% EWL), a 
commonly used clinical outcome that defines the weight loss normalized to the excess-
weight loss needed to reach an ideal body weight defined by a BMI of 25 (Boza et al., 
2010).  Figure 5.1B shows that %EWL was significantly higher for the RYGB group than 
the LAGB group (P<0.05), an observation consistent with previous long-term (Boza et 
al., 2010) and short-term findings (Tice, Karliner, Walsh, Petersen, & Feldman, 2008).  
The higher success rate in the RYGB group compared to the LAGB group was not 
related to a difference in the time of data collection with respect to how long ago was the 
surgery:  The median times of data collection after the surgery were 35 and 34 months for 
RYGB and LAGB, respectively.  Additionally, Figure 5.1C shows that %EWL was 
independent of the average calories consumed based on 4-day food diaries, as LAGB and  
RYGB groups consumed similar amounts of calories that were less than the NW 
and PreB-Ob.  Importantly, even though LAGB and RYGB subjects consumed similar 
amounts of calories per day, %EWL was significantly lower for LAGB group than 
RYGB group.  Based on food frequency questionnaires as shown in Table A.1, the 
RYGB group consumed fewer calories than the other groups, and PreB-Ob consumed 
more than the others, although this finding was not statistically significant.  
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Figure 5.1.  Subject’s body mass index (BMI), % excess weight loss (%EWL), and 
average daily calorie intake.  (A) BMI distribution of the subjects that participated in this 
study. Empty circles represent BMI at the time of sampling and full circles represent 
recorded BMI before surgeries retrospectively.  The horizontal dashed lines indicate the 
BMI-based weight categories according to National Institutes of Health guidelines 
(nhlbi.nih.gov).  (B) Percent excess weight loss (%EWL) for the RYGB and LAGB 
groups.  The RYGB group had significantly higher % EWL than the LAGB subjects.   
(C) Median calorie intake per experimental group.  * Denotes Mann-Whitney U test P < 
0.05.  
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5.3.2 Post-RYGB and PreB-Ob subjects had distinctive fecal microbiomes and 
metabolomes  
We evaluated community-level differences in the fecal microbiota of NW, 
RYGB, LAGB, and PreB-Ob populations using unweighted and weighted Unifrac 
metrics (Lozupone et al., 2006).  Weighted Unifrac analysis, which takes into account 
abundances of operational taxonomic units (OTU) and reflects differences in the most 
dominant OTUs, did not show any specific clustering pattern (Figure A.1A), although 
NW group was significantly distant from the other groups on PC1 (Figure A.1B).  Due to 
the dominance of Firmicutes and Bacteriodetes phylotypes, as shown in Table A.2, the 
impact of the surgeries on microbiome was not obvious.  Unweighted Unifrac analysis 
accounts for the presence or absence of OTUs; hence, it is a metric that reflects changes 
in less dominant phyla.  Figure 5.2A depicts the unweighted Unifrac distances on 
principal coordinates (PCoA).  In PC1 the microbiome of RYGB and PreB-Ob subjects 
formed clusters and there were some degree of separation from the other groups.  The 
microbiomes of NW and LAGB groups did not show any clustering pattern.  As shown in 
Figure A.2, microbiomes did not cluster based on other patients data such as: BMI, diet 
composition, gender, or age.  Therefore, RYGB surgery was the principal factor 
responsible for the alteration of gut microbial community structure. 
As seen in Figure 5.2B, the unweighted Unifrac distance between the RYGB and 
PreB-Ob groups was greater than the distance between the RYGB and NW groups, 
evidence that RYGB community profiles were more similar to NW than PreB-Ob 
profiles.  This trend was also valid for LAGB subjects; the distance between LAGB and 
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Pre-Ob was greater than the distance between LAGB and NW.  Overall, both surgeries 
change the microbiomes more towards that observed in NW subjects.   
Since we observed the greatest difference between RYGB and PreB-Ob groups on 
PCoA-based unweighted Unifrac distances, we visualized these groups with the class-
level phylotypes that promoted their separation.  Figure 5.2C illustrates that the presences 
of unique phylotypes from Bacilli, Gammaproteobacteria, Fusobacteriia, and Mollicutes 
caused the microbiome of RYGB subjects to separate from the microbiome of PreB-Ob 
subjects.  These phylotypes were the most abundant in the RYGB group (P<0.05), as 
shown in Figure 5.2D.  They also were in greater abundance in the LAGB group 
compared to non-surgical groups, although not statistically different (P > 0.05).  Based on 
linear discriminant analysis (LDA) effect-size algorithm (Segata et al., 2011), as shown 
in Figure A.3, Bacilli, Gammaproteobacteria, Fusobacteriia, and Synergistales were the 
microbial signatures discriminating RYGB microbiota from nonsurgical microbiome 
(NW and PreB-Ob).  Fusobacteriia and Bacilli also discriminated RYGB from the 
LAGB group.  Only two genus-level phylotypes, Prevotella and an unidentified 
Parabacteroides, discriminated LAGB from the nonsurgical subjects.   
Our findings reinforce previous studies showing that Gammaproteobacteria and 
Fusobacteriia increased in relative abundance after RYGB (Furet et al., 2010; Graessler 
et al., 2013; Zhang et al., 2009).  High levels of Gammaproteobacteria phylotypes have 
been associated with weight loss in post RYGB subjects (Furet et al., 2010), but 
Fusobacteriia have not been evaluated in the context of weight loss or adiposity.  In 
addition to Gammaproteobacteria and Fusobacteriia, Bacilli and Mollicutes were 
enriched after RYGB surgery, a trend not previously reported.  Interestingly, Bacilli 
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includes many species that are known to protect against diet-induced obesity, such as 
Enterococcus sp. (Nadal et al., 2009). 
 
 
Figure 5.2.  Microbial community structure after RYGB and LAGB surgeries compared 
to NW and PreB-Ob controls.  A) Unweighted Unifrac distances between the samples 
visualized using principal coordinate analysis showed two distinctive clusters: RYGB and 
PreB-Ob.  B) Pairwise comparison of median unweighted Unifrac distances between the 
groups suggested that both surgeries result in microbial profiles that resemble normal 
more than obese microbiota.  C) Class-level phylotypes on principal coordinates show the 
taxa that are responsible for clustering of RYGB subjects.   
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D) Relative abundance of the four main class level phylotypes that separated the RYGB 
group from normal, LAGB, and PreB-Ob groups.  E) Principal component analysis 
(PCA) of fecal metabolites from NW, RYGB, and PreB-Ob subjects show that RYGB 
and PreB-Ob had different metabolomes.  F) Spearman’s rho correlations between 
Gammaproteobacteria, Fusobacteriia, Mollicutes, and Bacilli and fecal metabolites.  The 
line thickness indicates the strength of the correlation. 
 
We evaluated whether distinctive microbiomes of RYGB and PreB-Ob groups 
also resulted in distinctive fecal metabolomes by using principal component analysis 
(PCA).  Figure 5.2E shows the distribution of fecal metabolomes of NW, RYGB and 
PreB-Ob groups based on 64 metabolites that were detected with NMR.  Even though 
subjects didn’t separate on PCA based on their metabolomes, similar to the observations 
that are derived from 16S rRNA gene, RYGB and PreB-Ob groups showed the greatest 
separation.  NW metabolomes did not separate from the other groups, although they 
showed narrow distribution.  These findings suggest that obesity and RYGB surgery not 
only change the microbial community structure (microbiome) but also change the 
microbial community functions, reflected by the metabolome.   
To probe the associations between fecal microbiome and metabolome, we 
calculated Spearman’s rho coefficients between the four phylotypes 
(Gammaproteobacteria, Mollicutes, Bacilli, and Fusobacteriia) that separated RYGB 
from PreB-Ob and fecal metabolites.  Gammaproteobacteria, Fusobacteriia, and Bacilli 
positively correlated with amino acid degradation products: isobutyrate, isovalerate, and 
o-cresol, as shown in Figure 5.2F.  Putresine concentration positively correlated with the 
relative abundances of Bacilli and Fusobacteriia.  Fusobacteriia also positively 
correlated with 2-aminobutyrate, a catabolic product of branched-chain-amino-acids.  On 
the other hand, Mollicutes relative abundance negatively correlated with many 
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metabolites including lysine, methanol, propionate, uracil and arginine.  β-alanine, an 
amino-acid derivative, negatively correlated with the following order level phylotypes: 
Mollicutes, Bacilli, and Gammaproteobacteria.  Metabolites that positively correlated 
with Gammaproteobacteria, Fusobacteriia, and Bacilli were at greatest abundance in the 
RYGB group compared to other groups.  We show the differential connection between 
fecal microbiome and metabolome after two bariatric surgeries.  Our findings indicated 
that the impact of bariatric surgery on the microbiome is reflected at the functional level 
by gut metabolism; hence those differences can contribute to the weight loss.   
5.3.3 Bariatric surgery reduces microbial diversity in the gut 
We also evaluated the variation within the microbial communities.  As seen in 
Figure 5.3A, within-community unweighted Unifrac distance was the smallest in the 
RYGB group compared to the other groups (P < 0.05).  Thus, we postulated that RYGB 
induced a more uniform microbiome in subjects and that this might be related to lower 
community diversity.  According to the alpha diversity indexes for the communities, 
RYGB and LAGB groups had lower diversity than the controls, as seen in Figure 5.3B.   
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Figure 5.3.  Within-community variation and alpha diversity indexes reveal differences 
in the community structure.  A) Within-group Unweighted Unifrac distance was the 
smallest for the RYGB group.  B) Alpha diversity parameters: observed species and PD 
whole tree showed greater diversity in nonsurgical groups compared to RYGB and 
LAGB.  
 
The PreB-Ob group had the highest diversity and, ranked highest in terms of 
within-community Unifrac distances.  This result contrasts with previous studies that 
have associated obesity with low alpha diversity (Qin et al., 2010; Turnbaugh et al., 
2006), possibly because our PreB-Ob group followed a pre-bariatric surgery weight loss 
diet.  We can speculate that this diet, as seen in Figure A.4, could have increased 
microbial diversity and established a healthier microbiota (David et al., 2014).  The fiber 
intake trends, as seen in Figure A.4, align with the alpha-diversity trends, supporting 
previous observations that fiber intake is important for microbial diversity (De Filippo et 
al., 2010).  Similarly, the lower diversity in the RYGB and LAGB groups may be 
explained by the restrictive diets imposed after surgery.  Patients often develop food 
intolerances after bariatric surgery, further limiting their dietary choices (Schweiger, 
Weiss, & Keidar, 2010).  Moreover, surgery-induced alterations in environmental 
   86 
conditions, such as higher pH imposed on gut microbiota after RYGB surgery, might 
further contribute to a reduction in gut microbial diversity, thereby reducing the variation 
within the RYGB group.   
Overall, RYGB and LAGB had different long-term effects on gut microbiomes.  
RYGB had a stringent clustering effect on microbial phylotypes, whereas LAGB did not 
impose any condition that distinguished its microbiome from non-surgical groups.  
Community-level differences between the RYGB and other groups may be explained by 
changes to the gastrointestinal environmental created by the surgery.  The rearrangement 
of the gastrointestinal tract after RYGB alters gut pH, oxygen content, and bile-acid 
concentrations, and nutrient exposure that are delivered to the colon (Li et al., 2011).  
Similar changes would not be anticipated after LAGB surgery, as anatomical 
rearrangement is not performed.  Therefore, RYGB may create environmental changes in 
the gut critical for new colonization and succession of microbial species in the colon.   
5.3.4 Weight-loss associated oral microorganisms were enriched in the fecal microbiomes 
after RYGB 
Table A.4 documents that the RYGB group had more facultative anaerobes and 
fewer anaerobes than the other three groups, which supports a previous hypothesis that 
RYGB surgery increases the oxygen content of the gut (Zhang et al., 2009).  Figure 5.4 
shows phenotypes that were most prevalent in the RYGB group similar to anaerobic and 
facultative anaerobic genera.  In addition to previously reported Escherichia (Liou et al., 
2013), Klebsiella (Graessler et al., 2013), and Fusobacterium (Furet et al., 2010), we 
observed a higher abundance of phylotypes from Firmicutes such as Streptococcus and 
Veillonella.  Some of these phylotypes are from the most abundant phylotypes of the 
   87 
gastric mucosa, such as Veillonella, Enterococcus, Haemophilus, Fusobacterium, 
Prevotella, and Streptococcus, and are commonly found together in individuals with 
dental cavities or periodontitis (Liljemark & Bloomquist, 1996).   Proton pump inhibitors, 
which reduce gastric acid secretions, increased the abundance of oral cavity associated 
microorganisms including Enterococcus, Streptococcus, and Veillonella (Imhann et al., 
2016).  The great abundance of these phylotypes after RYGB suggests that the conditions 
in the gut after this surgery allowed higher transport and survival of oral microorganisms 
and promoted growth of the upper-gastrointestinal tract species in the more distal bowel 
by a similar aggregation mechanism as oral biofilm formation. 
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Figure 5.4.  Significantly abundant genera in the RYGB subjects compared to the other groups.  * Denotes P < 0.05 of Mann             
Whitney U-test adjusted results.  The box-plots were not presented if the phylotypes were under detection limit for certain 
groups. 
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Gut pH could have been another important confounding factor for enrichment of 
these phylotypes.  Fusobacteria, Prevotella, Atopobium, and Escherichia (Ling et al., 
2010) are typically found at high relative abundance in patients with bacterial vaginosis, a 
condition that results in an increased vaginal pH (from 4 to 6) (Ling et al., 2010), and 
they also proliferated in the large bowel of mice when gastric acid secretion was inhibited 
(Kanno et al., 2009).  Since RYGB reduces gastric acid contact with the nutrient stream 
(Rubin, Nguyen, & Schwentker, 2004) and increases the distal excluded stomach pH to ~ 
4 (Liou et al., 2013), these facultative anaerobes from the oral and gastric mucosa, which 
thrive at more neutral pH levels, can bypass harsh stomach acid in transit to the colon.  In 
contrast, the decreases seen in these species after LAGB, where normal digestive 
physiology is retained, further supports that the observed microbiome changes were due 
to rearrangement of the gastrointestinal tract after RYGB surgery.  We did not see a 
significant difference in fecal pH (NW = 7.4, RYGB = 7.2, LAGB= 7.8, and PreB-Ob = 
7.45), probably because biochemical selection of species happens within the stomach and 
small intestine, before microorganisms reach the colon, where production of fatty acids 
through fermentation results in a decline in the pH. 
A majority of the genus-level phylotypes that were enriched in the RYGB group 
positively correlated with %EWL, since the RYGB group had greater excess weight loss 
than the LAGB.  Table 5.2 shows Spearman correlation coefficients of the relationships 
between genera and EWL% and BMI.  When we performed Spearman’s correlation on 
the combined data set (n= 63), we observed that Prevotella, Escherichia, Veillonella, 
Enterococcus, and Carnobacterium with unidentified phylotypes from Gemellaceae and 
Enterococcaceae, positively correlated with the %EWL.  Nadal et al., reported an 
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increase in Prevotella and a decrease in Enterococcus associated with weight loss in 
adolescents (Nadal et al., 2009).  In humans and animals, an increase in the relative 
abundance of Escherichia after RYGB surgery has been associated with weight reduction 
and adiposity independently from diet (Furet et al., 2010; Liou et al., 2013).  Bacteroides, 
Oscillospira, Sutterella, and an unknown phylotype from Ruminococcaceae negatively 
correlated with %EWL.  
As seen in Table 5.2, Methanobrevibacter, Ruminococcus, and Coprococcus 
moderately and negatively correlated with BMI, whereas Sutterella, Bacteroides, 
Oscillospira, and Holdemania positively correlated with the BMI.  Methanobrevibacter 
(Zhang et al., 2009), Ruminococcus, and Coprococcus (Kasai et al., 2015) have been 
associated with an obese metabolic type, but we speculate that these changes may reflect 
diverse diets and host physiology of the subjects studied and, therefore, the relationship is 
ambiguous. 
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Table 5.2.  Spearman correlation coefficients between genus-level phylotypes in fecal 
samples and excess weight loss and body mass index (BMI) distributions of subjects.  
 
 EWL %  BMI 
 Spearman's  
rho 
P value  Spearman's  
rho 
P value 
Unidentified  
Carnobacteriaceae 
0.531 0 Methanobrevibacter -0.305 0.018 
Unidentified 
 Enterococcaceae 
0.467 0 Ruminococcus -0.322 0.012 
Unidentified  
Gemellaceae 
0.464 0 Unidentified RF39 -0.328 0.01 
Enterococcus 0.454 0 Unidentified SHA -0.331 0.01 
Escherichia 0.448 0 Coprococcus -0.373 0 
Veillonella 0.424 0.001 Unidentified  
Coriobacteriaceae 
-0.374 0.003 
Prevotella 0.388 0.002 Oscillospira 0.209 0.109 
Klebsiella 0.312 0.013 Bacteroides 0.307 0.017 
Bacteroides -0.314 0.014 Sutterella 0.308 0 
Oscillospira -0.348 0.006    
Sutterella -0.358 0    
Unidentified  
Ruminococcaceae 
-0.437 0    
 
5.3.5 Butyrate, Propionate, and Branched-Chain-Fatty-Acids were at Great 
Concentrations only in Post-RYGB Group   As	seen	in	Figure	5.5A,	the	concentration	of	acetate,	a	major	carbohydrate-fermentation	product,	was	higher	in	the	PreB-Ob	group,	followed	by	the	RYGB	and	LAGB	groups.		NW	group	had	the	lowest	acetate	concentration.		The	RYGB	group	had	the	highest	concentrations	of	butyrate	and	propionate.		LAGB	and	NW	groups	had	comparable	levels	of	butyrate	and	propionate,	and	they	were	lower	than	the	RYGB	and	PreB-Ob	groups.		Figure	5.5B	shows	the	fecal	butyrate-to-acetate	and	propionate-to-acetate	ratios	in	the	groups,	which	indicates	preferred	fermentative	
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pathways	by	gut	microbes.		Butyrate-to-acetate	ratio	was	significantly	highest	in	the	RYGB	group,	and	propionate-to-acetate	ratio	was	significantly	higher	in	RYGB	compared	to	LAGB	and	PreB-Ob	groups.		Figure	5.5C	shows	that	the	RYGB	samples	had	the	highest	concentrations	of	branched-chain-fatty-acids	(BCFA)	isobutyrate	and	isovalerate.			In	addition	to	carbohydrate-fermentation	products,	we	measured	branched-chain-amino-acids	(BCAA)	fermentation	products:	branched-chain-fatty-acids	(BCFAs).		When	we	looked	at	the	abundance	of	leucine,	isoleucine,	and	valine	in	post-RYGB	in	comparison	to	NW	and	PreB-Ob	groups,	we	observed	that	the	concentrations	were	not	statistically	different	among	the	groups,	although	NW	group	had	slightly	lower	concentrations	of	these	BCAAs	(Figure	5.5D).	Using	PICRUSt	to	analyze	predicted	genes	involved	in	the	BCFA	production	and	consumption	pathways,	we	found	that	BCFA	production	associated	genes	such	as	leucine	2,3-aminomutase	and	butyryl-CoA	dehydrogenase,	were	significantly	more	abundant	in	the	NW	group	compared	to	the	other	groups,	as	shown	in	Figure	5.5E.		The	predicted	genes	involved	in	BCFA	production	and	consumption	pathways	were	in	greater	and	lower	abundances	in	the	RYGB	group,	respectively	compared	to	the	other	groups.			High	propionate-to-acetate	and	butyrate-to-acetate	ratios	in	RYGB	subjects	can	be	explained	by	the	higher	relative	abundance	of	propionate-	or	butyrate-producing	species	such	as	Escherichia,	Veillonella,	Klebsiella,	Fusobacterium,	and	
Prevotella	(Strobel,	1992).		These	phylotypes	form	a	metabolic	network	that	involves	production	of	vitamins	and	fermentation	of	carbohydrates	and	proteins.		
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For	example,	Streptococcus,	Escherichia,	Klebsiella,	Prevotella,	and	Enterococcus	ferment	sugars	and	produce	lactate	and	pyruvate	for	microorganisms	that	cannot	utilize	sugars,	such	as	Veillonella	(Hojo,	Nagaoka,	Ohshima,	&	Maeda,	2009).		
Veillonella	produces	vitamin	K,	which	stimulates	the	growth	of	Prevotella	(Hojo	et	
al.,	2009).		As	illustrated	in	Figure	5.5F,	Fusobacterium	degrade	proteins	and	peptides	into	amino	acids	(Bachrach,	Rosen,	Bellalou,	Naor,	&	Sela,	2004).		
Prevotella	and	Enterococcus	ferment	BCAAs	(valine	and	leucine)	into	BCFAs	(isovalerate	and	isobutyrate)	(Takahashi,	Saito,	Schachtele,	&	Yamada,	1997).		Finally,	Prevotella	and	Fusobacterium	produce	alkali	to	neutralize	the	pH	due	to	acid	production	during	amino	acid	fermentation	to	BCFA	(Takahashi	et	al.,	1997).		
SCFAs and BCFAs can have many effects on host energy metabolism.  Acetate 
has been associated with fat depositions in the liver (Siddiqui et al., 2015), whereas 
butyrate and propionate have been associated with weight loss (Lin et al., 2012).  Higher 
fecal propionate concentrations also were observed in mice that received fecal transplants 
from lean or post-RYGB mice, and they correlated with diet-independent weight loss 
(Liou et al., 2013; Ridaura et al., 2013).  Propionate and, to a lesser extent, butyrate can 
regulate weight loss hormones, such as glucagon-like peptide-1  (GLP-1), and both were 
previously shown to protect against obesity (Lin et al., 2012).  Besides GLP-1, 
propionate can induce secretion of the satiety-inducing, appetite-reducing hormone 
peptide YY (PYY) (Chambers et al., 2015).  Therefore, propionate-to-acetate ratio is an 
important factor for the evaluation of microbiota’s contribution to host energy balance.  
Conversion of BCAA to BCFA is optimal at pHs above neutral, such as pH 8 
(Thierry, Maillard, & Yvon, 2002).  The reduction in gastric acid secretion after RYGB 
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(Rubin et al., 2004) may stimulate the production of BCFA by increasing the BCFA-
producing bacteria or favor thermodynamics of these reactions.  A previous study showed 
that leptin-deficient obese mice had lower isobutyrate levels than controls, indicating that 
the obese mice had lower leucine and valine fermentation (Won et al., 2013).  Moreover, 
increased isobutyrate, isovalerate, and other SCFA have been associated with increased 
satiety via increases in PYY (Haenen et al., 2013).  An increase in satiety hormones, 
including PYY, was previously observed in individuals who have had RYGB (Karra & 
Batterham, 2010).  Our results of higher concentrations of BCFAs in the RYGB group, 
independent from diet, suggest that RYGB surgery enhanced the abundance of bacteria 
and pathways producing BCFAs.  In summary, our analysis showed that RYGB surgery 
increased fecal butyrate, propionate, isovalerate, and isobutyrate.  RYGB had higher 
concentration of SCFAs and BCFAs that can interact with free fatty acid receptors and 
regulate the hunger/satiety response, suggesting a microbiota-associated role in sustained 
weight loss.  These important changes were not observed after LAGB.  
 
 
 
 
 
 
 
 
 
   95 
Figure 5.5.  Fecal fermentation products and substrates.  A) The most abundant 
fermentation products: acetate, propionate, and butyrate showed different distribution 
among the groups.  B) Ratios of butyrate to acetate and propionate to acetate were 
greatest in the RYGB group compared to NW, LAGB, and PreB-Ob groups.   
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C) Isobutyrate and isovalerate, which are fermentation products of branched chain amino 
acids (isoleucine and valine) were at greater abundance in the RYGB group compared to 
the other groups.  D) Branched-chain-amino-acids: valine, leucine, and isoleucine 
concentrations did not significantly vary among the groups.  E) PICRUSt predicted 
relative abundance of the genes involved in the consumption and production of BCFAs. 
F) Illustration of conversion of carbohydrates and proteins into short chain and branched 
chain fatty acids by significantly abundant taxa in RYGB subjects.  *denotes Mann-
Whitney U-test Padj value < 0.05 and **denotes Padj<0.01 
 
We observed major differences in the structure of the fecal microbiome and its 
metabolites in post-RYGB and post-LAGB subjects, compared to PreB-Ob and NW 
subjects.  The changes were more substantial after RYGB than after LAGB, and can be 
related to the very different environmental conditions caused by the radically altered 
gastrointestinal anatomy following RYGB.  Greater abundances of metabolites associated 
with weight loss, such as short chain fatty acids and branched chain fatty acids, were 
observed in post-RYGB subjects compared to post-LAGB subjects.  These new data on 
microbial community structure and function significantly expands knowledge on how the 
microbiome is associated with weight loss following bariatric surgery. 
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CHAPTER 6 
MICROBIAL SIGNATURES OF SUCCESSFUL AND UNSUCCESSFUL ROUX-EN-
Y GASTRIC BYPASS SURGERY 
6.1 Introduction 
In Chapter 5, I summarized the major differences in the gut microbiome of post-
RYGB individuals.  I detected higher abundances of Streptococcus, Veillonella, 
Enterococcus, and many phylotypes from Gammaproteobacteria such as Escherichia and 
Klebsiella compared to nonsurgical controls.  Higher abundance of phylotypes from 
Gammaproteobacteria, especially Escherichia, compared to individuals without RYGB 
surgery had been reported in many other studies (Zhang, et al., 2009, Furet, et al., 2010, 
Tremaroli, et al., 2015).  Besides Gammaproteobacteria, an increase in the relative 
abundance of Verrucomicrobia such as Akkermansia (Zhang et al., 2009) and a decrease 
in the relative abundances of Lactobacillus and Bifidobacterium (Furet et al., 2010) were 
also previously reported.  Similar changes in the gut microbiota have been observed in 
rats (Li et al., 2011) and mice (Liou et al., 2013) post-RYGB surgery.  To date, these 
observations are only valid for post-RYGB subjects or animals that successfully lost 
weight, but not for the unsuccessful ones that regain some of the lost excess weight in the 
long-term.  Even though RYGB is a relatively successful surgery with high percent 
excess weight loss (%EWL), up to 40% of the patients fail to lose weight or regain some 
of the lost excess weight (Prachand et al., 2006).  In cases of unsuccessful outcomes, 
revisional surgeries are performed to enhance weight loss after primary surgeries, which 
might increase post-surgery complications (Shimizu, et al., 2013). 
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The success of RYGB relies on many factors; changes in dietary habits, the 
psychology, neurology, and hormonal response of the patients (Sarwer, et al., 2011).  
Changes in hormonal response after RYGB, for example an increase in Glucagon like 
peptide (GLP1) and peptide tyrosine tyrosine (PYY) after RYGB (Berthoud, et al., 2011) 
was associated with reduction in appetite, and weight loss (le Roux, et al., 2007).  Since 
the gut microbiome can regulate the production of neurotransmitters or hormones such as 
PYY (Cani & Delzenne, 2009), the microbiome might contribute to weight loss via 
interfering with host satiety signaling pathways.  
A mechanistic link to microbiota associated weight loss after RYGB was shown 
in mice (Liou et al., 2013).  Fecal transplantation from sham-operated, sham-operated 
weight-management, and RYGB-operated mice to gnotobiotic mice resulted in reduced 
body weight and adiposity independently from the diet only in the RYGB-microbiota 
recipient mice (Liou et al., 2013).  Even though, the microbiota’s role in post-RYGB 
weight loss is unknown, some hypothesized mechanisms include increased abundance of 
microbial products such as short chain fatty acids (SCFAs) (Lin et al., 2012) that mediate 
cross talk between the host and the gut microbiota.  SCFAs can reduce food intake by 
altering gut hormonal response towards satiety (Fruebis et al., 2001, Lin et al., 2012).  On 
the other hand, microbially produced protein degradation products such as putrescine and 
cadaverine can act as leptin (hunger hormone) signaling molecules due to their toxicities 
(Hyman et al., 2007).  Microbiome composition and metabolism in unsuccessful RYGB 
patients has not been reported, and differentiation of microbiome and metabolites in 
successful and unsuccessful patients can enhance the understanding of microbial 
contribution to successful and sustainable weight loss.  
   99 
Among different microbiota associated weight loss mechanisms post-RYGB, we 
focus on microbial products that are involved in the stimulation of weight-loss and 
weight-gain associated hormones or neurotransmitters. The objectives of this research 
were: (i) to define what conditions define a successful RYGB surgery, (ii) to characterize 
fecal microbiota structure at least 13 months after successful and unsuccessful RYGB 
surgery, and (iii) to identify microbial metabolites that might contribute to the success of 
RYGB surgery.  In order to achieve these objectives, we employed 16S rRNA gene 
sequencing to analyze microbial structure and H-Nuclear Magnetic Resonance to analyze 
microbial metabolites/functions.  
6.2 Materials and Methods 
6.2.1 Subjects and Fecal Sampling 
The Institutional Review Board of Mayo Clinic Scottsdale and Arizona State 
University approved our study (IRB # 10-008725).  We recruited: 9 normal-weight 
(NW), 12 pre-operative morbidly obese individuals (Ob-), and 24 post-RYGB 
participants for this study.  
The RYGB subjects that qualified for our study had their surgery at least 13 
months (median = 35 months) before they donated their samples. Each subject donated a 
fecal specimen, and shipped it to Mayo Clinic in Scottsdale, Az.  The samples were 
shipped to Arizona State University from Mayo Clinic on dry ice.  Upon arrival I stored 
them at -80oC until further analysis.  16S rRNA gene sequencing and metabolomics were 
performed on each sample.  Participants filled out diet diaries, food frequency 
questionnaires, and symptom checklist 90.  
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6.2.2 DNA Extraction, Sequencing and 16S rDNA Data Analysis 
DNA extraction, sequencing and 16S rDNA data analysis were described in detail 
in Chapter 4’s materials and method section.  Briefly, I extracted DNA using the QIAamp 
Mini Stool kit with enhanced lysis for Gr (+) bacteria.  The sequencing was performed 
with an Illumina Miseq Instrument using V4-V6 primers at University of Minnesota, IL 
Sequencing facility.  We paired the forward and reverse reads using PANDAseq (Masella 
et al., 2012) and analyzed data using QIIME 1.8 suite (Caporaso et al., 2010).  
6.2.3 Metabolite Extraction and H-NMR Analysis of Metabolites 
For each fecal specimen, approximately one gram of wet weight (precise weight 
was recorded and used for calculations) was diluted with 20 mL of milliQ water (18 
ohms).  This step was performed in triplicates for process control. The homogenate was 
vortexed at the highest speed for three minutes to achieve complete mixing. Then the 
homogenates were centrifuged at 13,000 rpm for 15 minutes and the supernatants were 
filtered through 0.2-um PVDF membranes (PALL Coorparation).  30 uL of reference 
solution was added to 270 uL of the filtrate.  The reference solution was composed of 
100% D2O, 5 mM DSS and 0.1% sodium azide.  The resulting mixture was loaded into 
3mm H-NMR tubes (Bruker Inc) (duplicates for analytical controls) and shipped to 
Pacific Northwest National Laboratories (PNNL) on ice blocks for NMR analysis.  There, 
the metabolite analysis was performed using a Bruker 500 MhZ NMR as previously 
described (Kajimoto et al., 2014).  Chenomx suite 8.1 was used to collect NMR 
spectrums (chenomx.com).  From the metabolome data, we calculated the mean of the six 
data points for each compound and normalized the concentrations to per gram dry weight 
of feces.  
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6.2.4 Statistical Analysis  
We performed statistical analyses with Statistical Package for Social Sciences 
(SPSS v22) (Chicago, IL) and R using Bioconductor package (www.bioconductor.org).  
For the subject metadata, which includes, age, BMI, diet information, and symptom 
checklist 90, we used Mann-Whitney’s U test since this data had non-normal distribution.  
We considered P values smaller than 0.05 as significant.  We normalized the H-NMR and 
16S rRNA gene data using the following methods: dividing the metabolite quantities for 
each subject by the respective dry weight of the stool sample normalized data.  Any zero 
quantity for a metabolite was considered a missing value.  For NMR data, we conducted 
one-way analysis of variance (ANOVA) with post-hoc tests of all pairwise comparisons 
using Tukey-Kramer p-value adjustments (Tukey, 1949) for multiple comparisons.  We 
also conducted Mann-Whitney’s U test and performed Bonferroni correction.   
 For 16S rRNA gene data, we used a similar approach to NMR normalization.  
After assuming the zeros were missing values, we normalized the data using the 75th 
quartile method.  We conducted pairwise differential abundance tests using edgeR which 
assumes a negative binomial distribution for OTU count data and conducts a likelihood 
ratio test (McCarthy et al., 2010).  Then, we performed DeSeq2 test, which is more 
conservative compared to edgeR for significance to provide a secondary check.   
6.2.5 Refining the Definition of Successful RYGB   
We used three methods to sub-group RYGB subjects into successful and 
unsuccessful categories:  For the first method, we classified the individual who lost less 
than 50% of the %EWL or regained ≥ 20% of the % nadir EWL as unsuccessful.  All 
RYGB patients in our study lost more than 50% EWL; however, seven of these patients 
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regained at least 20% EWL and were classified as URYGB.  The remaining 14 were 
classified as SRYGB.  Throughout this chapter, I will refer to this classification as 20% 
regain method.  This method has been commonly used in clinical studies to assess the 
success of bariatric surgery procedures (Dayyeh et al., 2011).  Since the definition of 
successful bariatric surgery is subjective and unclear (Puzziferri, et al., 2008), we utilized 
machine-learning algorithms to understand which parameters are important in defining 
success.   
For the second method, we used k-means clustering (Hartigan et al., 1979) and 
picked 2 as seed size: one for successful and one for unsuccessful, I refer to this method 
as 2-means clustering.  For the third method, we evaluated the distribution of %EWL, 
max % EWL, %EWL rate and changes in BMI, decided to use max 85%-maxEWL as a 
cut-off as it formed two clusters.  In order to understand how these three methods define 
success, we calculated the following weight loss associated metrics: Delta BMI, weight 
loss percent, lowest weight loss percent, weight loss percent rate, excess weight loss 
percent at follow-up, nadir excess weight loss percent, and regained excess weight loss.  
The formulas used to calculate these metrics were summarized in Appendix 5.  Then we 
evaluated how good the methods separate successful ones from the unsuccessful ones: 
6.3 Results and Discussion 
6.3.1 Subject Characteristics and Categorizing RYGB Subjects into Successful and 
Unsuccessful Groups 
RYGB group contained 24 individuals with different degrees of  %EWL; the 
median was 73.75%, the minimum was 51%, and the maximum was 104%.  We used 
three different classification methods --- 20% regain, 2-means clustering, and 85%- 
   103 
maxEWL --- to evaluate the success of surgery.  As shown in Figure 5.1A, with 20% 
regain method we observed relatively good separation of successful and unsuccessful 
groups based on delta BMI and weight loss percent metrics but poor separation based on 
other metrics.  2-means clustering method had the best separation of successful and 
unsuccessful subjects based on majority of the metrics as seen in Figure 5.1B; those 
metrics were excess weight loss at follow-up, nadir excess weight loss percent, and 
weight loss percent rate.  Figure 5.1C shows the metrics based on 85%-EWL; similar to 
2-means clustering method, 85%-maxEWL method resulted in good separation based on 
excess weight loss at follow-up, nadir excess weight loss percent, and weight loss percent 
rate. 
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Figure 6.1 Weight loss metrics based on A) 20% regain, B) 2-means clustering, and C)85%-maxEWL classification methods. 
Numbers represent: 1-Delta BMI, 2-EWL percent, 3-Nadir EWL, 4-Regained EWL, 5-Weight loss percent rate, 6-Lowest 
weight loss percent, 7- Total weight loss 
104 
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Figure 6.2 shows %EWL, % nadir EWL, and % regain of EWL of successful and 
unsuccessful RYGB groups based on three different types of classification: 20% regain, 
2-means clustering, and 85%-maxEWL methods.  As seen in Figure 6.2A, 20% regain 
method formed SRYGB and URYGB groups with significantly different %EWL and 
%regain, but not nadir %EWL.  Grouping based on 2-means clustering and 85%-
maxEWL yielded similar results for %EWL and % nadir EWL but opposite trends for 
%regain.  With 2-means clustering method, %EWL and nadir %EWL were statistically 
different between SRYGB and URYGB groups, whereas %regain was not different.  
Based on 85%-maxEWL method, only nadir %EWL was statistically different between 
SRYGB and URYGB groups.  Among the three classification methods we used, 20% 
regain was the only method that separated the subjects that regained weight.  SRYGB and 
URYGB groups had significantly different %EWL with 20% regain and 2-means 
clustering methods.  Neither of the classification methods we used in this chapter showed 
statistical difference on diet composition between successful and unsuccessful 
individuals.  
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Figure 6.2 %EWL, nadir %EWL, and %regain of successful and unsuccessful RYGB 
groups classified by A) 20% regain method, B) 2-means clustering method, C) 85%-
maxEWL method. 
 
In order to better understand whether we can predict the success of RYGB using 
the datasets we collected (clinical metadata, diet, 16S rRNA gene data, and NMR 
metabolomics data), we used Naïve Bayes classifier (Russel and Norvig 2002) and 
evaluated the predictions based on the classification methods (20% regain, 2-means 
clustering, and 85% maxEWL) we used.  Figure 6.3 shows the results of how selected  
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features from 16S rRNA gene and NMR dataset can accurately classify subjects 
into their true categories.  As seen in Figure 6.3A, based on genus-level phylotype 
presences/abundances, all three classification methods did poorly on predicting NW and 
Ob(-) subjects into their true groups.  Among the three methods, 85%-maxEWL method 
performed better placing SRYGB and URYGB subjects into their true groups than 20% 
regain and 2-means clustering methods.  85%-maxEWL method can place successful 
subjects into successful group with 71.8% accuracy and unsuccessful ones to 
unsuccessful group with 68% accuracy.  
When we tried to classify subjects based on NMR metabolomics data, we did not 
achieve accuracies as high as we got from 16S rRNA gene data.  As seen in Figure 6.3B, 
metabolomics data failed to predict the success of surgery.  Among the three 
classification methods, 20% regain performed better placing SRYGB subjects into 
SRYGB group but failed to place URYGB subjects into URYGB group.  All 
classification methods did poorly placing URYGB into URYGB group.  The majority of 
the URYGB subjects were placed into SRYGB group, which indicated metabolomics 
data is good enough to distinguish the effect of surgery on metabolome, however not 
good enough to assess the success of the surgery based on the classification methods 
provided.  
Overall these results indicate that 16S rRNA gene data is a better predictor of the success 
of RYGB than NMR based fecal metabolomics data.  Additionally, the ways we define 
success have an impact on the prediction of success.  85%-maxEWL method provides 
better separation and classification of post RYGB subjects into successful and 
unsuccessful groups, compared to 20% regain and 2-means clustering methods. 
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Figure 6.3.  Machine-learning results on predictions of success of RYGB surgery under three scenarios: 20% regain, 2-means 
clustering, and 85%-maxEWL.  Panel A summarizes the results of predictions based on 16S rDNA results and Panel B 
summarizes the results based on H-NMR metabolomics data.  The true class predictions are bolded and the matrix of accuracy 
percentages are colored as a heatmap, with higher accuracies tending toward darker blue and lower accuracies tending toward 
white.   
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6.3.2 Gut Microbiota Post SRYGB was Peculiar and Different than Post URYGB 
As I demonstrated in Chapter 5, post-RYGB subjects had different microbiome 
structure than the non-surgical subjects from NW and Ob(-) groups.  After demonstrating 
RYGB had an impact on microbial community structure, I investigated how different 
classification approaches (20% regain, 2-means clustering, and 85%-maxEWL) cluster 
RYGB subjects based on their success, and I present the results in Figure 6.4.  When I 
used the weighted Unifrac approach, the methods: 20% regain, 2-means clustering and 
85% -maxEWL failed to form clusters based on success, even though the 20% regain 
method showed slight separation of unsuccessful subjects from the successful subjects.  
This finding indicated that the most abundant OTUs do not contribute to the success of 
the surgery.  
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Figure 6.4. Beta diversity analyses on post-RYGB samples.  Subject microbiomes are 
color-coded based on success of the surgery: light blue as SRYGB and dark blue as 
URYGB.  Figure A, C, and E show weighted and unweighted Unifrac distances among 
the subjects based 20% regain, 2-means clustering, and 85% max-%EWL methods. 
Figures B, D, and F show the difference among SRYGB and UYGB groups on the PC1 
and PC2 axes. 
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When I employed unweighted Unifrac approach, which relies on presence or 
absence of OTUs in a phylogenetic context, giving more weight to minor taxa, 2-means 
clustering and 85%-maxEWL methods formed gradient clusters on PC2.  As shown in 
Figure 6.4D and 6.4F, the PC2 distances were statistically different among successful and 
unsuccessful groups for two of the success definitions used.   
Based on these findings, I concluded that the definition of regain of more than 
20% of	%EWL does not separate the microbiome structure significantly but might be 
important for the distribution of more abundant OTUs.  2-means clustering method and 
85% max EWL methods generated similar results:  They did not contribute to clustering 
based on weighted Unifrac metric but showed some level of separation based on 
unweighted Unifrac metric. These findings indicate that presence of unique and possibly 
low abundant phylotypes are important for success in terms of excess weight loss or nadir 
excess weight loss rather than abundance of highly abundant phylotypes. 
6.3.3 Abundance of Genus-Level Phylotypes in Successful and Unsuccessful RYGB 
Groups Relied on Definition of Success 
Classification results have shown that 16S rDNA data at the genus level is better 
predictor of the success of the surgery than patient metadata, psychology of the patients 
or fecal metabolome data.  As discussed in detail in Chapter 5, many genus-level 
phylotypes such as Veillonella, Streptococcus, Enterococcus, Klebsiella, Megaspheara, 
Haemophilus and Prevotella were at greater abundance in post-RYGB subjects than in 
non-surgical subjects (NW and Ob(-)).  
In order to better understand whether microbial phylotypes that were enriched 
after RYGB have any connection to successful and sustainable weight loss, we compared 
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their normalized abundances in successful and unsuccessful groups that were defined 
based on three different methods (20% regain, 2-means clustering, and 85%-maxEWL), 
as shown in Figure 6.5. 
 
 
Figure 6.5. Normalized log10 abundance of genus-level phylotypes that were 
significantly more abundant in the SRYGB compared to URYGB based on all three 
methods used to define success: 20% regain, 2-means clustering, and 85%-maxEWL. 
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Based on 20% regain method, Fusobacterium and Haemophilus were more 
abundant; Enterococcus and Coprococcus were less abundant in the URYGB compared 
to SRYGB.  Interestingly, those phylotypes were significantly more abundant in post-
RYGB subjects than the nonsurgical subjects.   Based on 2-means clustering and 85%-
maxEWL methods, four different genus-level phylotypes were statistically more 
abundant in the URYGB than the SRYGB, and we did not observe any phylotype that 
was significantly more in the SRYGB than URYGB based on these methods.  For 2-
means clustering, these phylotypes were: Prevotella, Fusobacterium, Blautia and 
Ruminococcus, whereas for 85%-maxEWL method, they were: Fusobacterium, 
Haemophilus, Bifidobacterium, and Ruminococcus.  Interestingly, Fusobacterium was the 
common signature of unsuccessful RYGB based on all three classification methods, 
Haemophilus was common for 20% regain and 85%-maxEWL methods, and 
Ruminococcus was common for 2-means clustering and 5% maxEWL methods.   
 Fusobacterium was reported to be more abundant in post-RYGB subjects (Furet, 
et al., 2010) and our findings reported in Chapter 5 confirm that.  Higher abundance of 
Fusobacterium species in oral microbiome (Goodson, et al., 2009) and fecal microbiome 
(Angelakis, et al., 2012) were previously associated with obese metabolic type in 
humans.  Increased abundance of Fusobacterium was also observed in many health 
conditions such as colorectal cancer (Kostic, et al., 2012), and it is known to produce 
lipopolysaccharides that can induce inflammation (Sveen et al., 1977).  Since obesity is 
associated with low-grade inflammation (Everard, et al., 2013), Fusobacterium might be 
involved in the weight gain processes after RYGB.   
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 Haemophilus has not been associated with weight gain or weight loss before.  
Ruminoccoccus was found to decrease in individuals that lose weight via dieting and 
exercise (Nadal, et al., 2009, Santacruz, et al., 2009).  Interestingly, Bifidobacterium 
species were found more abundant in not obese compared to obese populations 
(Santacruz, et al., 2010).  Prevotella was found more abundant in obese population than 
normal weight or post-RYGB populations (Zhang, et al., 2009), here we observed higher 
Prevotella in post-RYGB population compared to nonsurgical, however significantly 
more in URYGB than SRYGB.   
 Our results have shown that the method used to define success can yield different 
outcomes in terms of associating microbial phylotypes with success of the surgery.  
Although some phylotypes such as Fusobacterium in this case, appear to be signature of 
unsuccessful RYGB regardless of the method used to define success.  Understanding 
Fusobacterium metabolism and its interactions with the host might explain weight gain or 
inability to loose excess weight after RYGB.  
6.3.4 Fecal Metabolites Mainly from Amino Acid Degradation Pathways form Signatures 
of Successful and Unsuccessful Bariatric Surgery 
Fecal metabolome profiles of post-RYGB, NW, and Ob(-) groups were different.  
Figure 6.6 shows principal component analysis based on fecal metabolomes.  Principal 
component analysis demonstrated that post-RYGB metabolomes are different than NW 
and Ob(-) metabolomes.  Additionally, NW and Ob(-) metabolomes were different from 
each other as well.  Ob(-) subjects had the highest fecal concentrations of many of the 
metabolites detected including short chain fatty acids (SCFAs), and amino acids (AAs), 
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whereas NW subjects had relatively lower concentration of the majority of the 
metabolites compared to RYGB and Ob(-) groups.  
 
Figure 6.6.  Principal component analysis performed on fecal metabolomes of 
individuals from NW, post-RYGB, and Ob(-) groups.   
 
Branched chain fatty acids: isovaleric and isobutyric acids and phenlyacetic acid 
were significantly more abundant in the RYGB group compared to NW and Ob(-) groups 
as seen in Table 6.1.  Lactic acid was also significantly more abundant in the RYGB 
group.  Molecules that form conjugates with bile acids (taurine and glycocholic acid) and 
choline, which is the precursor of neurotransmitter acetylcholine, were significantly more 
abundant in the Ob(-) group compared to RYGB group.  Additionally, amino acid 
arginine was significantly lower in the RYGB group compared to NW and Ob(-) groups. 
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Table 6.1.  Log 2 transformed concentrations of metabolites that were significantly more 
or less abundant in the RYGB group compared to NW and Ob(-).   
  NW RYGB Ob(-) 
Isobutyric acid* 2.55±0.91 3.31± 0.78 2.54±0.82 
Isovaleric acid* 2.31±0.82 3.24±0.75 2.21±0.76 
Phenylacetic acid** 1.98±1.08 2.72±0.86 1.72±0.79 
Choline** -4.43±1.24 -3.97±1.37 -2.85±1.36 
L-arginine** -0.60±0.54 -1.82±0.83 -0.95±0.8 
L-lactic acid* -2.48±0.54 -1.46±1.36 -2.34±0.93 
Taurine** 0.50±0.93 -1.13±1.72 2.07±2,38 
* indicates significantly greater abundance and ** indicates significantly less abundance. 
Isobutyric, isovaleric, phenylacetic, and lactic acids were at greater abundance in 
the RYGB group, slightly higher in SRYGB groups however there was no statistical 
difference between SRYGB and URYGB regardless of how we define the success.  
Next, we evaluated how defining success of the RYGB surgery with three different 
methods can identify signatures of successful or unsuccessful RYGB surgery. When we 
compared the abundances of fecal metabolites in successful and unsuccessful groups 
using ANOVA, we did not observe any significant difference between the groups 
regardless of the classification method used.  With Mann-Whitney’s U test, we detected a 
few metabolites that distinguished successful groups from unsuccessful ones.  I also 
performed Receiver Operator Characteristics (ROC) analysis based on three different 
definitions of success.  As seen in Figure 6.7A, 4-hydroxyphenylacetate, xanthine, ribose, 
choline, and taurine emanated as signatures of unsuccessful RYGB with Area Under the 
Curve (AUC) values of greater than 0.6.  2-means clustering and 85%-maxEWL methods 
yielded comparable results.  As shown in Figures 6.7B and 6.7C, putrescine, malonate, 
ethanol, and hydroxyisobutyrate were signatures of unsuccessful surgery with both 
methods. In summary, ROC analysis failed to identify signatures of successful surgery 
but showed some indications of unsuccessful surgery. 
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Figure 6.7 Receiver operator characteristics (ROC) analysis of fecal metabolites shows 
signs of successful and unsuccessful surgeries.  A) 4-hydroxy-phenylacetate and xanthine 
were signatures of unsuccessful surgery based on 20% regain method.  Putrescine and 
malonate were signatures of unsuccessful surgery based on B) 2-means clustering method 
and C) 85% maxEWL method 
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Based on Mann-Whitney’s U test results, with the 20% regain method xanthine 
and 4-hydroxyisobutyrate were significantly more abundant in the URYGB than 
SRYGB.  Putrescine and malonate were significantly more abundant in the URYGB than 
SRYGB based on 2-means clustering method.  
In summary we fatty acids did not distinguish successful and unsuccessful 
subjects, even though isobutyric and isovaleric acids were at greater abundance in the 
SRYGB group based on 20% regain method.  However, we should not neglect the fact 
that the unsuccessful subjects in this study had some degree of weight loss (at least 50% 
of the EWL); therefore these branched chain fatty acids are possibly contributing to 
weight loss.  The branched-chain fatty acids isobutyrate and isovalerate serve as signaling 
molecules that show potent activity against the G-protein-coupled receptor GPR41 (Le 
Poul, et al., 2003) and free-fatty-acid receptors 2 and 3, which are involved in the 
regulation of appetite (Schmidt, et al., 2011).  Higher abundance of these branched chain 
fatty acids in post-RYGB groups can give a slight edge and contribute to host weight loss 
via signaling hormonal and neural networks of the host.  
Based on ROC analysis, 4-hydroxyphenylacetate and xanthine were signatures of 
URYGB based on 20% regain method, and significantly more abundant in the URYGB 
subjects.  This finding indicates that these two metabolites might contribute to weight 
gain in the long-term.  Many microbial species, especially the ones that degrade nucleic 
acids such as Enterococcus species are known to produce xanthine from purine 
degradation (Huycke, et al., 2002), and xanthine triggers lipolysis in the adipose tissues 
and then lead to release of hunger hormone ghrelin (Beavo, et al., 1970).  Xanthine has 
been observed at higher concentrations in obese patients compared to normal-weight 
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patients (Calvani, et al., 2010).  On the other hand, 4-hydroxyphenylacetate is the 
precursor of 4-cresol, and mainly produced from Clostridia species (Holmes, et al., 
2011).  4-hydroxyphenylacetate has not been associated with host metabolism yet 
although it has been observed to be at greater concentrations in aged mice compared to 
young mice (Calvani, et al., 2014).  Putrescine and malonate discriminated URYGB 
subjects from SRYGB subjects based on 2-means clustering and 85%-maxEWL methods, 
and URYGB subjects had significantly higher fecal concentrations of these metabolites 
compared to SRYGB subjects based on these two methods.    
Fusobacterium, Bacteroides and Pseudomonas can degrade ornithine and produce 
putrescine (Noack, et al., 2000).  Fusobacterium was at greater abundance in the 
URYGB group than the SRYGB one regardless of the classification method used.  Li et 
al. detected an increase in urinary putrescine in rats after RYGB surgery (Li, et al., 2011) 
but did not associate putrescine with weight loss or weight gain.  In a different study 
putrescine has been associated with the accumulation of fat and it has also been suggested 
as urinary biomarker for diabetes (Kim, et al., 2010).   
Besides putrescine, Fusobacterium species can produce malonate (Dzink & 
Socransky, 1990).  Malonate can inhibit oxidation of glutamate because it is an inhibitor 
of succinate dehydrogenase enzyme (Greene & Greenamyre, 1995). Malonate has been 
reported in many toxicity studies but it hasn’t been associated with weight gain or weight 
loss.   
In conclusion, success of bariatric surgery depends on many factors, and the description 
of successful RYGB to date is variable and subjective.  Our results show that gut 
microbiome can be one of the contributors of successful and sustainable weight loss 
   120 
after RYGB.  Fecal metabolome was not a good indicator of the successful RYGB 
surgery, although we identified a few promising metabolites as signatures of unsuccessful 
RYGB.  Pathways involved in weight loss and weight gain are redundant, so 
identification of multiple microbial signatures would be important for the estimation of 
success of RYGB.  Sample size was our main limitation to validate some of the findings 
with robust statistics; future studies with greater number of subjects will help validate 
these findings. 
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CHAPTER 7 
LONGITUDINAL CHANGES IN LUMINAL AND MUCOSAL MICROBIOME, 
AMINO ACID, AND BILE ACID METABOLISM AFTER RYGB SURGERY 
7.1 Introduction 
Roux-en-Y gastric bypass (RYGB) is an efficient treatment strategy for morbid 
obesity and its comorbidities such as diabetes mellitus (Ryan et al., 2014).  RYGB 
changes hormonal response (Korner et al., 2009), energy metabolism (Korner et al., 
2009), and bile-acid circulation in the body (Ryan et al., 2014).  A number of studies 
have shown that RYGB transforms gut microbiota (Furet et al., 2010; Graessler et al., 
2013; Palleja et al., 2016; Tremaroli et al., 2015; Zhang et al., 2009), although only a few 
of them (Furet et al., 2010; Graessler et al., 2013; Palleja et al., 2016) have monitored gut 
microbiota before and after the surgery in the same individuals.  Studies with human 
subjects have shown that gut microbiota composition shifts promptly, as soon as three 
months after the surgery (Furet et al., 2010) and those shifts have been reported 
prominent even 12 months after the surgery (Palleja et al., 2016). Post-RYGB patients 
have unique diets; they begin consuming small portions of solid food only eight-nine 
months post-operatively (Brolin, Robertson, Kenler, & Cody, 1994), therefore diet can 
impact the results of cohort studies, and it is essential to validate their results with cross-
sectional studies.   
Changes in gut microbiota after RYGB have been associated with remission of 
diabetes in humans (Graessler et al., 2013) and weight loss in rats (Liou et al., 2013) and 
in humans (see Chapter 5).  These associations possibly rely on production of microbial 
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metabolites because (as discussed below) these metabolites are key for host-microbial 
interactions.  Metabolic products of the gut microbiota after RYGB exert beneficial 
effects on host metabolism (Liou et al., 2013).  Microorganisms produce a variety of 
metabolites that enhance communication between the host and the microbes; these 
molecules vary from fermentation end-products such as short chain fatty acids (SCFAs) 
to secondary bile acids (Nicholson et al., 2012).  SCFAs butyrate and propionate, which 
are known to induce satiety in animals due to their affinity to free fatty acid receptors 
(Nilsson, Kotarsky, Owman, & Olde, 2003), increase in concentrations after RYGB 
surgery.  On the other hand, acetate can induce fattiness in the liver (Hanson & Ballard, 
1967), and microbial hydrogen metabolism can control acetate production (Nie, Liu, Du, 
& Chen, 2008).  Bile acids are another group of metabolites that are microbially 
transformed, and their concentrations change in the plasma after RYGB surgery (Kohli et 
al., 2013; Ryan et al., 2014), some researchers consider bile acids and their 
transformation one of the possible factors that leads to successful weight loss after 
bariatric surgery (Li et al., 2011).  RYGB surgery also increases the abundance of amino 
acid degradation genes (Palleja et al., 2016), although the metabolic products have not 
been identified or quantified in humans yet.  
Additionally, human gut microbiome studies after RYGB to date have only relied 
on fecal samples (Furet et al., 2010; Graessler et al., 2013; Palleja et al., 2016; Tremaroli 
et al., 2015; Zhang et al., 2009).  Microbiota of mucosal surfaces in individuals with 
morbid obesity and after RYGB are unknown. 
Microorganisms inhabit luminal and mucosal surfaces of our gastrointestinal 
tracts.  Due to invasive nature of mucosal sample collection, a vast majority of the gut 
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microbiota studies rely on luminal sample collection (Durban et al., 2011).  It has been 
previously shown that mucosal and luminal samples from healthy individuals vary in 
microbiota composition, and luminal microbiota do not represent the mucosal microbiota 
(Durban et al., 2011).  Many factors including nutrients, physical and chemical 
conditions in the gut, and immune system interactions diverge mucosal microbiota from 
luminal microbiota (S. Macfarlane & Dillon, 2007).  For instance, a decreasing vertical 
oxygen gradient exists from mucus layer to the lumen, which creates a facultative 
anaerobic to obligate anaerobic zone (Espey, 2013).  Another important difference 
between mucosal and luminal microbiota is the organic substrate: luminal communities 
often utilize undigested diet components such as plant polysaccharides, whereas mucosal 
communities utilize host-derived glycans (Hooper, Midtvedt, & Gordon, 2002).  The 
composition of the mucosal microbiota can change drastically during gastrointestinal 
diseases (S. Macfarlane & Dillon, 2007).  Inflammatory diseases such as ulcerative colitis 
(UC) affect the colonic mucosa or sub-mucosa, and UC patients had different microbiota 
than healthy individuals (S. Macfarlane & Dillon, 2007).  Similarly, luminal and mucosal 
microbiota composition change in colorectal cancer (Chen, Liu, Ling, Tong, & Xiang, 
2012).  Variations in the mucosal and luminal microbiota were also observed in diabetic 
mice (Amar et al., 2008; Cani et al., 2008).   
The objectives of this study were: (i) to investigate microbial and metabolic 
changes after the surgery and compare findings with cross-sectional studies, (ii) to 
explore if changes in microbiota after surgery increase weight loss and reduce weight 
gain associated metabolic products, (iii) to reveal differences between mucosal and 
luminal communities in morbidly obese individuals before and after RYGB surgery. 
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Here, we characterized microbiome structure and metabolism after RYGB using multi-
omic techniques including, 16S rRNA gene fingerprinting, gas chromatography mass 
spectrometry, liquid chromatography mass spectrometry, and nuclear magnetic 
resonance.  We also provided a comprehensive analysis on changes to microbiome and 
metabolome after RYGB by comparing cohort and case-study results.   
7.2 Materials and Methods 
7.2.1 Study Design and Ethical Consideration 
 
The Institutional Review Board of Mayo Clinic Scottsdale and Arizona State 
University  (IRB# for both = 10-008725) approved our study.  We recruited 10 morbidly 
obese subjects that were scheduled to undergone RYGB surgery and 10 normal weight 
controls. One of the subjects dropped the study after baseline sampling and two of them 
missed the 6-months sampling.  The pre-surgical population consisted of 5 female and 5 
male subjects whereas normal group consisted of 7 females and 3 males.  Median age of 
the subject groups was not statistically different among the groups.  In order to confirm 
results of case-control studies with this cohort study, we expanded our study to include 
subjects that had RYGB surgery 9 months to 60 months before the sample collection.  
We collected samples from pre-bariatric morbidly obese subjects (RYGB baseline) 
before the surgery, 6-months and 12-months after the surgery in addition to 36 
retrospective (retro-RYGB) and 10 normal-weight (NW) subjects.  Fecal samples were 
collected from all the individuals at each time point.  Subjects donated the fecal samples 
216±41 days and 455±124 days after the surgery.  Rectal biopsies were collected during 
non-sedated sigmoidoscopy from 10 NW subjects and 9 pre-bariatric surgery subjects 
before and 12-months after the surgery at Mayo Clinic, Scottsdale U.S.A.  Mayo Clinic 
   125 
personnel immediately transferred the samples into sterile RNAse/DNAse free cryogenic 
tubes with sterile forceps. The tubes were instantly submerged in liquid nitrogen for one 
minute and then transferred to a -80 oC freezer on dry ice.  Samples were shipped to ASU 
on dry ice and placed into a -80 oC freezer immediately upon receipt.  The samples were 
shipped to ASU from Mayo Clinic on dry ice and were kept at -80oC until analysis. 
7.2.2 DNA and RNA Extraction Protocols 
We extracted microbial DNA and RNA from fecal and biopsy samples to 
represent luminal and mucosal microbiota.  For DNA and RNA extractions, we used 
MOBIO PowerSoil DNA extraction (MOBIO Laboratories, Carlsbald, CA, USA) and 
MOBIO PowerSoil RNA extraction kits (MOBIO Laboratories, Carlsbald, CA, USA), 
respectively.  RNA extracts were treated with MOBIO DNase Max kit (MOBIO 
Laboratories, Carlsbald, CA, USA), and cDNA synthesis was performed using 
Omniscript Reverse Transcription kit (Qiagen, Santa Clarita, CA, USA) according to 
manufacturer’s instructions.  
7.2.3 16S rRNA Gene Sequencing and Analysis 
We prepared sequencing libraries using the protocols from Earth Microbiome 
project using V4 forward and reverse primers with Illumina Miseq Instrument (Gilbert, 
Jansson, & Knight, 2014).  PANDAseq (Masella, Bartram, Truszkowski, Brown, & 
Neufeld, 2012) paired reads were analyzed using QIIME 1.9 suite (Caporaso et al., 
2010).  The analysis was followed by Kang et al. with the following modification: 
clusters were formed at 99% sequence similarity in addition to 97% sequence similarity 
(Kang et al., 2015).   
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We utilized alpha and beta diversity metrics of Phylogenetic Diversity Whole Tree 
(Faith, 1992), and Unifrac (Lozupone, Hamady, & Knight, 2006) to better understand 
microbial community structures. 
7.2.4 Quantitative-PCR on Hydrogen Consuming Microorganisms 
We performed quantitative polymerase chain reaction (q-PCR) on targeted 
microbial genes (fthfs, mcrA, and dsrA) to detect homoacetogenesis, methanogenesis, and 
sulfate reduction using Eppendorf thermocyclers according to previously described 
methods (Ontiveros-Valencia et al., 2012; Parameswaran, Torres, Lee, Krajmalnik-
Brown, & Rittmann, 2009).  We carried out quantitative PCR assays in 20 uL reactions 
consisting of 1X SYBR Premix Ex Taq (Tli Rnase H Plus) (Takara), 10 ng/ ul genomic 
DNA or cDNA, 10 mM forward and reverse primers, and DNase free water.  We 
quantified formyltetrahydrofolate synthetase (fthfs) gene for homoacetogens(Leaphart & 
Lovell, 2001), dissimilatory sulfide reductase (dsrA) gene (Kondo, Nedwell, Purdy, & 
Silva, 2004) for sulfate reducers, and methyl coenzyme-M reductase (mcrA) gene for 
methanogens (Luton, Wayne, Sharp, & Riley, 2002).   
7.2.5 H-NMR Analysis of Water-Soluble Fecal Metabolites 
For each fecal specimen, approximately one gram of wet weight (precise weight 
was recorded and used for calculations) was diluted with 20 mL of milliQ water (18 
ohms). This step was performed in triplicates for process control.  The homogenate was 
vortexed at the highest speed for three minutes to achieve complete mixing.  Then the 
homogenates were centrifuged at 13,000 rpm for 15 minutes and the supernatants were 
filtered through 0.2-um PVDF membranes (PALL Coorparation).  30 uL of reference 
solution was added to 270 uL of the filtrate.  The reference solution was composed of 
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100% D2O, 5 mM DSS and 0.1% sodium azide.  The resulting mixture was loaded into 
3mm H-NMR tubes (Bruker Inc) and shipped to Pacific Northwest National Laboratories 
(PNNL) on ice blocks for NMR analysis.  There, the metabolite analysis was performed 
using a Bruker 500 MhZ NMR as previously described (Kajimoto et al., 2014).  
7.2.6 Gas Chromatography-Mass Spectrometry Analysis of Fecal Metabolites  
 Fecal samples were lyophilized before extraction.  Fecal metabolite derivatization 
and GC-MS analysis were based on the protocols described by Kaiser et al. (Kaiser et al., 
2013).  
7.2.7 Liquid Chromatography-Mass Spectrometry Analysis of Bile Acids 
Bile acids were extracted from fecal samples at PNNL following the protocol 
from Humbert et al. (Humbert et al., 2012).  Briefly,  fecal matter was lyophilized and a 
protocol using NaOH extraction was performed.  Once the bile acids were extracted, they 
were identified and quantified with High Pressure Liquid Chromatography (HPLC-
MS/MS) coupled with tandem mass spectrometry as described by Hubert et al. (Humbert 
et al., 2012).   
7.2.8 Statistical Analyses of Microbiome and Metabolome Data Sets 
We used Statistical Package for Social Sciences (SPSS) for all the statistical 
analysis and R packages.  The NMR, GC-MS, and GC-LS generated datasets were log2 
transformed.  The 16S rRNA gene sequence data was normalized based on 75th quartile 
method described by Paulson et al. (Paulson, Stine, Bravo, & Pop, 2013).  For the 
longitudinal data analysis, we performed Wilcoxon signed-rank test and accepted P 
values less than 0.05 as significant.  For group comparisons, we used Mann-Whitney’s U 
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test and accepted P values that were False Discovery Rate corrected and less than 0.05 as 
significant.   
7.3 Results and Discussion  
7.3.1 Subjects Achieved the Greatest Weight Loss Six Months after the RYGB Surgery 
Figure 7.1 shows short-term and longer-term effects of RYGB surgery on weight 
loss.  The median body mass index (BMI) before surgery was 45 kg/m2, and in 6 months 
it dropped to 35 kg/m2.  The median BMI dropped minimally from 6 months to 12 
months and remained at an average of 33kg/m2 as shown in Figure 7.1A.  Even though 
subjects lost substantial amount of weight, and the drop was statistically significant at 6 
and 12 months, the majority of the subjects remained clinically obese with BMIs higher 
than 30 kg/m2 even one year after RYGB.  Percent excess weight loss (%EWL) 
calculations, as seen in Figure 7.1B, confirmed that the subjects achieved the greatest 
weight loss during the initial 6 months and the subjects maintained the weight loss 
benefits a year after the surgery.   
Figure 7.1. Parameters that indicate weight loss after RYGB surgery showed the greatest 
weight loss period being 6-months after the surgery.  A) Body mass index (BMI) index of 
subjects before the surgery (baseline), 6-months and 12-months after the surgery.   
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B) % Excess Weight loss 12 months after the surgery, 6 months after the surgery and 6 to 
12 months after the surgery. 
 
Weight loss after the surgery was correlated to the diet and exercise regimens of 
the subjects.  Table 7.1 summarizes total dietary calories, dietary composition and 
calories burned as a result of exercise of the subjects.  Based on total calories, morbidly 
obese subjects (RYGB baseline) were consuming fewer calories than the NW subjects.  
The subjects reduced the amount of calories they consume by 30% during the first 6 
months. Compared to their baseline, subjects were consuming 22% less calories at 12 
months, yet the weight loss benefits were sustained.  The subjects also increased the 
amount of calories consumed due to exercise after the surgery, which possibly 
contributed to their weight-loss and maintenance of body weight.  The dietary 
composition of the morbidly obese subjects did not significantly change after the surgery, 
although compared to NW individuals, carbohydrates formed smaller fraction of the diets 
of post RYGB subjects.   
Table 7.1.  Dietary composition of the normal-weight (NW), pre-surgical morbidly obese 
baseline (RYGB-base), 6 months (RYGB-6m), and 12 months (RYGB-12m) after the 
surgery samples. 
 
 NW RYGB-base RYGB- 
6m 
RYGB- 
12m 
Calorie intake (cal) 2159±681 1820±706 1311±513 1419±465 
Carbohydrate % 51±7.4 42.5±7.6 40.0±5.8 37.0±6.5 
Fat% 33±5.7 36.5±6.3 36±5.4 38.0±5.6 
Protein % 14±2.9 19.5±4.2 20.0±8.0 21±8.3 
Fiber intake (g) 21±9.1 14±12.5 18±6.5 14±4.6 
Exercise (cal) 2076±3074 532±1446 1845±1908 952±1012 
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7.2 RYGB Changed Microbial Community Structure Longitudinally and the RYGB-retro 
Cohort Validated Cross-Sectional Study Results.  
Figure 7.2A underscores the longitudinal changes in luminal microbiome after 
RYGB surgery.  We performed unweighted (Figure 7.2A) and weighted Unifrac (Figure 
B.1) analyses to understand changes in microbiome structure after the surgery.  We 
observed greater differences in community structure after the surgery with unweighted 
Unifrac, which enhances the differences in the microbiome structure of minor phylotypes 
of the community because the analysis is based on changes on presence or absence and 
not on abundances.  Based on unweighted Unifrac distances, changes in the luminal 
microbiome were apparent as short as 6 months after the surgery.  This difference could 
be due to changes in the gut environment (Zhang et al., 2009) and changes in the diet 
(Brolin et al., 1994) after RYGB.   
 
Figure 7.2.  Longitudinal changes on luminal microbiome structure after RYGB surgery.  
A) Unweighted Unifrac analysis shows that minor taxa in the lumina changes after 
RYGB.  B) The location of RYGB-base and RYGB-12m subjects on principal coordinate 
1 (PC1) based on luminal samples.  C) The location on PC2 of RYGB-base subjects NW 
and RYGB-6m subjects based on luminal samples 
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On PC1, baseline and 12-months samples form two distinct clusters.  
Additionally, RYGB-12m samples were distant from NW group samples, which 
indicated that after RYGB surgery microbiome does not become similar to NW 
microbiome.  As shown in Figure 7.2B, the location of RYGB-base and RYGB-12m 
samples were significantly different on PC1 axis. Also, the PC2 axis, which explains less 
variation of the dataset than PC1, showed that RYGB-base samples were located 
distantly from NW samples.  Additionally, impact of the surgery after 6 months was more 
apparent on PC2.  Our results on luminal microbiome were consistent with the previous 
reports (Furet et al., 2010; Palleja et al., 2016) showing that microbiome structure 
changes a few months after RYGB and the changes persist in the long-term such as one 
year after the surgery.   
Figure 7.3 shows the relative abundance of significantly enriched or depleted 
genus-level phylotypes in the luminal space one year after RYGB.  The surgery altered 
relative abundances of 21 genus level phylotypes.  The majority of enrichments or 
depletions of genus-level phylotypes occurred within the first 6 months after the surgery 
and were sustained at least one year after the surgery.  Interestingly, the abundances of 
these phylotypes were significantly different in RYGB-6m and RYGB-12m groups 
compared to NW group.  Even though RYGB surgery is known to enrich phylotypes 
from Gammaproteobacteria (Furet et al., 2010; Palleja et al., 2016; Zhang et al., 2009), 
our analysis showed that RYGB impacts the abundance of many genus-level phylotypes 
from other phyla such as Firmicutes, Actionobacteria, Fusobacteria, and Bacteroides.  
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Figure 7.3.  Heat-map visualization of genus-level phylotypes significantly enriched or depleted prospectively 6 and 12months 
after RYGB surgery, and RYGB-retro (cross sectional RYGB subjects 34 months (median) after the surgery).  Luminal genus-
level phylotypes in NW, RYGB-base, RYGB-6m, RYGB-12m, and RYGB-retro groups 
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We observed an increase in the abundance of Proteobacteria phylotypes: Rothia, 
Aggregatibacter, Granulicatella, Citrobacter, Janthinobacterium, and Klebsiella.  
Firmicutes was another phylum that had many phylotypes whose relative abundances 
were affected by the surgery; while most of the phylotypes such as Streptococcus, 
Enterococcus, Lactococcus, Veillonella, and Granulicatella got enriched, other 
phylotypes such as Ruminococcus, Blautia, and Roseburia got depleted after the surgery.  
Akkermansia from Verrucomicrobia and Adlercruetzia and Rothia from Actinobacteria 
were also at greater abundance after RYGB. 
Figure 7.3 also shows the relative abundance of the aforementioned phylotypes in 
a cross-sectional retrospective RYGB group (RYGB-retro).  RYGB-retro group consisted 
of post-RYGB subjects that were unrelated and donated a sample 13 months to 60 
months after the surgery; therefore it was a heterogeneous group.  The trends we 
observed in the retro-RYGB group paralleled the RYGB-6m and RYGB-12m groups.  
This sustained changes in the microbiome after RYGB indicates that surgery imposed 
permanent environmental changes that affected gut microbiota, and the data presented 
here shows that those changes occurred soon after the surgery.  This observation was 
mainly derived from comparison of unrelated individuals; therefore it was unknown 
whether if it was the surgery or any other interpersonal variation affecting their 
abundance and leading to different profiles compared to non-surgical controls (NW and 
RYGB-baseline).  To our knowledge, this is the first study that characterized post-RYGB 
microbiome by employing both longitudinal (changes in the same individual) and cross-
sectional (changes comparing post surgery to other controls) studies. 
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Our analysis demonstrated that after RYGB surgery there is a wide spectrum of 
changes in the luminal space.  The abundances of phylotypes such as Klebsiella, 
Akkermansia, Citrobacter etc. in post-RYGB subjects were not only statistically different 
than their baseline counterparts but also normal weight controls.  Our analysis also 
demonstrated that in the short-term and long-term, abundances of several genus-level 
phylotypes from diverse group of microorganisms changed after RYGB surgery, and 
those sustained changes might possibly change the metabolic outcome of the gut 
microbiome, and contribute to weight loss.  
7.3 Post-RYGB Surgery Microbiota Changes Fecal Metabolome, Reduces Acetate 
Production and Enhances the Fermentation of Amino Acids.  
Changes in the gut microbiome structure after RYGB surgery were also reflected 
on the microbiome functione by analizing the luminal metabolome.  Figures 7.4A and 
7.4B show fecal metabolomes after RYGB on principal components detected by NMR 
and GC-MS based methods, respectively. Principal component analysis for metabolites 
detected by NMR showed that RYGB-6m and RYGB-12m fecal metabolomes clustered 
away from their baseline (RYGB-base).  GC-MS metabolome data showed comparable 
patterns to NMR metabolome data.  GC-MS data, which includes dietary components in 
addition to microbial metabolites in the fecal samples revealed greater differences after 
the surgery. In Figure 7.4C, we overlayed metabolomes of the RYGB-retro subjects to 
the metabolomes illustrated in Figure 7.4B metabolomes of the RYGB-retro group 
clustered together with RYGB-6m and RYGB-12m subjects.  This observation indicates 
that RYGB surgery not only changes microbiome in the short-term and in the longer-
term, but also that the impact of the surgery on metabolome is greater than any other 
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inter-personal variation that might influence metabolome such as diet and lifestyle.  
Moreover, observing similar clustering patterns with metabolome (Figures 7.4A and 
7.4B) and microbiome (Figures 7.2A), strengthens the connection between microbiome 
and metabolome after RYGB surgery and shows that these changes are severe and one 
directional.   
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Figure 7.4.  Fecal metabolites detected with H-NMR and GC-MS. Principal component 
analysis based on metabolites detected by (A) NMR and (B) GC-MS based metabolomes 
before and after the surgery.  C) Principal component analysis based on GC-MS 
metabolome that includes RYGB-retro group samples.  
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The major SCFAs of the human gut; acetate, butyrate, and propionate did not 
show any significant difference before or after the surgery, the results are summarized in 
Table 7.2.  The concentrations of these fatty acids in RYGB-retro and RYGB-12m 
groups were comparable.  Even though, concentrations did not show any significant 
difference, propionate to acetate and butyrate to acetate ratios increased 6 and 12 months 
after the surgery, and the difference between baseline and 12 months samples was 
statistically significant.  Higher butyrate and propionate to acetate ratios after the surgery 
compared to baseline indicates that there is a shift in microbial metabolism from acetate 
production to butyrate and propionate production.  Butyrate and propionate are molecules 
that can signal free fatty acid receptors, and induce satiety response in the brain (Lin et 
al., 2012), and shifts in microbial metabolism to produce more of them can be potential 
mechanisms that microorganisms contribute to weight loss.   
Table 7.2. Dry weight normalized concentrations of acetate, butyrate, propionate, 
propionate to acetate and butyrate to acetate ratios in NW, RYGB-base, RYGB-6m, and 
RYGB-12m, and RYGB-retro groups.  The numbers represent median values of the 
groups.  
 
 Propionate
/ Acetate 
Butyrate
/ Acetate 
Acetate Butyrate Propionate sCOD 
/tCOD* 
   µmoles/
g stool 
µmoles/g 
stool 
µmoles/g 
stool 
% 
NW 0.396 0.248 114.1 31.3 45.2 20 
RYGB-base 0.366 0.244 226.7 47.0 75.4 25 
RYGB-6m 0.375 0.267 240.8 61.1 103.4 22 
RYGB-12m 0.407 0.315 162.8 41.8 69.6 18 
RYGB-retro 0.408 0.343 182.7 68.6 81.4 21 
* %Soluble Chemical oxygen demand (sCOD) of total chemical oxygen demand (tCOD).  
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In order to evaluate fermentation efficiency within the groups, we measured total 
and soluble chemical oxygen demand (COD) of fecal samples collected from subjects 
and calculated % soluble COD (SCOD) of total COD (TCOD), SCOD is the soluble 
fraction of TCOD that does not include solids and is a good proxy of fermentation 
efficiency or soluble calories remaining in feces.  As seen in Table 7.2, %SCOD was 
greatest in the RYGB-base group and after the surgery the percentage dropped 
significantly.  Percentage of soluble COD was similar in RYGB-12m and RYGB-retro 
groups.  This finding indicated that due to differences in microbiome, a reduction in 
dietary calories (see Table 7.1), and microbial processes, the fermentation capacity of 
microbiome drops after the surgery.   
Accumlation of hydrogen gas, a fermentation end product, can mediate 
fermentation pathways (Samuel & Gordon, 2006)  the type and abundance of hydrogen 
consuming microorganisms will affect fermentation end products and their ammounts.  
Figure 7.5 shows abundances  of fthfs, mcrA, and dsrA genes for homoacetogenesis. 
methanogenesis, and sulfate reduction, respectively.  The copy numbers of the genes for 
methanogenesis and sulfate reduction were relatively lower than the genes for 
homoacetogenesis (Figure 7.5A).  We observed an increase in fthfs copy numbers after 
RYGB surgery although these results were not similar to what we observed on the 
RYGB-retro group.  mcrA copy numbers were significantly lower in the obese(-) group 
compared to the others.  dsrA copy numbers did not significantly vary among the groups.  
Figure 7.5B demonstrates the expression levels of these genes before and after the RYGB 
surgery.  RYGB-base group had the highest expression of fthfs gene and the lowest 
expression of the mcrA gene. 
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Previously, higher levels of methanogens were observed in obese populations in 
comparison to normal weight populations (Mathur et al., 2013).  High levels of 
methanogens were also observed in anorexic individuals compared to normal-weight 
individuals (Armougom, Henry, Vialettes, Raccah, & Raoult, 2009).  In our study, 
methanogens were almost non-detectable in many of the subjects from RYGB-base group 
hence this is different to the previous reports where methanogens are associated with 
obese phenotype (Mathur et al., 2013).  Our presurgical morbidly obese population was 
on negative energy balance, this probably changed their gut microbial ecology and its 
interpretation based on host phenoytype.  Breath hydrogen concentrations were not 
significantly different among the groups, even though there was an increase in breath 
hydrogen concentration after the surgery.  This finding indicated that subjects in this 
study either did not generate significantly different amounts of hydrogen or had similar 
levels of hydrogen consumption activity.  The expression of mcrA gene was relatively 
higher after the surgery and this finding was consistent with breath methane 
concentrations observed among the groups (Figure 7.5C).   Similar to mcrA gene 
expression, dsrA expression was greater after the surgery.  After the surgery, the subjects 
increased their protein consumption (Table 7.1), which might explain higher dsrA 
expression, an indication of sulfate reduction.  Previously, animal based diets, which 
contain high levels of protein and fat, were shown to increase sulfate-reducing 
microorganisms (David et al., 2014).   
The expression results of hydrogen consumer genes were similar between RYGB-
12m and RYGB-retro groups, which indicated RYGB surgery affects microbial hydrogen 
metabolism and have an impact on fermentation efficiency. 
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Figure 7.5.  Hydrogen consumers in RYGB-base, RYGB-m6, RYGB-m12, and 
RYGB-retro (retrospective RYGB subjects) subjects.  A) Q-PCR analysis of genes that 
are involved in hydrogen consumption: fthfs for homoacetogens, mcrA for 
methanogenesis, and dsrA for sulfate reducers.  B) Expression of fthfs, mcrA, and dsrA 
genes.  C) Breath hydrogen and methane concentrations before and after the RYGB 
surgery. 
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We looked also at abundance of branched-chain-amino-acids, as these were 
important findings in chapter 5. Fermentation of branched-chain-amino-acids increased 
after RYGB surgery. As seen in Figure 7.6A, the fecal concentrations of branched-chain-
fatty-acids: isobutyrate and isovalerate increased after RYGB.  The RYGB-retro and 
RYGB-12m groups had similar concentrations of these BCFAs; therefore we can deduce 
that an increase in the abundance of these BCFAs is a result of changes induced by 
bariatric surgery.  Branched chain amino acids (BCAA): leucine, isoleucine, and valine 
were at significantly lower abundance 12 months after the surgery and their 
concentrations were comparable among RYGB-retro and RYGB-base groups, despite a 
higher protein consumption by this group (Figure 7.6C).  Even though BCAA 
concentrations were variable, their fermentation products were always greater post-
RYGB.  Figure 7.6B shows that microorganisms in the human gut can ferment branched-
chain amino acids such as leucine and isoleucine to branched chain fatty acids: 
isobutyrate and isovalerate.  These species among others got enriched after RYGB.  In 
summary, BCFA usually produced microbially from BCAA were at higher 
concentrations after surgery, BCAA were at lower concentrations despite higher protein 
consumption suggesting that higher BCFA concentrations were due to after RYGB 
induced higher microbial conversion rates from BCAA to BCFA.  Overall, changes in 
microbiome due to RYGB surgery potentially alter luminal amino acid metabolism, and 
can contribute to weight loss by producing branched chain fatty acids that are capable of 
signaling free fatty acid receptors (Newgard et al., 2009).   
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Figure 7.6.  Branched chain amino acid and fatty acid metabolism.  A) Branched chain 
fatty acids: isobutyrate and isovalerate measure with NMR after RYGB surgery 
prospectively and retrospectively.  B) Concentrations of isoleucine, leucine, and valine, 
branched-chain-amino-acids (BCAA) measured with NMR after RYGB surgery 
prospectively and retrospectively.  C) Microorganisms enriched post surgery that convert 
BCAA into branched chain fatty acids (BCFA).  The color pattern in figure 7.2 was 
followed and colors: purple, light orange, orange, and pink represent RYGB-base, 
RYGB-6m, RYGB-12m, and RYGB-retro groups, respectively.  
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Besides SCFAs and BCFAs, we analyzed widespectrum of metabolites.  Most of 
the metabolites detected with H-NMR and GC-MS were at greater abundance in the 
RYGB-baseline group and after the sugery their concentrations dropped (Tables 7.3 and 
B.1).  Considering that fecal water was analyzed with NMR and lyophilized fecal matter 
was analyzed with GC-MS, we observed variations in the metabolites detected with these 
techniques.  NMR technique provided mainly volatile and water-soluble compounds, 
whereas GC-MS identified many metabolites of the undigested nutrients and components 
of microbial cells. The majority of the metabolites detected were significantly more 
abundant in the baseline samples compared to 12-months after the surgery samples, 
however as shown in Table 7.3 besides isovalerate and isobutyrate, concentrations of 
xylose and isopropanol increased after RYGB surgery.  Greater abundance of fecal 
xylose after the surgery indicates whether the subjects adapted more plant based diets, or 
they lost some microbial hydrolytic capabilities to breakdown xylose.  Fiber intake of the 
subjects did not increase or decrease significantly after the surgery, although it was 
statistically lower in post RYGB subjects compared to NW subjects.  Our results on fiber 
intake along with fecal xylose lead us to speculate that a reduction of microbial pathways 
that are involved in xylose degradation occurred after RYGB surgery.  An increase in the 
concentration of isopropanol after the surgery is possibly due to enrichment of Clostridia 
species in the lumen, as many Clostridia species are known to produce isopropanol (Lee, 
Chou, Ham, Lee, & Keasling, 2008).  Although health effects or weight loss effects of 
isopropanol on host physiology are unknown, increased concentrations of isopropanol 
accompanied with weight loss suggest that isopropanol might be a future target for 
microbiome associated weight loss detection and enhancement strategies. 
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Table 7.3. Dry weight concentrations of luminal metabolites that were statistically 
different between RYGB-baseline and RYGB-12months samples. 
 
 
 NW RYGB 
baseline 
RYGB-
6months 
RYGB-
12months 
Alanine 10.05 16.49 9.72 6.89 
Cadaverine 0.22 0.77 0.58 0.73 
Glucose 5.84 26.14 6.08 3.94 
Glutamine 3.54 5.83 2.61 2.54 
Isopropanol 0.17 0.08 0.20 0.20 
Methanol 0.92 1.70 1.10 0.67 
Succinate 2.89 4.56 2.51 2.06 
Taurine 0.66 1.31 1.00 0.85 
Threonine 1.01 1.94 0.70 0.68 
Thymidine 0.00 8.00 0.00 0.00 
Tyrosine 0.24 0.82 0.00 0.00 
Uracil 0.66 1.52 0.76 0.52 
Uridine 4.99 7.80 4.84 3.40 
Valerate 2.47 3.38 1.85 2.05 
Valine 0.00 1.31 0.00 0.00 
Xylose 7.92 9.57 13.92 16.36 
Leucine 6.65 9.74 6.06 5.55 
Lysine 4.44 7.38 3.76 2.54 
Isoleucine 5.40 9.03 5.14 3.96 
Isovalerate 4.97 5.04 7.00 9.32 
Isobutyrate 4.83 5.99 6.92 9.12 
 
Based on GC-MS results, amino acids and sugars were mainly at greater 
abundance at baseline compared to 6-months and 12-months (Table B.1).  Concentrations 
in the RYGB-retro group were similar to RYGB-12m group.  This could be due to 
unvarying post-RYGB diets in combination with the altered GI tract due to surgery.  
Interestingly, the concentrations of many saturated fats increased after the surgery.  This 
could be due to a reduction of fatty acid absorption and reduced bile acid secretions (see 
below) due to the altered GI after the surgery. 
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7.4 RYGB Surgery Drops Fecal Bile Acid Concentrations  
Figure 7.7 shows the fecal bile acids measured at baseline, 6 months and 12 
months after the RYGB surgery.  Fecal concentrations of primary bile acids: CA and 
CDCA and their glycine and taurine conjugated forms (TCA, GCA, TCDCA, and 
GCDCA) significantly dropped 6 months after the surgery, and remained at similar 
concentrations even at 12 months after the surgery, as seen in Figure 7.7A.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.7.  Fecal bile acids measured before and after RYGB surgery.  A) Fecal primary 
bile acids.  B) Fecal secondary bile acids that are produced by gut microbiota.   
C) Bile acid biosynthesis genes predicted via PICRUSt.  D) Fecal bile acid and 
microbiome co-occurrence network based on Spearman’s rho correlation coefficient.  
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Figure B.2 illustrates the conjugation and transformation reactions of CA and 
CDCA and secondary bile acids produced from them by gut microbiota.  Our findings 
show that not only primary bile acids, but also microbially produced secondary bile acids 
significantly diminished after RYGB surgery, possibly due to less amounts of primary 
bile acids.  Interestingly, abundances of PICRUSt (Langille et al., 2013) predicted genes 
(Figure 7.6C) of secondary bile acid biosynthesis were greater after the surgery even 
though the secondary bile acid concentrations dropped after the surgery.   
The concentrations of secondary bile acids, solely produced by the gut microbiota 
(Jason M. Ridlon, Kang, Hylemon, & Bajaj, 2014), were also greater at the baseline in 
comparison to 6 months or 12 months after the surgery.  As seen in Figure 7.7B, the 
concentrations of the following secondary bile acids: LCA, its glycine conjugated form 
GLCA and taurine conjugated DCA (TDCA) significantly dropped after surgery.   
Table B.2 summarizes the median concentrations of primary and secondary bile 
acids observed in NW and retro-RYGB groups in comparison to RYGB-12m and RYGB-
base groups.  The concentrations observed in RYGB-retro group were similar to the 
RYGB-12m group, which indicates that the response of surgical modification on bile acid 
metabolism is very strong and can be predicted even if the baseline time-points before the 
surgery are missing.  Interestingly, bile acid levels of post-RYGB groups were similar to 
NW.  Overall, our findings indicate that fecal concentrations of primary and secondary 
bile acid drop after RYGB surgery, and lower levels that are similar to normal-weight 
individuals were maintained even years after the surgery.   
Considering that gut microbiota can produce secondary bile acids (J. M. Ridlon, 
Kang, & Hylemon, 2006) and deconjugate primary bile acids (Jason M. Ridlon et al., 
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2014), and concentrations of bile acids can affect gut microbiota composition (Jason M. 
Ridlon et al., 2014), we performed co-occurrence network analysis between order-level 
microbial phylotypes and bile acids.  As shown in Figure 7.7D, many secondary bile 
acids such as TDCA, HDCA, GDCA, TLCA, and GLCA positively correlated with 
Actinomycetales and Turicibacteriales phylotypes, Actinomycetales contain primary bile 
acid hydrolyzing microorganisms (Islam et al., 2011), although microorganisms from the 
Turicibacteriales order have not been previously described as secondary bile acid 
producers.  Bifidobacteriales order positively correlated with primary bile acid 
concentrations: CA, GCA, and GCDCA.  Strikingly, Fusobacteriales, which gets 
enriched after RYGB negatively correlated with the concentrations of those primary bile 
acids. 
Our findings are different to previous studies (Pournaras et al., 2012; Sayin et al., 
2013), which reported increased bile acids, especially secondary bile acids after RYGB 
surgery in blood samples.  One difference among those studies and ours is that we 
measured fecal samples whereas the others measured serum ones; hence these findings 
are not comparable.  Fat and cholesterol intake play a big role in the production and 
secretion of bile acids (Jason M. Ridlon et al., 2014).  As seen in Table 7.1, the subjects 
did not reduce the fat % of their diets although they consumed lower calories after 
RYGB, which overall leads to lower amounts of fat being consumed.  Lower delivery of 
fat to the GI tract might have played a role in the lower concentrations of primary and 
secondary bile acids measured in this study in feces. 
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Given that bile acids have been reported to modify the gut microbiome (Jason M. 
Ridlon et al., 2014), lower delivery of bile acids to the colon might have played a role on 
some of the microbiome compositional changes observed.  
7.5. Mucosal-microbiome structure and composition changed after RYGB.   
We expand our analysis on gut microbiome and also investigated whether 
changes in the luminal microbiome were prominent in the mucosal microbiome as well. 
Using weighted and un-weighted Unifrac metrics (Lozupone et al., 2006), we 
investigated changes in mucosal and luminal communities after RYGB.  As seen in 
Figure 7.8A, the location microbes occupy in the colon (luminal or mucosal) had the 
greatest effect on clustering based on unweighted Unifrac metric, which enhances the 
differences in microbiome based on presence of unique phylotypes allowing to quantify 
changes in minor taxa.  This change was statistically different, this is illustrated in Figure 
7.8B.   
A key difference between mucosal and luminal surfaces is the substrates that are 
available to microorganisms; in luminal surfaces, substrates are usually dietary molecules 
whereas in mucosal surfaces they are host-derived glycans (Hooper et al., 2002).  
Another difference is the electron acceptor type on mucosal and luminal surfaces (Espey, 
2013).  Oxygen derived from the eukaryotic tissues is gradually depleted in the mucosal 
layer by facultative anaerobes and therefore, luminal surfaces become anaerobic 
(Zoetendal et al., 2002).  Microorganisms that live on luminal surfaces are also affected 
by other host-associated factors such as transit time, frequency of dietary intake and bile 
acids (G. T. Macfarlane & Macfarlane, 1993).   
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Figure 7.8.  Mucosal and luminal microbiome after RYGB surgery.  A) Unweighted 
Unifrac analysis of luminal and mucosal samples after RYGB.  B) Location of mucosal 
and luminal samples on PC1 coordinate.  The location of mucosal RYGB-12m samples 
was significantly different than other mucosal and closer to luminal samples.  C) Genus-
level phylotypes that were significantly higher after RYGB surgery in the mucosa.  
 
The effect of surgery on mucosal microbiome is reflected on PC1; before and 
after surgery samples formed two separate clusters (Figure 7.8A).  Additionally, mucosal 
baseline RYGB and RYGB-12m samples were distant from the mucosal NW samples.  
Interestingly, mucosal microbiomes after RYGB were more similar to luminal 
communities than the mucosal microbiome of presurgical morbidly obese and normal 
weight individuals.  Based on unweighted Unifrac distances, RYGB-12m mucosal 
samples appeared closer to luminal samples than mucosal samples on PC1, which 
indicated that possible outward movement of mucosal microbiome towards lumina or 
   150 
inward movement of luminal microbiome towards mucosa after RYGB surgery.  This 
finding indicated that possibly due to a reduction in the nutrient stream, luminal 
microbiota moved towards to mucosa for resources and colonized the mucosal surfaces, 
which resulted in the observation of luminal phylotypes in the mucosal space.  
Mucosal microbial communities are important in obesity and diabetes research 
because inflammation has been suggested as one of the factors that contribute to 
development of these conditions (Devaraj, Hemarajata, & Versalovic, 2013).  Previously 
disrupted gut barrier has been associated with the development of obesity and 
inflammation (Brun et al., 2007) and microbiome has been associated with obesity and 
inflammation in animal studies (Everard et al., 2013).  Mucosal microbiome 
characterization in the context of obesity has been limited to only a few animal studies 
(Cani et al., 2007; Everard et al., 2013; Kellermayer et al., 2011) and changes in mucosal 
microbiome has not been characterized for post-RYGB subjects.  Our findings contribute 
to the understanding of microbiome changes in the context of weight loss both in the 
luminal and the mucosal space.  Additionally, both short-term and long-term changes in 
the luminal microbiome structure have not been evaluated until our study.  Our data 
showed that the luminal microbiome changes as early as 6 months after surgery and that a 
unique RYGB luminal microbiome gets established and is sustained in the longer-term or 
at least until one year post surgery.   
Six genus-level phylotypes got significantly enriched in the mucosa after RYGB 
surgery; these phylotypes were Granulicatella, Lactococcus, Streptococcus, Blautia, 
Dorea, and Akkermansia, as shown in Figure 7.8C.  Relative abundances of these 
phylotypes were also greater in the NW mucosa compared to the RYGB-baseline 
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mucosa.  After the surgery, abundances of these phylotypes in the RYGB mucosa became 
similar to the abundance observed in the NW mucosa.  Besides Akkermansia, the 
remainder microorganisms are from Firmicutes phylum and have capabilities to form 
biofilms and play a role in lactate metabolism (Antharam et al., 2013).  Lactococcus, 
Streptococcus, and Granulicatella are lactate-producing microorganisms, whereas Dorea 
and Blautia are lactate oxidizers (Jost, Lacroix, Braegger, & Chassard, 2013).  
Streptococcus and Lactococcus species have been used as probiotics to enhance gut 
barrier and integrity (Radha & Goethe, 2013); weak gut barrier has been associated with 
the development of fattiness (Everard et al., 2013).  Akkermansia is a known mucin 
degrader, and in animal models, its presence has been shown to improve gut barrier, 
reduce fattiness of the host organs, and protect against insulin resistance and obesity 
(Derrien, Vaughan, Plugge, & de Vos, 2004; Everard et al., 2013).  An increase in the 
relative abundance of Akkermansia in mice after RYGB has been reported (Liou et al., 
2013) and previously by our group in human fecal samples (Zhang et al., 2009),  our 
results validate these findings.   
Conclusion 
 
We demonstrated the impact of RYGB surgery on gut microbiome, metabolome, 
and bile acid concentrations.  Changes in fecal metabolome mirrored the changes in 
luminal microbiome, which showed that composition and quantities of dietary 
compounds reaching the colon were altered after the surgery, hence substrate availability 
to the gut microorganisms was altered too.  As a result microbial metabolite profiles 
changed after the surgery.  Bile acid delivery to the colon diminished after the surgery 
and as a result microbiome and metabolome profiles were affected.  For the first time, we 
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showed that changes in gut microbiome after RYGB are not limited to luminal space; due 
to surgical alterations and nutritional limitations; microorganisms of the mucosal space 
were permanently transformed too.  The changes in microbiome were more prominent in 
the luminal space; possibly due to greater environmental changes occur in lumina than 
mucosa after RYGB.   
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CHAPTER 8 
KEY FINDINGS AND RECOMMENDATIONS FOR FUTURE WORK 
8.1. Key Findings 
 The gut microbiome has been associated with development of obesity, but 
microbiome structure and function in weight-gain and weight-loss have not been fully 
explored due to the complexity of the problem.  Bariatric surgery provides a unique 
aspect to obesity-microbiome research, because it alters the conditions in the gut and in 
return changes the microbiome and it makes it possible to study changes in microbiome 
in the context of sustainable weight loss.  My research advances the knowledge on 
microbiome in obesity, surgical weight loss and host energy metabolism.  My work 
details and provides comprehensive analysis on; (i) how environmental factors such as 
gut pH after bariatric surgery affect the microbiome, (ii) differences in microbiome 
structure of different post-bariatric surgery patients, (iii) the contribution of microbiome 
to sustainable weight loss, and (iv) spatial and temporal changes in microbiome after 
Roux-en-Y gastric bypass surgery.  
 After Roux-en-Y gastric bypass, reduction in gastric acid secretions and 
rearrangement of the gastrointestinal tract alter colonic environment (Aron-Wisnewsky et 
al., 2012).  Reduction in gastric acid secretion due to proton pump inhibitors has been 
shown to affect gut microbial communities (Seto et al., 2016).  A possible explanation of 
the altered microbiome after RYGB could be increased pH along the gastrointestinal 
tract.  Typically, microorganisms of the oral cavity and ingested microorganisms through 
our diets are eliminated in the stomach or small intestine due to harsh acidic conditions 
(Lang et al., 2014).  Lower gastric acid exposure after RYGB might enhance the survival 
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of oral microorganisms in the colon.  In Chapter 3, I evaluated whether small differences 
in colonic pH with varying levels of buffering has an impact on development of microbial 
communities from fecal inoculum and community function.  My fecal enrichment 
cultures at three different initial pH (6.0, 6.5, and 6.9) showed that even small differences 
in pH could set off great differences in microbiome structure and function.  Abundances 
of microbial phylotypes from Streptococcus and Veillonella, Bacteroides and 
Escherichia; phylotypes commonly found in dental plaques (Al-Ahmad et al., 2007) 
responded differently to the varied  pH conditions..   
Besides their growth, these microorganisms’ functions and microbial interactions 
were mediated by pH.  In Chapter 4, I investigated the impact of small variations in 
starting pH on metabolic interactions of lactate-producing and -consuming communities.  
After enriching these microorganisms at different initial pH, I characterized their 
metabolisms and functions in mono- and co-cultures.  I demonstrated that Veillonella and 
Streptococcus enhance each other’s growth and metabolism, whereas versatile 
microorganisms that contribute to redundancy of gut function such as Bacteroides do not 
rely on other microorganisms to provide resources.  Due to sensitivity of Veillonella to 
acidic environments, lactate produced by Streptococcus accumulated at pH 6.0, and 
Veillonella fermented lactate into acetate and propionate at pH 6.5 and 6.9.  Our results 
from this chapter provide insights into pH-derived changes in gut microbiota and 
metabolism after RYGB. 
 In Chapter 5, I demonstrated differences in microbial community structure and 
function in patients that underwent two different types of bariatric surgeries: Roux-en-Y 
gastric bypass (RYGB) and laparoscopic adjustable gastric banding (LAGB).    
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Differences in microbiome in post-RYGB and nonsurgical controls have been 
demonstrated before (Zhang et al., 2009, Tremaroli et al., 2015) although findings were 
summarized for bariatric surgeries in general.  Since LAGB surgery is relatively 
unsuccessful compared to RYGB, I tested the hypothesis that microbiome evolves 
differently after different types of bariatric surgeries, and have varying effects on weight 
loss.  The greater changes imposed on microbiome after RYGB due to anatomical 
rearrangement compared to LAGB resulted with different microbiomes and different 
weight loss achievements.  Different microbiomes as a result of different surgeries 
affected the distribution of fermentation end products.  Branched chain fatty acids that are 
fermentation products of branched chain amino acids were greater in fecal metabolomes 
after RYGB compared to LAGB or nonsurgical subjects.  Furthermore, our work also 
showed that microbial products that are associated with appetite regulation such as 
butyrate and propionate were significantly higher in post-RYGB subjects compared to 
post-LAGB subjects.   
 After identifying key differences in microbiome structure between LAGB and 
RYGB surgeries, I focused on microbial components that made RYGB surgery more 
successful.  Even though RYGB microbiome structure has been known, which gut 
microbes or microbial metabolites contribute to the success of the surgery is unknown.  
In Chapter 6, I first addressed the problem of defining successful surgery, as the 
definition can be relatively subjective.  In the scope of this chapter, I found that 
Fusobacterium consistently shows up in unsuccessful subjects regardless of the definition 
of success.  In this chapter, I also showed that putrescine, a microbial degradation product 
of ornithine, which was produced by mainly Fusobacterium, was at greater concentration 
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in unsuccessful subjects.  Putrescine has been associated with weight gain in animals, 
therefore my results from this chapter indicate that putrescine along with Fusobacterium 
could be important targets to manage the success of RYGB surgery.  
 Human microbiome research, especially in the context of obesity, has relied 
heavily on cross-sectional studies based on single time-point stool collections.  Therefore, 
it was essential to investigate longitudinally luminal and mucosal changes in the gut 
microbiome after RYGB surgery.  In Chapter 7, I documented those microbial and 
metabolic changes in the luminal space 6 months and 12 months after RYGB as well as 
previously undocumented changes in mucosal microbiome after RYGB surgery.  My 
findings reveal that changes in microbiome occur in the luminal and the mucosal space 
and the scale of changes in the luminal space are much greater.  I also demonstrated that 
wide-spectrum changes in gut metabolism, from microbially produced fatty acids, amino 
acid degradation products to altered bile acids, occur as short as 6 months after RYGB 
and permanent.  Additionally, by comparing the results of this cohort study to the 
findings of Chapter 5, which is a case control study, I demonstrated the microbial and 
metabolic changes after RYGB are due to surgery and not due to diet or other 
interpersonal variations.   
Finally, I present research ideas that can enhance microbiome research in the field 
of obesity, and for continuation of this dissertation.  
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8.2 Recommendations for future work 
8.2.1 Develop Continuous Flow Stirred Reactors to Understand Early Colonization of the 
Gastrointestinal Tract and Factors that Can Affect Colonization 
 The pH and substrate gradients along the gastrointestinal tract (GI) initiate 
colonization of microorganisms to different sections of the colon.  Moreover, many oral 
and food associated microorganisms that are acid-sensitive and cannot colonize the gut 
because the gastric acid in the GI tract eliminates them (Lang et al., 2014).  Small 
changes in colonic pH after RYGB surgery due to reduced gastric acid secretions could 
be a major factor affecting the development of post-RYGB microbiome.  In Chapter 3, I 
demonstrated that small differences in initial pH have tremendous effects on the 
development of fecal communities, and especially microorganisms involved in lactate 
and propionate metabolism.   
Findings from Chapter 3, Chapter 4, and reports from the literature suggest that 
RYGB surgery interferes with the colonization of oral or diet-associated microbiome in 
the downstream GI tract. To better understand colonization of the gut under the influence 
of gastric pH and after RYGB, I propose to develop continuous stirred flow reactors 
(CSTRs) in sequence similar to the human gut reactor Simulator of Human Intestinal 
Microbial Ecology (SHIME) (Molly et al., 1994) but with more components.  One CSTR 
will generate the oral microbiome and be fed twice daily with a media representing the 
average Western diet (McDonald et al., 2013).  The “oral” CSTR will be connected to 
two stomach CSTRS in parallel.  Both stomachs will have same amount of acid, the pH 
will set between 1-2. The first stomach reactor will retain contents of oral CSTR for one 
hour, i.e. a normal GI tract, whereas the second one for 15 minutes, i.e. the RYGB GI 
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tract.  Both stomach CSTRs will deliver their contents to two separate and additional 
CSTRs that represent colons.  The first colon CSTRs for both RYGB and normal GI 
reactors will have fecal seeds; the second CSTRs will be sterile from the beginning to 
understand microbial community function.   
This design will allow the researcher to test two kinds of hypotheses:  First, 
reduction in gastric acid secretions or lower exposure time to gastric acid after RYGB 
allows survival of pH sensitive microorganisms from the oral cavity or food.  Second, 
changes in gastric acid production after RYGB changes the microbial interactions and 
synthrophies in the colon.   
8.2.2 Role of Branched Chain Amino Acids and Fatty Acids on Host Energy Regulation 
 
Gut microbiota ferments dietary carbohydrates and produce mainly short chain 
fatty acids (SCFAs) (acetate, propionate, and butyrate), and some minor products such as 
hydrogen gas (Macfarlane & Macfarlane, 2003).  Fermentation of proteins yields SCFAs 
and many phenoloic and indolic compounds.  Fermentation of branched chain amino 
acids (leucine, valine and isoleucine) produces branched chain fatty acids (isobutyrate, 
isovalerate, 2-methylbutyrate (Windey et al., 2012).   
Protein fermentation in the gut is limited due to efficient digestion and absorption 
of dietary proteins in the duodenum and small intestine (Borgstrom et al., 1957); 
therefore protein fermentation products are often neglected in gut microbiome studies.  
Protein fermentation products were previously observed at greater concentrations in the 
subjects that were on animal-based diet compared to plant-based diet (David et al., 2014) 
and in subjects with colorectal cancer (Wang et al., 2012). 
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SCFAs produced by gut microbiome can interact with the host epithelial cells; for 
instance, butyrate is the energy source of colonyctes, and a reduction in its production 
was associated with the weakening of the integrity of the colonic epithelial layer (Wang 
et al., 2012).  SCFA can also serve as signaling molecules for endogenous free fatty acid 
receptors and protect against diet-induced obesity (Lin et al., 2012).  Furthermore, 
isobutyrate and isovalerate have been shown to signal those receptors (Di Paola & 
Lorusso, 2006), but did not receive much attention due to their lower concentrations in 
the gut.   
In Chapter 5, 6, and 7, I demonstrated BCFAs (isobutyrate and isovalerate) were 
at greater concentrations in post-RYGB subjects, mainly in the highly successful ones.  
Subjects that undergo RYGB surgery often develop malabsorption against some nutrients 
and proteins are speculated to be one of those (Odstrcil et al., 2010).   
I propose to study the effect of greater production of these BCFAs on host 
metabolism and energy regulation.  Whether these products are more or less potent 
against these receptors are unknown.  For this study, I propose a colonic epithelial tissue 
culture study.  Main BCFA producers such as monocultures of Enterococcus (Hume et 
al., 2004) can be grown on BCAA media and the filtered supernatant of these media can 
be exposed on single layer of epithelial cells.  Using qPCR techniques, activities of these 
receptors can be quantified.  The proposed study will help the understanding of branched 
chain amino acid fermentation on host metabolism and, in particular, on signaling 
pathways.  It will also provide an understanding on how changes in the gut microbiome 
post-RYGB can alter host metabolism. 
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8.2.3 Understand the Role of Hydrogen on Energy Regulation 
The role that gut microorganisms play in host weight gain or loss is unknown.  
However, the products of fermentation, like short chain fatty acids (SCFAs) and gases 
(CO2, H2, CH4), are known to contribute to host energy balance (Boden & Shulman, 
2002).  Therefore, it stands to reason that microbial fermentation products regulate 
weight gain and loss.  The main SCFAs of the human gut microbiota are acetate, 
propionate, and butyrate (Macfarlane & Macfarlane, 1993) and an increase in the fecal 
acetate concentration is associated with weight gain (Jumpertz et al., 2011), because 
acetate can be converted into fat by the liver (Yamashita et al., 2001).  In contrast, fecal 
propionate is associated with weight loss via a mechanism that involves appetite 
regulation (Sleeth et al., 2010, Arora et al., 2011).  
Acetate-producing fermentative reactions evolve H2 gas, while propionate-
producing reactions consume H2 gas (Mitsumori & Sun, 2008).  Hydrogen accumulation 
inhibits acetate-producing fermentation (Shock & Helgeson, 1990) and stimulates 
propionate-producing reactions.  Besides propionate producers, H2 produced in the gut 
can be consumed by hydrogen-consuming microorganisms: methanogens, sulfate 
reducers, and homoacetogens (Gibson et al., 1990).  Methane and hydrogen have also 
been associated with host metabolism: breath methane and hydrogen concentrations were 
higher in obese subjects with greater body mass index than lower body mass index 
(Mathur et al., 2011, Mathur et al., 2013).  Moreover, methanogens in the gut were at 
higher abundance in the obese subjects compared to normal-weight or post-RYGB 
surgery subject (Zhang et al., 2009).  Other studies found methanogens detected at 
greater abundance in anorexic individuals (Armougom et al., 2009) and depleted in obese 
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individuals (Million et al., 2011).  Co-habiting the most abundant methanogen of the 
human gut: Methanobrevibacter smithii with a polysaccharide degrading bacteria: 
Bacteroides thetaiotaomicron in gnotobiotic mice showed that M. smithii enhances 
polysaccharide degradation and acetate production of B. thetaiotaomicron by removing 
the accumulated H2 (Samuel et al., 2007).  
In Chapter 7, I summarized the results for hydrogen and hydrogen consuming 
microorganisms.  It is necessary to study, in-vitro, how H2 partial pressure influences 
acetate and propionate production with a reactor that simulates the conditions of the 
human gut.  I propose to study this concept using a reactor that was developed in our 
laboratory, the Membrane Biofilm Reactor (MBfR) (Lee & Rittmann, 2000), which 
delivers a constant H2 partial pressure through hollow fibers.  Hydrogen-consuming 
microorganisms form biofilms by attaching to the membrane surface and consuming 
hydrogen.  The unique design of MBfR provides a steady H2 partial pressure while 
retaining microorganisms and mimicking the conditions in the gut, such as pH, 
temperature, and retention time.   
 I propose two hypotheses to be tested with this design: (1) H2 gas accumulation 
due to fermentative reactions in the gut promotes the production of the weight loss-
associated microbial metabolite propionate and inhibits the production of weight gain-
associated metabolite acetate.  (2) The type and abundance of H2-consuming 
microorganisms (homoacetogens, methanogens, and sulfate reducers) in the gut 
contribute to weight balance via acetate, methane, or H2S production.  By applying 
different constant H2 partial pressures to fermentative communities, and comparing the 
resulting microbiota and metabolites (especially acetate and propionate ratios), it will be 
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possible to identify how different H2 partial pressures shape gut microbiota and 
contribute to host energy balance.  
Identification of H2 gas-regulated gut microbial dynamics can lead to weight loss 
therapies by supplementing the gastrointestinal tract with right type of microorganisms 
(probiotics).  Obesity, a disease that affects millions of people and costs billions of 
dollars annually, often cannot be treated with exercise and diet regimens.  Gut 
microbiota-based approaches can provide cost-effective solutions.   
Findings from this study will enable subsequent studies that involve the transplant 
of laboratory-derived microbial cultures with desired properties to mouse gastrointestinal 
tracts and finally lead to clinical trials.  
8.2.4 Understand Gut-Brain Connection:  Develop Microcosms and Test What Makes 
Post-RYGB Microbiome Induce Weight-Loss 
 RYGB is considered as a metabolic surgery due to its beneficial effects on host 
health (Li et al., 2011).  It induces healthier dietary habits and improves physiology and 
psychology of the patients (Holsen et al., 2015).  Changes in hormonal response and 
metabolic improvement have been observed in a number of different studies (Vincent & 
le Roux, 2008, Berthoud et al., 2011, Nannipieri et al., 2013).  Additionally, 
neurobiological changes after RYGB has been reported (Romanova et al., 2004) and 
altered serotonin signaling has been shown in mice that underwent RYGB surgery 
(Carmody et al., 2015).   
Most recently, gut microbiome have been demonstrated to play a role in hormonal 
and neurobiological regulation (Lin et al., 2012, Sayin et al., 2013, Ryan et al., 2014).  
Given the evidence that gut microbiome can alter hormonal and neurobiological 
   163 
responses and alterations in those responses after RYGB were associated with weight 
loss, I propose to study changes in hormonal response and microbiome in humans and in 
animals after RYGB surgery.  The first phase of the study will be focusing on analysis of 
human microbiome before and after surgery along with fecal, urinary, and blood 
metabolomes and screening for hormonal and neurological changes in host body. This 
study will be the extension of Chapter 7, which includes an extra component of 
understanding of metabolic changes in the host physiology.    
I propose a more targeted approach for the second phase of this study.  After 
characterizing which microorganisms are associated with the induction of hormonal and 
neurological response, I propose the development of multiple-species microcosms that 
are involved in neurotransmitter and hormone production.  In particular, I propose the 
study of microorganisms that alter weight loss or behavior associated metabolites such as 
serotonin, peptide YY, and ghrelin which were associated with the regulation of host 
metabolism.   
Third phase of this study will include transplant the fecal microbiome into germ-
free mice from successful and unsuccessful RYGB subjects that did or not demonstrate 
altered hormonal response, weight loss and behavioral improvements. Microbiome 
transplants from the laboratory-developed microcosms to germ-free mice should be 
performed to demonstrate which microorganisms or microbial interactions are 
responsible of hormonal, neurological, and metabolic changes after RYGB.   
The outcomes of this study will strengthen the tie between microbiome and host 
energy balance, and also will show that RYGB is also a microbial surgery.  The findings 
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will also aid the development of microbiome-associated therapies on individuals with 
obesity, metabolic condition and psychological problems.  
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APPENDIX A  
MICROBIAL COMMUNITY STRUCTURE AND SUBJECT METADATA RESULTS 
THAT SUPPORT FINDINGS OF CHAPTER 5 
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Figure A.1.  Microbial community analysis of dominant OTUs after RYGB and LAGB 
surgeries compared to NW and PreB-Ob controls.  A) Weighted Unifrac analysis 
illustrated on Principal coordinates.  B) Median PC1 coordinates illustrated for each 
group. * Mann Whitney U test P < 0.05 and **Mann Whitney U test P < 0.01.  
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Figure A.2.  Unweighted Unifrac distance visualized on principal coordinates.  Color changes are based on body mass index 
(BMI), age, gender, total calories consumed, carbohydrate, lipid and protein fractions of the diet, and fiber consumption.
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Figure A.3.  Linear discriminant-effect score (LEFSE) analysis shown on a cladogram.  
A) Discriminant analysis comparing RYGB group to non-surgical group.  B) LAGB 
group vs nonsurgical group.  C) RYGB group versus LAGB group.  The blue shading 
represents possible microbial signatures of RYGB surgery, whereas red shading 
represents possible microbial signatures of LAGB surgery. The grey shading represent 
microbial signatures of non-surgical subjects. 
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Figure A.4. Box-plots representing median values for dietary composition of NW, 
RYGB, LAGB, and Ob(-) subjects.  
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Table A.1.  Median values of the items from the food frequency questionnaires that 
summarizes annual dietary habits of the subjects from NW, RYGB, LAGB, and PreB-Ob 
groups.  
 
 NW RYGB LAGB PreB-Ob 
Calories consumed 1371±313 1101±286 1332±473 1719±639 
Fat (gr) 51±9 51±16 56±12 82±31 
Fat % 36±6 39±5 43±7 40±4 
Saturated fat (gr) 17±4 15±5 20±4 25±9 
Saturated fat % 11±2 12±3 14±4 12±2 
Monounsaturated fat (gr) 20±5 21±6 26±7 32±13 
Polyunsaturated fat (gr) 10±4 11±3 13±4 18±8 
Protein (gr) 52±9 49±11 48±10 78±26 
Protein % 15±1 16±3 16±3 17±3 
Carbohydrates (gr) 198±41 116±94 168±52 222±72 
Carbohydrates % 47±5 45±6 41±7 44±5 
Cholesterol (gr) 142±22 151±63 254±112 240±98 
Fiber (gr) 15±7 13±4 13±7 19±6 
Alcohol % 2±3 0±2 0±2 0±2 
Sweets % 12±4 12±9 10±6 8±4 
Vitamin A  638±147 487±247 567±121 688±142 
Beta Carotene 5129±2708 2898±2403 2985±2647 4034±1385 
Vitamin C 85±31 69±36 48±46 71±32 
Vitamin E 7±3 7±3 6±2 9±3 
Vitamins B1 and B2 1±0 1± 1±0 1±1 
Niacin 15±1 13± 14±6 21±8 
Folate 494±54 315± 335±190 501±183 
Vitamin B6 2±0 1±0 1±1 2±1 
Calcium 688±136 568±196 627±189 813±293 
Zinc 9±2 8±1 7±2 11±4 
Iron 10±3 8±4 8±3 13±4 
Potassium 1955±450 1780±557 2003±714 2944±999 
Sodium 2188±486 1795±702 2381±683 3758±1569 
Magnesium 261±84 230±106 225±89 329±102 
All values are median ±median absolute deviation. 
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Table A.2.  Relative abundances of phylotypes at the phyla-level in NW, RYGB, LAGB, 
and PreB-Ob groups.  
 
 
 
Actinobacteria Bacteroidetes Firmicutes Proteobacteria Verrucomicrobia 
NW 1.0 ± .04 40.1±9.6 48.5±7.7 2.5±1.1 0.4±0.3 
RYGB 0.3±0.4 55.8±14.5 34.4±15.3 4.3±2.1 0.3±0.3 
LAGB 0.5±0.4 53.8±16.2 36.3±16.8 3.3±1.4 0.2±0.4 
PreB-Ob 0.2±0.1 52.2±12.6 42.2±7.5 3.2±1.6 0.1±0.4 
All values are median ±median absolute deviation. 
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Table A.3.  NMR detection of metabolites that were statistically different in the RYGB group compared to nonsurgical groups. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Padj values represent False Discovery Rate corrected MannWhitney U test P values.   
 
 
Compounds Median FDR Padj 
 NW PreB-Ob RYGB NW vs PreB-Ob NW vs RYGB RYGB vs PreB-Ob 
4-Hydroxyphenyl-
acetate 0.24±0.17 0.26±0.12 0.15±0.08 0.766 0.094 0.016 
Arginine 0.25±0.25 0.33±0.20 0.19±0.20 .095 0.827 0.013 
Glycocholate 0.27±0.20 0.11±0.11 0.00±2.62 0.552 0.006 0.047 
Histidine 0.58±0.35 1.05±1.12 0.69±0.26 0.370 0.736 0.451 
Isobutyrate 5.07±1.50 6.23±1.66 11.10±3.67 0.882 0.020 0.013 
Isovalerate 4.39±1.09 4.29±1.40 10.05±2.92 1.000 0.007 0.002 
Lysine 6.04±2.27 9.86±3.90 5.69±1.97 0.038 0.677 0.033 
Methanol 1.17±0.42 2.92±1.82 1.49±0.91 0.056 0.392 0.072 
Propionate 45.68±22.17 93.48±45.21 92.55±28.30 0.412 0.414 0.051 
Putrescine 0.00±0.00 0.00±0.00 0.19±0.01 0.766 0.222 0.587 
Serine 6.16±2.93 5.95±1.08 7.61±1.76 0.882 0.207 0.283 
Uracil 2.22±0.85 3.36±1.32 3.09±1.33 0.295 0.254 1.000 
Valerate 8.30±3.07 12.77±7.15 17.08±6.41 0.941 0.040 0.099 
o-Cresol 0.58±0.19 0.45±0.14 0.92±0.38 0.656 0.079 0.016 
β-Alanine 0.27±0.12 0.23±0.19 0.00±0.85 0.824 0.142 0.107 
198 
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Table A.4.  Physiological characteristics of microbiota composition among NW, RYGB, 
LAGB, and PreB-Ob groups.  The values represent median values.  Pairwise group 
comparisons with the Kruskal Wallis test showed no significant differences of the 
functional microbial fractions among the groups (FDR corrected P value > 0.05).  
 
 Gram (-) 
% 
Aerobes 
% 
Facultative 
anaerobes % 
Biofilm 
formers % 
Stress 
tolerant % 
NW 27.6 1.6 0.8 4.0 9.9 
RYGB 41.9 3.6 1.9 5.5 3.7 
LAGB 47.6 2.5 0.9 6.6 9.9 
PreB-
Ob 
46.8 5.0 0.0 5.2 1.1 
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APPENDIX B  
16S RRNA GENE SEQUENCING, METABOLITE, AND BILE-ACID RESULTS 
THAT SUPPORT FINDINGS OF CHAPTER 7
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Table B.1.  GC-MS analysis of fecal metabolites in NW, RYGB-base, RYGB-6m, and 
RYGB-12m subject groups.  Log2 transformed concentrations were reported. 
 
  RYGB-
base 
RYGB-
6m 
RYG
B-12m 
RYGB-
retro 
NW 
 
 
 
Amino acid 
l-leucine 3.68 1.62 1.51 2.85 3.69 
l-methionine 0.39 -1.49 -1.59 -0.19 0.55 
l-threonine -1.04 -2.23 -2.29 -1.33 -1.14 
l-valine 1.68 0.44 0.58 1.25 1.92 
l-alanine 3.80 3.32 3.09 3.73 4.10 
l-isoleucine 3.18 -0.34 -2.33 -1.24 -0.05 
Microbially 
produced 
amino acid 
dehydroalanine -2.43 -2.20 -2.00 -2.26 -2.27 
Nucleic 
acid 
uracil 2.12 1.46 1.16 2.04 2.51 
 
 
 
 
 
 
 
 
Saturated 
fatty acid 
heptadecanoic 
acid 
2.83 4.04 4.65 3.99 3.27 
octadecenoic 
acid 
6.05 7.27 7.78 7.21 7.21 
oleanitrile 0.63 1.36 1.54 0.93 0.77 
palmitic acid 7.33 8.26 8.63 8.11 7.72 
stearic acid 7.01 7.88 8.14 7.88 7.77 
pentadecanoic 
acid 
0.58 1.94 2.26 1.83 1.89 
arachidic acid 2.61 4.48 4.80 4.23 3.41 
linoleic acid 2.35 1.11 1.53 1.60 2.90 
heneicosanoic 
acid 
-0.93 0.50 0.31 -0.02 -0.37 
dodecanoic 
acid 
0.93 2.68 3.49 2.89 2.90 
dodecanoic 
acid 
0.93 2.68 3.49 2.89 2.90 
oleamide 2.20 2.93 3.03 3.31 3.23 
Short chain 
fatty acid 
l-(+)lacticacid 0.45 1.47 1.22 0.83 0.74 
 
 
Sugars 
pectin 1.69 -0.69 -1.50 0.33 1.36 
d-xylose 3.38 1.10 -0.79 2.21 2.97 
d-ribose 4.14 3.07 2.06 3.90 4.22 
d-fructose 2.10 0.07 -0.23 1.50 2.41 
d-glucose 4.01 1.82 1.92 3.18 3.65 
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Table B.2.  Primary and secondary bile acids measured in fecal matter from the subjects 
that formed NW, RYGB-retro, RYGB-12m, and RYGB-base groups.  P stands for 
primary bile acids and S stands for secondary bile acids. 
 
 
  
 Bile acid type  Acronym  Type NW RYGB-
Retro 
RYGB 
-12m 
RYGB-
base 
Chenodeoxycholic 
acid and 
deoxycholic acid 
CDCA 
and DCA 
P+S 5.17 4.38 4.50 5.61 
Cholic acid CA P 1.82 1.16 1.15 2.87 
Gylco-
chenodeoxy-cholic 
acid 
GCDCA P 0.56 0.63 0.01 2.28 
Taurocholic acid TCA P -0.02 -1.52 -1.25 -0.10 
Glycocholic acid GCA P 1.99 1.45 0.78 2.90 
Tauro-
chenodeoxy-cholic 
acid 
TCDCA P -0.47 -1.94 -2.09 0.00 
tauro-αmuricholic 
acid 
TalphaM
CA 
P -6.24 -7.57 -3.44 -7.88 
              
Taurohydroxy-
cholic acid 
THDCA S -5.78 -5.92 -5.28 -3.63 
Glycocholic acid GDCA S 0.39 0.13 -0.48 1.60 
Taurodeoxycholic 
acid 
TDCA S -0.88 -2.97 -2.64 0.15 
Lithocholic acid LCA S -0.55 -1.86 -1.56 0.38 
Glycolithocholic 
acid 
GLCA S -1.93 -1.18 -1.93 -0.50 
Taurolithocholic 
acid 
TLCA S -0.77 -1.09 -1.30 -0.13 
Hyacholic aicd HCA S -1.03 -1.89 -1.84 -1.59 
Ursodeoxycholic 
acid 
UDCA S -1.10 -1.08 -1.05 0.87 
Glycoursodeoxych
olic acid 
GUDCA S -3.87 -3.66 -4.11 -1.64 
Tauroursodeoxych
olic acid 
TUDCA S -7.80 -7.34 -6.69 -6.46 
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Figure B.1.  Weighted Unifrac analysis of mucosal and luminal communities.  A) 
Mucosal communities of NW, RYGB-base, and RYGB-12m groups.  B) Luminal 
communities of NW, RYGB-base, and RYGB-12m groups. 
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Figure B.2.  Transformation reactions of primary bile acids to their conjugated forms or 
to secondary bile acids.  CDCA and CA are two primary bile acids that are produced in 
the liver from cholesterol. They can be conjugated with glycine or taurine by the host.  
UDCA, HDCA, HCA, and LCA are all secondary bile acids derived from CDCA by gut 
bacteria. The gut bacteria can produce DCA from CA and its glycine and taurine 
conjugates.  CA=Cholic acid, DCA=deoxycholic acid, GDCA = glycodeoxycholic acid, 
TDCA= taurodeoxycholic acid, GCA= glycocholic acid, TCA=taurocholic aci. CDCA = 
chenodeoxycholic acid, LCA= lithocholic acid, HCA= Hyacholic acid, 
HDCA=Hyodeoxycholic acid, UDCA=Ursodeoxycholic acid, 
GUDCA=glycoursodeoxycholic acid, TUDCA= tauroursodeoxycholic acid, THDCA= 
taurohydroxydeoxycholic acid, GLCA= glycolithocholic acid, TLCA=taurolithocholic 
acid, GCDCA= glycochenodeoxycholic acid, TCDCA=taurochenodeoxycholic acid, 
αMCA=α-muricholic acid, βMCA = β-muricholic acid. 
 
 
 
 
 
 
